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ABSTRACT 
The intestinal epithelium acts as a barrier that excludes external molecules from the tissues 
beneath. Defects in this barrier function are increasingly associated with pathological states, 
including inflammatory bowel disease, irritable bowel syndrome, coeliac disease, obesity and 
food allergies. Understanding of epithelial biology and barrier function has been limited by a 
lack of physiologically representative in vitro models. Identification of intestinal epithelial stem 
cells and recent methodological advances have allowed intestinal stem cells to be cultured so 
that they proliferate, differentiate and self-assemble to mimic in vivo tissue architecture, 
forming a continuous epithelium around a hollow central lumen, known as an enteroid.  
The initial aim of this study was to evaluate the extent to which mouse small intestinal 
enteroids simulate their parent tissue. The second intention was to investigate whether this 
system can be used to model barrier function of both villous epithelium and specialised areas 
of epithelium overlying gut-associated lymphoid tissues, where antigen sampling occurs due to 
the presence of rare phagocytic M cells.  
Enteroids were shown to contain all major epithelial cell lineages and to retain region-specific 
differences in the distribution of cell types that are observed in vivo. An assay based on 
leakage of a fluorescent was developed to allow investigation of epithelial barrier function in 
3D enteroids. Peptide fragments of dietary gliadin were used to probe the ability of enteroids 
to model barrier function, since they are involved in the pathogenesis of coeliac disease and 
have been linked to increased epithelial permeability. A peptide spanning α-gliadin amino 
acids 56-68 induced rapid, dose-dependent luminal fluid secretion via activation of an apical 
chloride channel, the cystic fibrosis transmembrane regulator. In contrast, a second peptide 
had no effect on fluid secretion.  
Regarding modelling the follicle-associated epithelium, it was confirmed that M cell 
differentiation is stimulated by treatment of enteroids with the cytokine RANKL. Alternative 
pathway NF-κB signalling was required, as M cell-associated gene expression was not 
upregulated in RelB- or NF-κB2-deficient enteroids. As previously suggested, co-culture with B 
cells also appeared to promote M cell differentiation, although their presence was insufficient 
to induce mature M cells. Finally, plasmid constructs were generated to express a fluorescently 
labelled bacterial surface adhesion molecule for microinjection into the enteroid lumen. As a 
tool, this will allow modelling of bacterial adhesion to, and translocation by, enterocytes and M 
cells. 
This work supports a growing body of evidence showing that enteroids accurately reproduce in 
vitro many characteristics of the small intestinal epithelium. It is demonstrated that enteroids 
can be used to model barrier function, fluid secretion and the role of epithelium-intrinsic 
factors in differentiation of a rare cell lineage. Further assay developments will likely result in 
more widespread use of enteroids for various applications, including basic research, 
therapeutic screening and drug development. 
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ABBREVIATIONS USED 
AUC Area under the curve  
ANOVA Analysis of variance 
cAMP Cyclic adenosine triphosphate 
CFTR Cystic fibrosis transmembrane regulator 
CFTR-inh-172  Cystic fibrosis transmembrane regulator inhibitor 172 
CgA Chromogranin A 
DCLK1 Doublecortin like kinase 1 
ddH2O Double distilled water 
DMEM Dulbecco’s modified Eagle’s medium 
DMSO Dimethylsulfoxide  
EDTA Ethylenediaminetetraacetic acid 
EGF Epidermal growth factor 
EGTA Ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid 
FAE Follicle associated epithelium 
FD4 Fluorescein isothiocyanate-conjugated 4 kDa dextran 
GALT Gut-associated lymphoid tissue 
GP2 Glycoprotein 2 
GST Glutathione S-transferase  
IBD Inflammatory bowel disease 
IBS Irritable bowel syndrome 
IgA Immunoglobulin A 
IKK IκB kinase 
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IPTG Isopropyl β-D-1-thiogalactopyranoside 
LB Lysogeny broth 
LPS Lipopolysaccharide  
Lyz Lysozyme 
MAPK Mitogen-activated protein kinase 
M cell Microfold cell 
NCWS/NCGS Non-coeliac wheat sensitivity/non-coeliac gluten sensitivity  
NF-κB  Nuclear factor κB 
NIK NF-κB-inducing  kinase 
PB Phosphate buffer  
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
RANK Receptor activator of nuclear factor κB 
RANKL Receptor activator of nuclear factor κB ligand 
SD Standard deviation 
SEM Standard error of the mean 
sIgA secretory immunoglobulin A 
TBS/TBST Tris buffered saline/Tris buffered saline + 0.1% Tween-20 
TEER Transepithelial resistance 
TEM Transmission electron microscopy 
TFF3 Trefoil factor 3 
TG2 Tissue transglutaminase 2 
TNF Tumour necrosis factor 
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UEA-1 Ulex europeaus agglutinin 1 
ZO-1 Zonula occludens-1 
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1.1 Structure of small intestinal epithelium and regional differences along the 
small intestine 
1.1.1 Anatomy of the small intestine 
The gastrointestinal tract overall and small intestine in particular are largely anatomically and 
physiologically similar in both humans and mice, making mice a good model for many aspects 
of human intestinal biology (Nguyen et al., 2015; Hugenholtz and de Vos, 2018). The small 
intestine begins after the pyloric sphincter and ends with the start of the large intestine or 
colon. In humans, the small intestine is approximately 8 m in length, while in mice it is 
around 30 cm long (Bowcutt, 2014); this translates to a size relative to total body weight of 
10 cm per kilogram in humans compared to 1500 cm per kilogram in mice (Hugenholtz and 
de Vos, 2018). From proximal to distal, the small intestine is divided into three regions: 
duodenum, jejunum and ileum.  
The small intestinal wall consists of different functional layers. The outer layer is the serosa. 
Inside this is the muscularis, consisting of two smooth muscle layers, which are responsible 
for the shape, tone and peristaltic movement of the gut. Within this is the submucosal layer 
containing stromal elements, such as connective tissue, blood vessels and immune cells. 
Finally, innermost layer is the mucosa, which is smooth in mice but forms circular folds in 
humans (Hugenholtz and de Vos, 2018). The mucosa contains the lamina propria and a single 
layer of columnar epithelial cells makes up its luminal surface.  
The intestinal epithelium contains the same epithelial cell types in humans and mice. These 
fulfil various specialised roles, including nutrient and water absorption and secretion of 
hormones, enzymes and anti-microbial molecules. The epithelium adopts an intensely folded 
architecture, with invaginated crypts and protruding, finger-like villi. This is similar in humans 
and mice, although the villi in mice tend to be taller and their shapes vary slightly along the 
length of the small intestine (Nguyen et al., 2015; Hugenholtz and de Vos, 2018). The crypts 
and villi form distinct microenvironments, with most absorption taking place in the villus 
epithelium while secretion occurs mainly in the crypts. Villi serve to increase the surface area 
available for absorption of nutrients, fluid and electrolytes. Overlying the epithelium is a 
mucus layer made up of highly glycosylated mucins secreted by specialised cells within the 
epithelium. The key secreted mucin in the intestine is mucin 2 (encoded by MUC2/Muc2) 
(Pelaseyed et al., 2014). Unlike in the colon, the mucus layer is thinner and discontinuous in 
the small intestine (Johansson et al., 2011; Ermund et al., 2013). 
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1.1.2 Intestinal stem cells and epithelial renewal 
In the adult small intestine, leucine rich repeat containing G protein coupled receptor 5 
(Lgr5)+ intestinal epithelial stem cells are found at the crypt bases (Sato et al., 2009), where 
they give rise to all the intestinal epithelial cell lineages: absorptive enterocytes, Paneth cells 
and goblet cells (Figure 1.1). The stem cell niche at the crypt base is maintained by factors 
produced by Paneth cells, which flank the Lgr5+ stem cells (Sato et al., 2011) and other cells, 
such as myofibroblasts (Lahar et al., 2011). In addition, there is a second compartment of 
cells located at the +4 position of the crypt, which may or may not express Lgr5, along with 
other markers of quiescent stem cells, including Bmi1, mTert and Hopx (Potten et al., 2002; 
Clevers, 2013). These are committed to the secretory cell lineage but are able to act as a 
reserve stem cell population, generating daughters of all lineages following intestinal injury 
(Buczacki et al., 2013). Except for Paneth cells, which migrate downwards to the crypt base 
(Clevers and Bevins, 2013), daughter cells migrate upwards from the crypt base along the 
crypt-villus axis. The majority of the rest of the crypt consists of rapidly proliferating 
progenitor cells known as transit-amplifying cells. Transit-amplifying cells divide 4-5 times as 
they move up towards the crypt shoulder, before becoming terminally differentiated. The 
turnover period of the epithelium is around 5 days. The oldest epithelial cells undergo 
apoptosis and are shed from the villus tip (Bullen et al., 2006; van der Flier and Clevers, 
2009).  
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Figure 1.1. A crypt-villus axis within the small intestinal epithelium. The luminal surface of 
the small intestine is covered with small finger-like projections interspersed with invaginated 
crypts. Stem cells reside at the base of the crypts, where they divide to produce daughter cells. 
As they differentiate, cells move upwards towards the villus tip, creating a zone of dividing and 
differentiating cells known as ‘transit amplifying cells’. Cells on the villus are fully committed to 
one of the epithelial lineages, the major types of which are absorptive enterocytes, mucus-
secreting goblet cells, enteroendocrine cells and tuft cells. Paneth cells, the fifth major lineage, 
migrate down to the crypt base where they produce niche factors that maintain the stem cells. 
The whole epithelium turns over approximately every 5-6 days, with cells undergoing 
apoptosis and being shed into the lumen from the villus tip. Figure adapted from (Crosnier, 
Stamataki and Lewis, 2006).     
 
1.1.3 Intestinal epithelial cell types  
The intestinal epithelium comprises four major cell lineages that are derived from Lgr5+ crypt 
base stem cells. The same epithelial cell types are present in both human and mouse small 
intestine (Nguyen et al., 2015). Absorptive enterocytes are the most abundant of these and 
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are responsible for the uptake of nutrients from the small intestinal lumen. Although once 
thought to be purely devoted to absorption, the intestinal epithelium is also now known to 
have various important secretory roles. The major secretory cell types found in the 
epithelium are Paneth cells, goblet cells and enteroendocrine cells. As discussed previously, 
Paneth cells secrete factors such as Wingless-type MMTV integration site (Wnt) proteins, 
epidermal growth factor (EGF) and Notch ligands, which are crucial for the maintenance of 
Lgr5+ stem cells. Ablation of Paneth cells in vivo in mice, either by mutation of growth factor-
independent 1 transcription repressor (Gfi1) or expression of diphtheria toxin A under the 
Paneth cell-specific cryptdin 2 promoter, causes loss of intestinal stem cells (Sato et al., 
2011). Paneth cells also have a role in innate immunity by secreting anti-microbial molecules, 
such as lysozyme, defensins and cryptdins, into the intestinal lumen. Goblet cells secrete 
mucins to make up the mucus layer that physically excludes many microbes from contacting 
and translocating across the epithelium (Birchenough et al., 2015). The final major secretory 
lineage is enteroendocrine cells, which express sensory receptors that allow them to monitor 
the composition of the gut contents, particularly nutrient and chemical substances 
(Worthington et al., 2017). They respond to this by secretion of hormones, such as serotonin, 
cholecystokinin, gastric inhibitor polypeptide, ghrelin and glucagon-like peptide 1 
(Gunawardene et al., 2011; Furness et al., 2013; Worthington et al., 2017). Other epithelial 
cell types that are very rare in the intestine include tuft cells and microfold (M) cells, which 
are found throughout the crypt-villus axis and in the follicle-associated epithelium, 
respectively. Tuft cells play a role in immunity against parasitic infections (Gerbe and Jay, 
2016), while phagocytic M cells are involved in induction of immune responses via antigen 
sampling of the luminal contents (Mabbott et al., 2013).   
1.1.4 Intestinal epithelial cell differentiation 
The differentiation of intestinal epithelial stem cells into these separate lineages is 
determined by a complex interplay between cell signalling pathways (Figure 1.2). Wnt 
signalling is crucial for the maintenance of Lgr5+ stem cells at the crypt base (Crosnier, 
Stamataki and Lewis, 2006) as evidenced by the fact that mice lacking lymphoid enhancer 
factor/T cell factor (TCF), which complexes with β-catenin and translocates to the nucleus to 
activate Wnt target genes, results in loss of intestinal stem cells (Korinek et al., 1998).  A 
gradient of Wnt signalling is thought to exist from the base of the crypt, where Wnt ligands 
are produced by Paneth cells and are therefore at their highest concentration, to the top of 
the crypt where they are weakly expressed (Sato et al., 2011). As progenitor cells are pushed 
upwards along the crypt-villus axis they escape this region of high Wnt signalling and undergo 
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differentiation. Allocation of cells to either the absorptive or secretory lineages at this point 
is controlled by Notch signalling, which normally maintains the stem cell compartment (Riccio 
et al., 2008; Pellegrinet et al., 2011; VanDussen et al., 2012). Notch promotes expression of 
hairy and enhancer of split-1 (Hes) family of basic helix-loop-helix (bHLH) transcription 
factors, such as Hes1, which represses atonal bHLH transcription factor 1 (Atoh1, also known 
as Math1). Atoh1 expression is required for commitment to the secretory lineage (Yang, 
2001; VanDussen and Samuelson, 2010). As a result, experimental inhibition of Notch 
signalling causes goblet cell hyperplasia with concurrent decline in numbers of absorptive 
enterocytes (Milano et al., 2004; van Es et al., 2005; Kazanjian et al., 2010), while 
enhancement of normal Notch signalling results in loss of secretory lineages (Fre et al., 2005; 
Stanger et al., 2005). Progenitors that experience high Notch signalling and repress Atoh1 
commit to the absorptive lineage. Various other genes, including Ptk6, have been found to 
influence enterocyte differentiation but these do not appear to be specific for the absorptive 
lineage alone (Haegebarth et al., 2006).   
Following commitment to a secretory lineage, further signals regulate differentiation of 
progenitors into the distinct secretory cell types. Gfi1 activity has been proposed to be the 
switch controlling allocation of a common secretory progenitor to either Paneth/goblet cell 
or enteroendocrine cell lineages. This model is based on a report that the small intestine of 
Gfi1-/- mice contains Atoh1+ cells but no mature Paneth cells and fewer goblet cells, while 
showing parallel increases in the enteroendocrine cell population (Shroyer et al., 2005). In 
support of a common secretory Atoh1+ precursor, experimental expression of neurogenin 3 
(a member of another family of bHLH transcription factors) in the mouse intestine increases 
enteroendocrine cell numbers at the expense of goblet cells (López-Díaz et al., 2007).  
The precise pathways that govern these cell fate decisions are, however, far from completely 
understood. A later report found that Gfi1 is normally expressed by Paneth and goblet cells 
but not by enteroendocrine cells (Bjerknes and Cheng, 2010). This second group confirmed 
reduced Paneth and goblet cells in an independent line of Gfi1-deficient mice but also 
identified ‘mixed lineage’ cells expressing neurogenin 3 – required for commitment to the 
enteroendocrine lineage (Jenny et al., 2002) – and Paneth or goblet cell markers. To explain 
their observations, they propose an alternative model where Gfi1 mediates transcriptional 
repression of neurogenin 3 in Paneth and goblet cells, preventing them from becoming 
enteroendocrine cells. In Gfi1 deficiency, this repression is lost and some Paneth and goblet 
cells express neurogenin 3 and undergo reprogramming to the enteroendocrine lineage. This 
model does not depend on the existence of a common secretory progenitor. Further 
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downstream of neurogenin 3, multiple factors have been identified that direct differentiation 
of cells into the various subsets of enteroendocrine cells. 
Some evidence suggests the existence of a common goblet/Paneth cell precursor (Noah, 
Donahue and Shroyer, 2011). Abnormal cells with mixed goblet and Paneth cell 
characteristics were observed in mice following intestinal epithelium-specific deletion of liver 
kinase B1 (Lkb1), which is normally expressed strongly in Paneth and goblet cells (Shorning et 
al., 2009). Furthermore, decreases in both goblet and Paneth cell differentiation have been 
described following loss of several other factors, including sex determining region Y box 9 
(Sox9) (Bastide et al., 2007) and sterile alpha motif pointed domain containing ets 
transcription factor (Spdef) (Gregorieff et al., 2009; Noah et al., 2010). Goblet cell 
differentiation also appears to depend strongly on Notch signalling, with experimental 
expression of Notch Intercellular Domain (NCID) resulting in expansion of the goblet cell 
population (Zecchini, 2005). In contrast, the Paneth cell lineage relies on Wnt/β-catenin 
signalling. Loss of either the Frizzled 5 receptor, through which Wnt signalling is transduced, 
or the pro-Wnt signalling Lgr4 disrupted Paneth cell maturation (van Es et al., 2005; Mustata 
et al., 2011). Since Paneth cells themselves secrete Wnt ligands, this may form a positive 
feedback loop to support further Paneth cell differentiation, as well as maintaining the 
columnar base stem cell population. 
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Figure 1.2. Factors regulating differentiation of intestinal epithelial cell lineages. 
Differentiating epithelial cells that are exposed to strong Notch signalling undergo 
upregulation of Hes1, which guides them to become enterocytes. Hes1 inhibits expression of 
Atoh1/Math1, which specifies the secretory lineage in response to high Wnt signalling. Gfi1 
activity is important for Paneth and goblet cell development, whereas upregulation of 
neurogenin 3 results in suppression of Gfi1 and development into enteroendocrine cells. In 
cells dominated by Gfi1 activity, Sox9 is required for Paneth cell differentiation while Klf4 and 
Elf3 are expressed in developing goblet cells. Figure adapted from Van der Flier et al (van der 
Flier and Clevers, 2009). 
 
1.1.5 Regional identity in the small intestine 
In addition to the strictly regulated differentiation of the small intestinal epithelium along the 
crypt-villus axis, the characteristics of the small intestine also vary along its length, or 
cephalocaudal axis (Middendorp et al., 2014). This includes regional variation in enterocyte 
  
25 
 
gene expression profiles and distribution of cell types. Several studies have demonstrated 
differential regional expression of certain nutrient transporters using array-based and RNA 
sequencing approaches (Mutch et al., 2004; Anderle et al., 2005; Comelli et al., 2009; 
Middendorp et al., 2014), which largely correspond to specialisation in terms of nutrient 
absorption. For example, both Scl40a1 (encoding iron transporter ferroportin) and Cybrd1 
(encoding ferric reductase CYBRD1) are more strongly expressed in the duodenum, where 
the majority of iron absorption occurs (Anderle et al., 2005; Middendorp et al., 2014). In 
contrast, expression of the Na+-dependent bile acid transporter (ASBT) is greater in the ileum 
than the jejunum, consistent with this being the major site of bile acid reabsorption (Anderle 
et al., 2005; Middendorp et al., 2014). One study described differences in expression of 
certain region-specific genes; for example, Cybrd1 was expressed only in mouse duodenum, 
while its homologue in humans was expressed more highly in human ileum than duodenum 
(Middendorp et al., 2014). Another study found similar expression of most transporters 
between human and mouse small intestine (Anderle et al., 2005). Overall, these studies 
support the relevance of mouse as a model organism in this area. 
GATA4, a zinc finger transcription factor, is believed to be important in conferring regional 
identity in the small intestine. In both mouse and humans, GATA4 is expressed strongly by 
enterocytes throughout the duodenum and jejunum but at much lower levels in the ileum 
(van Wering et al., 2004; Bosse et al., 2006). This differential expression is required for 
maintenance of duodenal and jejunal phenotypes as the epithelium in these regions acquired 
ileal characteristics in an inducible Gata4-knockout mouse model (Bosse et al., 2006). 
Expression of transporters usually restricted to the ileum, such as Slc10a2, was observed in 
the jejunum of these mice and expression of jejunum-restricted transporter genes, such as 
fatty acid binding protein 1 (Fabp1), was greatly reduced. This indicates that GATA4 normally 
specifies regional identity by inhibiting expression of ileum-specific genes in the jejunum and 
duodenum. Location-specific function has been shown to be intrinsically programmed in 
adult intestinal epithelial stem cells. Region-specific expression profiles persist in long-term 
primary enteroid cultures derived from different small intestinal regions, even in the absence 
of any location-specific cues from stromal cells, luminal contents or microbiota (Middendorp 
et al., 2014).  
There are also differences in the cell type composition of the epithelium along the small 
intestine. Normally the abundance of goblet and Paneth cell populations increases from 
proximal to distal, likely reflecting the greater need for defence against the increasing 
presence of bacteria in the more distal regions of the small intestine (Bosse et al., 2006; 
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Sekirov, Russell and Antunes, 2010). Goblet cells were increased in the jejunum of Gata4-
knockout mice, suggesting that GATA4 has a role in determining region-specific cell type 
distribution as well as region-specific gene expression in enterocytes (Bosse et al., 2006). 
Exactly how GATA4 exerts these effects, however, remains to be investigated. 
 
1.2 Intestinal epithelial permeability  
As discussed above, the intestinal epithelium is far from an inert barrier, having important 
roles in absorption of nutrients and water, secretion of mucus, hormones and antimicrobial 
peptides, and immune regulation. These roles are varied but movement of substances across 
the epithelium is key to many of them. Molecules and larger particles may cross the epithelium 
via several routes (Figure 1.3), which exhibit surprisingly dynamic regulation. There are two 
major routes across the epithelium: the paracellular and transcellular pathways.  
1.2.1 Paracellular pathway 
The paracellular route involves passage of particles between enterocytes. In addition to the 
adherens junctions and desmosomes that hold epithelial cells together to form a sheet, there 
are also tight junctions between cells that regulate the permeability of the paracellular 
pathway. Tight junctions are multi-protein complexes, consisting of membrane-spanning 
proteins like occludins and claudins, which interact with a network of cytoplasmic adaptor 
proteins, including zonulin and cingulin. These interact in turn with actin filaments and 
microtubules of the cytoskeleton (Zihni et al., 2016). Tight junctions are not completely 
impermeable, instead selectively allowing passage of certain molecules based on size and 
charge (Shen et al., 2011). Tight junctions are thought to have two pathways of permeability: 
a pore-dependent pathway and a leak pathway (Shen et al., 2011; Zihni et al., 2016). The first 
is thought to be mediated by pores formed by intramembrane protein strands and allows 
movement of ions and certain small uncharged molecules. The leak pathway appears to 
facilitate a slower flux of larger solutes up to 60 Å in diameter and has been proposed to 
occur with the gradual remodelling of the junction. Selectivity varies between tight junctions 
in different tissues; for example, tight junctions in the crypt regions of the small intestine are 
permeable to much larger particles than those in the villi. Although it was formerly thought 
that tight junctions were stable and mostly fixed, many signalling proteins have been 
identified that dynamically regulate these structures to alter epithelial permeability (Capaldo 
and Nusrat, 2009; Fasano, 2011).  
  
27 
 
 
 
Figure 1.3. Paracellular and transcellular pathways of transport across the small intestinal 
epithelium from the lumen. Figure adapted from (Ménard, Cerf-Bensussan and Heyman, 
2010). 
 
1.2.2 Transcellular pathway 
In contrast to the paracellular route, transcellular transport is where molecules move across 
cells. This is important in the small intestine as one of its key functions is nutrient absorption. 
As mentioned above, absorptive enterocytes express transporters that allow absorption of 
particular solutes. For example, expression of Na+-glucose co-transporters facilitates uptake 
of glucose, which then exits the cell via glucose transporter 2 (GLUT2) at the basolateral 
membrane of the enterocyte to complete its passage across the epithelium. Aside from 
nutrient transport pathways, where molecules usually diffuse across the cytoplasm, other 
types of transepithelial paths also exist. Particles may be taken up at the luminal surface of 
the epithelium by endocytosis and moved across the cell in vesicles. This route is particularly 
relevant for the uptake of antigens, which is an important step in induction and regulation of 
some immune responses in the gut (Knoop, Miller and Newberry, 2013; Schulz and Pabst, 
2013).  
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Several cell types are involved in antigen uptake across the intestinal epithelium. The classical 
example of this is microfold (M) cells, which are epithelial cells specialised for antigen uptake 
and translocation in a number of ways that will be described in more detail at a later point. 
Antigen sampling by M cells has been shown to be necessary for induction of some antigen-
specific immune responses against pathogens (Mabbott et al., 2013). In addition to M cells, 
certain dendritic cell subsets have been reported to extend protrusions between epithelial 
cells into the intestinal lumen and take up antigens (Rescigno et al., 2001). These periscope-
like processes have been described under steady-state conditions but increased in number in 
the presence of pathogenic bacteria (Niess et al., 2005), possibly due to activation of Toll-like 
receptors on epithelial cells (Chieppa et al., 2006). In addition, luminal dextran was shown to 
form plumes across the epithelium that co-localised with goblet cells markers under steady-
state conditions in mice (McDole et al., 2012). Dextran was also observed in CD103+ lamina 
propria dendritic cells that associated closely with goblet cells at the basolateral surface. 
These so-called goblet cell-associated antigen passages represent a further route of 
transepithelial transport for low molecular weight particles.  
1.2.3 Intestinal permeability in disease 
There is evidence to suggest that altered intestinal permeability may contribute to a range of 
pathological states, including trauma-induced sepsis, inflammatory bowel disease, food 
allergies and metabolic disease (Ménard, Cerf-Bensussan and Heyman, 2010; Bischoff et al., 
2014). Abnormal permeability may occur acutely, for example in the case of trauma-induced 
sepsis, or chronically, as in inflammatory bowel disease. Several factors have been proposed 
to alter intestinal permeability, such as inflammation, degree of intestinal perfusion, 
infection and toxins, dietary factors and dysbiosis of the gut microbiota.  
An acute increase in intestinal permeability is common in critically ill patients (Bischoff et al., 
2014). Here, altered permeability is demonstrated by elevation of markers such as fatty acid 
binding protein – which is released from damaged enterocytes – and bacterial components, 
such as lipopolysaccharide (LPS), in the blood plasma. The cause is thought to be 
hypoperfusion of the intestine and the consequences can be severe, including gut-derived 
sepsis. In contrast, patients with Crohn’s disease are thought to have chronically altered 
intestinal permeability (Keita et al., 2008; König et al., 2016). Epithelial damage caused by 
ongoing inflammation and changes to epithelial tight junctions are thought to underpin this 
state; for example, tumour necrosis factor (TNF), characteristically elevated in Crohn’s 
patients (Jones-Hall and Nakatsu, 2016), has been shown to increase epithelial permeability 
(Ma et al., 2004). Increased epithelial permeability may also contribute to driving 
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inflammation by allowing greater access of immune-activating microbial components to the 
mucosa.  
1.2.4 Coeliac disease – intestinal permeability gone wrong 
Coeliac disease presents a unique example of the consequences of disrupted intestinal 
permeability and immune homeostasis. It is a multi-factorial disorder triggered by an 
abnormal adaptive immune response to dietary gluten. Most food antigens are thought to be 
fairly inert in the gut, either because they are rapidly digested and absorbed or because 
tolerance is developed against them (Ménard, Cerf-Bensussan and Heyman, 2010). Gluten 
contains gliadin proteins, which are broken down by digestive enzymes to form peptide 
fragments. These fragments are resistant to further digestion due to their high proline 
content so relatively large peptides (up to at least 33 amino acids) persist to interact with the 
mucosa (Shan, 2002). In certain genetically susceptible individuals, these gliadin-derived 
peptides initiate a chronic inflammatory response in the small intestine. In most populations, 
the prevalence of coeliac disease is 1 in 100-200 (Schuppan and Zimmer, 2013). The most 
commonly recognised symptoms are due to this small intestinal enteropathy and include 
diarrhoea, constipation, malnutrition and abdominal pain (Schuppan, Junker and Barisani, 
2009); however, coeliac disease can also manifest as extra-intestinal symptoms, such as 
dermatitis hepatiformis and neuropathy (Leffler, Green and Fasano, 2015).  
The sequence of pathological events that initiates coeliac disease is not fully understood. It is 
known that gliadin peptides somehow access the lamina propria, where they are modified by 
tissue transglutaminase (TG2), a ubiquitous enzyme that deamidates glutamine residues to 
form negatively charged glutamic acid (Di Sabatino et al., 2012). The modified peptides are 
ideal ligands for HLA-DQ2 and -DQ8 molecules on antigen-presenting cells. In this context 
they are recognised by certain CD4+ T cells, which become activated and drive an 
inflammatory response resulting in huge accumulation of intraepithelial lymphocytes, villus 
atrophy and crypt hyperplasia (Ciccocioppo et al., 2005; De Re et al., 2013). The HLA-DQ2/8 
alleles and exposure to dietary gluten are therefore the largest risk factors for coeliac 
disease; however, given that 30-40% of the population carry HLA-DQ2/8 and only a fraction 
develop the condition, additional factors are clearly also important (Schuppan et al., 2009; 
McAllister et al., 2018).  
Significant evidence suggests a role for abnormal intestinal permeability in the pathogenesis 
of coeliac disease (Heyman et al., 2012; Schumann et al., 2017). Genome-wide association 
studies have identified many genes that contribute to disease predisposition; the majority 
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with known functions are involved in regulating adaptive immunity but a number are also 
implicated in controlling intestinal barrier function (Schuppan et al., 2009; Schumann et al., 
2017). Furthermore, there are many reports of increased intestinal permeability in coeliac 
patients and even their unaffected first-degree relatives (van Elburg et al., 1993; Schumann 
et al., 2017). This suggests that a defect in intestinal permeability may exist prior to 
development of coeliac disease and could contribute to its initiation by facilitating exposure 
of immune cells to gliadin peptides, or by interfering with normal intestinal immune 
homeostasis. Certain gliadin-derived peptides have also been reported to have various direct 
effects on the intestinal epithelium; these effects are not dependent on the presence of 
coeliac  disease so could cause enhanced intestinal permeability in all individuals following 
gluten ingestion (Ciccocioppo et al., 2005; De Re et al., 2013).   
1.2.5 Non-coeliac gluten/wheat sensitivity and irritable bowel syndrome 
In addition to its role in coeliac disease, gluten has also been implicated in the 
pathophysiology of non-coeliac gluten sensitivity or wheat sensitivity (NCGS or NCWS) and in 
some cases of irritable bowel syndrome (IBS) (Aziz et al. , 2015). There is considerable 
overlap between the two conditions; both are associated with a range of symptoms, 
commonly including diarrhoea, abdominal pain and bloating (Schuppan et al., 2015; Catassi 
et al., 2017). Extraintestinal symptoms, such as skin rashes, foggy mind and fatigue, may also 
be reported. Importantly, patients with both conditions are serologically negative for coeliac 
disease and typically do not exhibit gluten allergy or signs of overt intestinal inflammation 
(Aziz et al., 2015). NCWS in particular has been associated with some controversy because of 
the lack of a clear underlying pathological process or diagnostic test and the difficulty in 
performing robust clinical trials (Pinto-Sánchez and Verdú, 2016; Casella et al., 2018). 
Adherence to a gluten-free diet is difficult to monitor and the popularity of gluten-free diets 
has increased dramatically among individuals who are not necessarily gluten-sensitive but 
perceive it to be healthier (Aziz et al., 2015).  
A link between gluten and certain cases of IBS or NCWS was suggested by a recent clinical 
trial, in which patients with IBS who managed their symptoms with a gluten-free diet 
reported worsened symptom control following introduction of dietary gluten, compared to 
those who consumed a placebo (Biesiekierski et al., 2011). In contrast, other studies have 
implicated non-gluten components of wheat, such as amylase/trypsin inhibitors, and 
fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) in 
non-coeliac gluten-related diseases (Junker et al., 2012; Biesiekierski et al., 2013). Altered 
intestinal permeability has been associated with both NCWS and gluten-sensitive IBS. One 
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study reported a greater increase in intestinal permeability in biopsies of patients with both 
coeliac disease and NCWS compared to non-coeliac controls following exposure to gliadin 
(Hollon et al., 2015). Another study found enhanced small intestinal epithelial permeability in 
patients with diarrhoea-predominant IBS (IBS-D) following a gluten-containing diet compared 
to those consuming a gluten-free diet (Vazquez-Roque et al., 2013). 
 
1.3 Mucosal immunity in the GI tract 
By surface area, the intestinal epithelium constitutes the largest external surface of the human 
body. It is continually exposed to foreign antigens that are ingested in the form of food and 
microbial contamination. The gastrointestinal tract is also intimately colonised by the 
commensal microbiota. As a result, intestinal immunity is a balance between protecting from 
pathogens and keeping the microbiota in check, while also maintaining oral tolerance to 
prevent excessive inflammation in response to harmless dietary antigens. The intestine 
contains gut-associated lymphoid tissues (GALT), which constitute the major foci of immune 
activity. In the small intestine, these mostly take the form of Peyer’s patches – distinct regions 
of the mucosa that are specialised for immune function in a number of ways. Development of 
GALT largely  occurs postnatally in response to signals from microbes, as demonstrated by the 
incomplete maturation of GALT in mice raised under germ-free conditions (Round and 
Mazmanian, 2009). The major tactic of intestinal immunity is immune exclusion, where foreign 
particles are barred from coming into contact with the epithelium (Strugnell and Wijburg, 
2010; Mantis, Rol and Corthésy, 2011). Several components contribute to this effect, including 
the mucus layer, epithelium and gut-associated lymphoid tissues.   
1.3.1 Role of the mucus layer 
The mucus layer forms a barrier that prevents the contents of the small intestine lumen from 
contacting the epithelium. It consists mainly of highly glycosylated mucin proteins, which are 
produced and secreted by goblet cells. The most abundant mucin in the small intestine is 
MUC2, which oligomerises to form a gel. In the colon, bacteria are physically excluded by a 
denser inner mucus layer but the single mucus layer in the small intestine is discontinuous 
and penetrated to some degree by bacteria (Pelaseyed et al., 2014; Johansson and Hansson, 
2016). These are mostly found at the level of the villus tips, with few apparently able to 
penetrate down to the tops of the crypts (Ermund et al., 2013). In addition to acting as a 
physical barrier, the mucus also retains anti-microbial peptides and antibodies, maintaining 
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higher concentrations of them in the vicinity of the epithelium (Johansson and Hansson, 
2016).  
1.3.2 Function and induction of IgA  
A huge volume of antibodies, mostly in the form of secretory immunoglobulin A (sIgA), is 
secreted into the intestinal lumen under homeostatic conditions, playing a crucial role in 
immune exclusion. Humans deficient in sIgA are frequently more prone to gastrointestinal 
and respiratory infections (Strugnell and Wijburg, 2010). IgA is produced by plasma cells, 
mostly in the lamina propria of the intestine. From here it is taken up by enterocytes via the 
polymeric immunoglobulin receptor (pIgAR), expressed on their basolateral surface. In 
complex with pIgAR, IgA is transcytosed by the epithelial cells and released into the intestinal 
lumen along with the secretory component.  
Once in the lumen, sIgA exerts protective effects against bacterial pathogens. IgA-mediated 
protection is mediated in part by direct binding to toxins or virulence factors, effectively 
neutralising them (Strugnell and Wijburg, 2010). For example, one IgA molecule directed 
against Shigella flexneri lipopolysaccharide was found to inhibit the type 3 secretion system 
required by this pathogen for invasion of epithelial cells (Forbes et al., 2011). Additional 
mechanisms of ‘immune exclusion’ have also been proposed, referring to physical 
interference of sIgA with bacterial-mucosal interactions, possibly by agglutinating the 
bacteria as in strain-typing (Mantis, Rol and Corthésy, 2011). Recently, Slack and colleagues 
showed that IgA enchains dividing bacterial daughter cells to generate clumps of rapidly 
dividing bacteria that are efficiently cleared (Moor et al., 2017).  
IgA responses are thought to be mainly initiated in gut-associated lymphoid follicles. In the 
small intestine, most lymphoid follicles are found as Peyer’s patches – domed areas where a 
follicle in the submucosa is covered by specialised follicle-associated epithelium (FAE; Figure 
1.4). Peyer’s patches are most abundant in the ileum but may also be found in the jejunum 
and duodenum. They vary in size and number between individuals. In addition to containing 
M cells, the FAE has additional characteristics that aid its role as a site of immune induction, 
including a much thinner overlying mucus layer as the FAE contains very few goblet cells.  
Initiation of an IgA response depends on antigen sampling. The FAE is thought to be a site of 
antigen sampling because it contains M cells, which transcytose luminal antigens and transfer 
them to antigen-presenting cells with which they are in close contact with at their basolateral 
surface. The antigen-presenting cells, including dendritic cells and B cells, migrate to the 
perifollicular areas of the lymphoid follicles where they interact with helper T cells (Mesin, 
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Sollid and Niro, 2012). B cells in the germinal centres that express cognate Ig receptors then 
become activated by the combination of signals from antigen-presenting cells and activated 
helper T cells. Activated B cells undergo immunoglobulin class switching, somatic 
hypermutation and affinity maturation and differentiate into plasma cells that secrete IgA 
with high antigen affinity. The importance of IgA to mucosal immunity is demonstrated by 
mice deficient in activation-induced cytidine deaminase, which lack IgA-secreting plasma 
cells. These mice exhibit defects in regulation of the gut microbiota, with 100-fold expansion 
of anaerobic bacteria in the small intestine and B cell hyperplasia (Fagarasan, 2002).  
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Figure 1.4. Peyer’s patch structure comparison of follicle-associated epithelium to villus 
epithelium. Peyer’s patches are found most commonly in the terminal ileum of the small 
intestine and appear as domes in comparison to the surrounding villi. They consist of a 
lymphoid follicle beneath the mucosa, covered by the specialised follicle-associated 
epithelium. In the sub-epithelial dome area, mesenchymal M cell inducer cells express RANKL, 
which acts on the epithelium to stimulate M cell differentiation. For this reason, M cells are 
largely restricted to the follicle-associated epithelium. Unlike villus enterocytes, M cells lack 
defined apical microvilli and have large basolateral pockets in which dendritic cells and 
lymphocytes are found. Fewer mucus-secreting goblet cells in the FAE results in a thinner or 
completely absent mucus layer compared to that over the villus epithelium. Figure adapted 
from (Ohno, 2016). 
 
1.4. M cells  
1.4.1. M cell morphology 
M cells are the key component of the FAE that make it a site of luminal antigen sampling and 
immune induction. They are a rare subset of intestinal epithelial cells, with reports of their 
frequency varying between 5-10% of cells within the FAE (Miller, 2007; Mabbott et al., 2013; 
Ohno, 2016). Aside from the FAE, M cells are also found in the epithelium overlying colonic 
lymphoid follicles. Whether there is any lineage relationship between M cells in the small and 
large intestines has not been investigate, although at the ultrastructural level they appear to 
be similar (Jacob et al., 1987). 
M cells were first described in the 1970s due to their distinct morphology and ability to take 
up particles. Using an electron microscope, it is noticeable that murine M cells have stunted, 
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irregular microvilli, while human M cells have microfolds, on their apical surface (Miller, 
2007). They possess large invaginated pockets in their basolateral membrane, in which 
immune cells like B cells and dendritic cells have been observed to reside (Miller, 2007). Such 
pockets are thought to facilitate close interactions between M cells and these antigen-
presenting cells in order to enable more rapid transfer of particles and antigens.  
1.4.2. M cell development  
Our knowledge of the factors guiding M cell differentiation has increased over the last three 
decades but many aspects of this process still remain to be understood. A major point of 
controversy has been whether M cells are specified as crypt progenitor cells, which then 
migrate from the crypts to the dome of Peyer’s patches, or whether they develop from 
differentiated enterocytes within the epithelium overlying a Peyer’s patch. In support of the 
first theory, it was reported in rabbit caecal patches that the pattern of glycosylation of M 
cells varied from the base of the dome to its top (Gebert and Posselt, 1997). M cells with 
similar glycosylation patterns were observed in clusters arranged like spokes radiating from 
the top of the dome and it was suggested that each spoke represented M cells derived from 
a common precursor cell in an associated crypt. More recently, it was demonstrated that M 
cells are derived from Lgr5+ crypt stem cells, along with the other major epithelial cell 
lineages (de Lau et al., 2012). 
1.4.2.1. Role of RANKL in M cell differentiation 
In a key study, Knoop et al demonstrated comprehensively that the TNF superfamily 
cytokine, receptor activator of NF-κB ligand (RANKL), is crucial for M cell differentiation. In 
Rankl-/- mice, Peyer’s patch M cells are almost completely absent and exhibit reduced 
uptake of nanoparticles (Knoop et al., 2009). Interestingly, the number of remaining M cells 
in Rankl-/- mice was greatest in the most distal Peyer’s patches and decreased in those 
located more proximally in the small intestine. This deficiency was largely rescued by 
injection of recombinant murine RANKL, with increased M cell numbers in Peyer’s patches 
and ectopic M cells appearing on the villi. These RANKL-induced M cells were able to take 
up both latex beads and fixed enteric bacteria, including Salmonella enterica serovar 
Typhimurium and Yersinia enterocolitica. Rankl-/- mice also have a number of another 
abnormalities, such as lack of teeth and lymph nodes (Kong et al., 1999). It could therefore 
be argued that the reduction in M cells in Rankl-/- mice might be an indirect result of the 
lack of RANKL, caused by other defects present throughout development; however, the 
authors also showed that adult wild-type mice treated with a neutralising RANKL antibody 
recapitulated the loss of M cells described in Rankl-/- mice. The concentration of IgA present 
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in the faeces of Rankl-/- mice was consistently lower than that of wild-type mice, suggesting 
that they have defective induction or production of IgA. RANKL also reportedly promotes 
differentiation of M cells found in the epithelium overlying nasopharynx-associated 
lymphoid tissues (Mutoh et al., 2016), indicating that it may be a feature common to many 
mucosae.   
RANKL – also referred to as TNF-related activation-induced cytokine (TRANCE) and TNFSF11 
– is a 316-amino acid type II homotrimeric transmembrane protein that undergoes 
proteolytic cleavage of its ectodomain to produce a secreted form. RANKL was initially 
described by two groups in 1997 as regulating T cell and dendritic cell function (Anderson et 
al., 1997; Wong et al., 1997). Around the same time, RANKL was also found to be the key 
stimulator of osteoclast differentiation expressed by osteoblasts and stromal cells 
(Nakagawa et al., 1998). The receptor for RANKL is receptor activator of NF-κB (RANK), 
which is expressed on the surface of osteoclast progenitors, many immune cells, and on 
both apical and basolateral surfaces of epithelial cells throughout the small intestinal 
epithelium (Knoop et al., 2009). In addition, RANKL also binds to a soluble decoy receptor 
known as osteroprotegerin (Nagy and Penninger, 2015).  
The source of the RANKL responsible for M cell differentiation in the FAE was long thought 
to be mesenchymal cells in the sub-epithelial dome as they have been shown to express 
RANKL (Taylor et al., 2007; Knoop et al., 2009). This has recently been confirmed and the 
cells have been termed microfold cell inducer cells (Nagashima et al., 2017). RANKL is highly 
expressed by podoplanin+MadCAM-1- sub-epithelial mesenchymal cells that directly contact 
the FAE. In two independent mouse models in which RANKL is knocked out specifically in 
mesenchymal cells (Tnfsf11fl/Δ; Twist2-Cre and Tnfsf11fl/Δ Col6a1-Cre mice), expression of 
RANKL by podoplanin+MadCAM-1- cells is dramatically reduced, with concurrent reductions 
in expression of Ccl20, Spib and glycoprotein 2 (Gp2) in the FAE and in numbers of GP2+ M 
cells in the FAE observed by immunostaining and scanning electron microscopy (Nagashima 
et al., 2017; Nagashima et al., 2017). In contrast, mice with a haematopoietic cell-specific 
deletion of RANKL have apparently normal M cells (Nagashima et al., 2017). Interestingly, 
mice expressing truncated RANKL, which lacks the cleavage sites required for release of its 
soluble form but is still expressed on the cell membrane, showed normal expression of M 
cell markers in the FAE, indicating that soluble RANKL may not be necessary for M cell 
differentiation (Nagashima et al., 2017).  
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Binding of RANKL to its receptor, RANK, results in receptor oligomerisation and recruitment 
of adaptor molecules to sites within the cytoplasmic region of RANK. TNF receptor-
associated factors (TRAFs) are particularly important in this context, with TRAF-2, -5 and -6 
all able to bind to RANK (Boyce and Xing, 2007). Of these, TRAF-6 is thought to be the 
principle driver of RANKL-induced osteoclast differentiation as only Traf6-/- mice are 
deficient in osteoclasts and exhibit osteopetrosis (abnormally dense bones). A recent study 
has confirmed that TRAF-6 is crucial for M cell differentiation driven by RANKL; this process 
is blocked when Traf6 is deleted in the intestinal epithelial cells of mice (Kanaya et al., 
2018). Recruitment of TRAFs activates further intracellular signalling, including activation of 
NF-κB, c-Src and mitogen-activated protein kinase (MAPK) pathways. This means that the 
RANKL-RANK interaction has a variety of consequences, including regulation of gene 
expression. Activation of NF-κB results in its translocation to the nucleus, while MAPK 
activation causes nuclear translocation of transcription factors c-Fos and c-Jun. These 
pathways are important for the role of RANKL in osteoclast differentiation, since mice 
lacking both of the NF-κB subunits, p50 and p52, or c-Fos also exhibit osteopetrosis (Nagy 
and Penninger, 2015). Intestinal epithelium-specific deletion of Traf6 resulted in impaired 
nuclear translocation of NF-κB complexes (Kanaya et al., 2018). 
The precise signalling cascades that drive M cell differentiation downstream of RANKL 
remain largely unclear. The transcription factor SpiB is required for RANKL-stimulated M 
cell differentiation (de Lau et al., 2012). This is demonstrated by evidence showing that SpiB 
is specifically expressed in M cells and that Spib-/- mice lack M cells. Reconstitution of Spib-/- 
mice with wild-type bone marrow did not restore the M cell population, indicating that the 
defect is not due to the absence of SpiB expression in the immune cells of the lymphoid 
follicle (de Lau et al., 2012; Sato et al., 2013). SpiB expression is increased in intestinal 
epithelial cells following RANKL stimulation and subsequently regulates expression of other 
M cell-associated genes; for example, expression of M cell marker GP2 is markedly reduced 
in Spib-/- mice (Sato et al., 2013). As such, SpiB has been described as the master 
transcription factor of the M cell lineage. It appears, however, that not all genes reported 
to be specific to M cells are controlled by SpiB. Gene expression analysis of the FAE of wild-
type versus Spib-/- mice showed that expression of Gp2 and uromodulin (Umod) was 
reduced whereas expression of MARCKS-like 1 (Marcksl1), fucosyltransferase 1 (Fut1) and 
peptidoglycan recognition protein 1 (Pglyrp1) were unchanged (Sato et al., 2013). GP2+ M 
cells detected by immunostaining were almost entirely absent in the FAE of Spib-/- mice, 
while a small number of cells remained that stained positively using alternative M cell 
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identifiers, NKM 16-2-4 (an anti-M cell antibody recognising a (1,2)-fucose-containing cell 
surface carbohydrate moiety (Nochi et al., 2007)) and wheat germ agglutinin (WGA) (Sato 
et al., 2013). Clevers and colleagues have suggested that a small proportion of M cells may 
develop independently of SpiB (Sato et al., 2013).  
1.4.2.2. Role of B cells in M cell differentiation 
Given that M cells are found in the FAE but not usually in the surrounding villus epithelium, 
it is reasonable to hypothesise that immune cells in the lymphoid follicle may have a role in 
triggering M cell differentiation. Support for this theory initially came from a study 
reporting that Caco-2 cells, a human intestinal cell line, could be converted to an M cell-like 
phenotype by co-culturing them with lymphocytes isolated from Peyer’s patches of BALB/c 
mice in a Transwell system (Kernéis et al., 1997). The Caco-2 cell monolayers lost the apical 
expression of villin that is typical of differentiated enterocytes and developed disorganised 
apical microvilli rather than the classical brush border. Unlike control monolayers, those 
cultured with the lymphocytes were able to translocate fluorescently tagged latex beads, 
suggesting that they had taken on an M cell-like phenotype, both morphologically and 
functionally. Co-culture of Caco-2 cells with Raji B cells – a human B cell lymphoma line 
(Karpova et al., 2005) – also induced an M cell-like phenotype in the epithelial cells, 
suggesting that B cells were the main driver of M cell differentiation (Gullberg et al., 2000; 
des Rieux et al., 2007).  
The factors secreted by Peyer’s patch B cells and Raji B cells that are responsible for 
stimulating M cell differentiation remain largely unknown. Gene expression analysis of Raji 
B cells that either induced or did not induce particle transport in Caco-2 monolayers 
revealed that genes associated with monolayer conversion include tumour necrosis factor 
(TNF) family cytokines (including TNF-α and lymphotoxin (LT)-β), growth factors of the 
transforming growth factor (TGF)-β family, the chemokine RANTES, and interferon-
regulatory factor IRF-1 (Gullberg, 2005). Others found that TNF and LTβ receptor agonists 
induce expression of certain genes associated with the FAE, such as Gp2 and chemokine (C-
C motif) ligand 20 (Ccl20), in primary rat small intestinal IEC-6 cells and Caco-2 cells (Wang 
et al., 2009). None of these factors alone, however, reproduce the same induction of 
particle transport as Raji B cells (Gullberg, 2005).  
In spite of this, the role of B cells in M cell differentiation is further supported by evidence 
that mice lacking B cells due to ablation of genes encoding the immunoglobulin genes had 
fewer Peyer’s patches and fewer cells with microfold morphology as assessed by scanning 
  
39 
 
electron microscopy (Golovkina et al., 1999). Mice deficient in either αβ or γδ T cells had 
normal Peyer’s patches. The authors also reported that Rag1-/- mice, which lack both 
mature B and T cells, showed the most severe reduction in Peyer’s patch numbers; 
however, another study reported that Rag1-/- mice have normal numbers of M cells within 
the FAE, although the Peyer’s patches in these animals were smaller than in wild-types and 
lacked follicles (Debard et al., 2001). This contradicts the claim that B cells are required for 
M cell differentiation. Furthermore, a population of CCR6hiCD11cint B cells found in the sub-
epithelial dome of the mouse Peyer’s patch promote M cell differentiation (Ebisawa et al., 
2011). This study, as well as others, have demonstrated that M cells are depleted in CCR6-
deficient mice, indicating that the interaction between CCR6 and its chemokine ligand 
CCL20 may be crucial for M cell formation (Lügering et al., 2005; Westphal et al., 2008). 
Accordingly, CCR6hiCD11cint B cells are also depleted in CCR6-deficient mice, while transfer 
of these cells to CCR6-deficient mice rescues the lost M cells (Ebisawa et al., 2011). More 
generally, B cells are already known to be involved in the development of secondary 
lymphoid organs by providing TNF and lymphotoxin required for maturation and retention 
of follicular dendritic cells (Aguzzi, Kranich and Krautler, 2014).  
1.4.2.3. Role of NF-κB signalling in M cell differentiation 
RANKL is a potent activator of NF-κB signalling, which is known to regulate intestinal 
inflammation and RANKL-induced osteoclast differentiation. The NF-κB pathway is 
therefore also likely to be involved in M cell differentiation. NF-κB signalling is mediated by 
transcription factors formed of dimers between different combinations of NF-κB subunits. It 
is broadly divided into the classical and alternative pathways, which are defined by the 
subunits involved and the mechanisms of activation. The classical pathway requires 
degradation of IκB inhibitors by IκB kinases (IKK), releasing NF-κB1 (p50)-RelA dimers to 
translocate into the nucleus and regulate gene expression (Sun, 2011). In contrast, the 
alternative pathway involves processing by NF-κB-inducing kinase (NIK) of p100 to NF-κB2 
(p52) to form transcriptionally active NF-κB2-RelB dimers. The complexity of this system is 
further increased by the existence of a fifth subunit, c-Rel, and the ability of most subunits 
to form both homo- and heterodimers.  
RANKL stimulates both classical and alternative NF-κB pathways (Sun, 2011). Furthermore, 
analysis of transcription factor binding site motifs in the promoters of genes found to be 
expressed specifically in the FAE identified a number with NF-κB binding motifs (Kobayashi 
et al., 2012). These data suggest NF-κB-mediated gene regulation may be important for M 
cell differentiation.  
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The relative roles of different NF-κB signalling pathways in M cell development have been 
investigated to some extent using knockout mouse models. Normal Peyer’s patches and M 
cells are found in c-Rel-deficient mice, indicating that c-Rel is not essential for M cell 
differentiation (Sehgal et al., 2017). In contrast, Peyer’s patches are absent in mice deficient 
in  NF-κB2, RelB (Yilmaz, 2003) or RelA (Alcamo et al., 2002), and in aly/aly mice that 
express dysfunctional NIK (Shinkura et al., 1999); this may be due to disruption of LT-β 
signalling via the alternative NF-κB pathway, which is crucial for the development of 
secondary lymphoid tissues (Karrer et al., 2000; Yilmaz, 2003). Whether any M cells can still 
be detected in these mice was not investigated, but in the absence of Peyer’s patches it is 
unlikely. This makes it difficult to assess the importance of these individual subunits in M 
cell differentiation. To get around this, one group injected alymphoplasia (aly/aly) mice 
with RANKL; they observed no formation of ectopic M cells as seen in wild-type mice, 
suggesting that NIK-dependent alternative NF-κB signalling is necessary for M cell 
differentiation itself (Kimura et al., 2015). Primary small intestinal cultures established from 
aly/aly mice also do not undergo M cell differentiation when treated with exogenous 
RANKL (Wood et al., 2016).  
The importance of alternative pathway NF-κB signalling in M cell differentiation has been 
confirmed during the course of the current study by the finding that both M cell 
differentiation and nuclear translocation of RelB are compromised in the FAE of mice 
carrying an epithelium-specific deletion of Traf6 (Kanaya et al., 2018). In contrast, RelB 
predominantly localised to the nuclei of FAE cells in wild type mice. Furthermore, treatment 
with RANKL rapidly upregulated expression of alternative pathway subunits, Relb and 
Nfkb2. The role of alternative pathway NF-κB signalling in M cell differentiation is further 
supported by experiments performed in murine thymic epithelial cells suggesting that Spib 
is a target gene of RANKL-NIK-RelB signalling (Akiyama et al., 2014). Finally, TNF-α – a 
known activator of the alternative pathway – enhances the effect of RANKL on M cell 
differentiation, possibly by increasing the availability of RelB and NF-κB2 subunits in 
enterocytes by causing their rapid induction (Wood et al., 2016).  
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Figure 1.5. Major events in the classical and alternative pathways of NF-κB signalling. The 
classical NF-κB pathway is activated by signalling via cell surface receptors including the TNF 
receptor (TNFR), TLRs, T cell (TCR) and B cell receptors (BCR). Through the activities of kinases 
such as RIP and TAK, the IKK complex (IKKα, β and γ) is activated and in turn causes the 
ubiquitin-dependent degradation of IκBα. Freed from its inhibition, the RelA-NF-κB1 (also 
known as RelA-p50) complex translocates to the nucleus where it regulates gene transcription. 
Alternative NF-κB signalling is switched on in response to activation of a different set of 
receptors, including RANK and LT-β. The result is stabilisation of NIK, allowing it to activate 
IKKα by phosphorylation. IKKα in turn phosphorylates p100, which is processed by cleavage of 
ankyrin repeats, which are then degraded to leave NF-κB2 (also known as p52). RelB-NF-κB2 
complexes are then able to enter the nucleus. This schematic is greatly simplified and does not 
show other possible subunit complexes, which include homodimers and heterodimers with an 
additional subunit, c-Rel. Figure adapted from (Sun, 2011) and (Taniguchi and Karin, 2018). 
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1.4.2.4. Induction of M cell differentiation by microbial signals 
In addition to signals from the underlying tissue, exposure to certain microbes has also 
been reported to stimulate M cell differentiation. Mahajan and colleagues described trans-
differentiation of enterocytes within the FAE of mice into M cells in response to wild type S. 
Typhimurium (Tahoun et al., 2012). This response was found to be dependent on the S. 
Typhimurium type III effector protein, SopB, as it did not occur with a ΔsopB strain. The 
authors found that a similar effect was also observed in bovine rectal epithelial cells derived 
from crypts neighbouring lymphoid follicles. Here, the effect was found to require SopB-
stimulated autocrine RANKL signalling and Wnt/β-catenin signalling-driven epithelial-
mesenchymal transition. Another group reported that cholera toxin is also capable of 
inducing trans-differentiation of FAE enterocytes into M cells (Wang et al., 2011). Since 
enteropathic bacteria have been shown to specifically target M cells for invasion (Miller, 
2007), it is speculated that such mechanisms allow them to boost M cell numbers and 
increase their own chances of host colonisation.  
1.4.3. M cell markers 
Results from efforts to identify specific cellular markers of M cells have been mixed and often 
contradictory (Casteleyn et al., 2013). This is largely due to the rarity of M cells in vivo and 
the challenge of isolating them. For some time, Ulex europaeus agglutinin-1 (UEA-1) – a lectin 
that selectively binds α(1,2)-fucose cell surface moieties – was the best available tool for 
defining M cells (Clark et al., 1993). The utility of UEA-1 as a marker is significantly limited, 
however, by the fact that it also binds goblet cells and is only specific for murine M cells 
(Ohno and Hase, 2010). As technologies advanced, two studies attempted to identify an M 
cell transcriptional profile by using DNA microarrays to compare gene expression in intestinal 
epithelial cells from FAE and villus regions (Hase et al., 2005; Terahara et al., 2008). These 
studies identified a number of genes whose expression was upregulated specifically in FAE, 
including genes encoding chemokines, such as CCL9 and CCL20, and others encoding proteins 
involved in immune defence. The latter include peptidoglycan recognition protein 2 and 
mannose receptor C type 1, which are involved elsewhere in pathogen recognition. A 
comprehensive list of putative M cell markers may be found in Table 1.1. Encouragingly, both 
studies confirmed elevated expression of some genes previously described as having M cell-
specific expression. A major limitation of these studies is that M cells only make up a small 
portion of cells within the FAE, so the starting material still contained a mixed population of 
M cells and non-M cells.  
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Importantly, these studies identified GP2 as an M cell-specific marker. M cell-specific 
expression of GP2 was confirmed by in situ hybridisation and immunostaining and it was later 
shown to have functional significance by acting as an uptake receptor for S. Typhimurium 
fimbrial adhesion molecule, FimH (Hase et al., 2009). GP2 is an integral membrane protein 
that localises to the apical surface of the M cell plasma membrane by a 
glycosylphosphatidylinositol linkage (Ohno and Hase, 2010). Notably, GP2 is expressed by 
both mouse and human M cells (Hase et al., 2009).  GP2 has since become the standard M 
cell marker; however, evidence suggests that it may only be expressed on more mature M 
cells. For instance, GP2 expression was only found to peak on day 3 after exogenous RANKL 
stimulation (Kanaya et al., 2012). Cells that exhibited the classical M cell morphology and 
expressed other M cell-specific markers but not GP2 have also been identified; these GP2-
low cells showed much reduced uptake of latex beads compared to GP2-high cells (Kimura et 
al., 2015). The lack of robust markers uniquely expressed by M cells and the lack of 
understanding about how expression of putative markers changes throughout M cell 
differentiation has been a major obstacle for progress in this area.  
  
  
44 
 
Table 1.1. Putative M cell markers. 
Marker Species Additional details Citation  
SpiB Mouse, 
human 
M cell lineage master transcription 
factor 
(de Lau et al., 2012; 
Kanaya et al., 2012; 
Rouch et al., 2016) 
GP2 Mouse, 
human 
Involved in uptake of FimH+ bacteria (Hase et al., 2009; Kim 
et al., 2010) 
α(1,2)-fucose 
(recognised 
by UEA-1) 
Mouse UEA-1 also recognises mouse goblet 
cells and Paneth cells 
(Clark et al., 1993) 
α(1,2)-fucose 
(recognised 
by NKM 16-2-
4 antibody) 
Mouse Also appears to recognise mouse 
Paneth cells in experiments 
performed by our group 
(Nochi et al., 2007) 
MARCKS-
related 
protein  
Mouse SpiB-independent expression (Terahara et al., 2008; 
Kanaya et al., 2012; 
Wood et al., 2016) 
Annexin V Mouse SpiB-independent expression (Verbrugghe et al., 
2006; Wood et al., 
2016) 
Uromodulin  Mouse  (Sato et al., 2013) 
CCL9 Mouse Involved in recruitment of CD11b+ 
dendritic cells to the sub-epithelial 
dome region; SpiB-dependent 
expression 
(Terahara et al., 2008; 
Kanaya et al., 2012) 
M-Sec or 
TNFaip2 
Mouse SpiB-dependent expression (Hase et al., 2009; 
Wood et al., 2016) 
Sgne-1 Mouse SpiB-dependent expression (Hase et al., 2005; 
Kanaya et al., 2012) 
Siglec-F Mouse  (Rochereau et al., 
2013; Gicheva et al., 
2016) 
Clusterin Human Also expressed by enteroendocrine 
cells in the villus epithelium. Highly 
expressed in mouse FAE but M cell-
specific expression not confirmed 
(Verbrugghe et al., 
2006, 2008) 
Cellular prion 
protein (PrPC) 
Mouse Also highly expressed in chicken 
bursa of Fabricius, which contains a 
high density of M cells 
(Nakato et al., 2012) 
Cyclophilin A Cow  (Hondo et al., 2016) 
Sialyl Lewis A Human Anti-sialyl Lewis A monoclonal 
antibodies also strongly stained 
goblet cell mucins 
(Giannasca et al., 
1999) 
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1.4.4. M cell function 
1.4.4.1. Antigen uptake 
In comparison to absorptive enterocytes, M cells have enhanced phagocytic and 
transcytotic capacities. This allows them to function as immune surveillance posts, sampling 
antigens from the intestinal lumen and transport them to the lamina propria, where they 
can interact with immune cells. The importance of antigen sampling by M cells for initiation 
of IgA responses against luminal bacteria is demonstrated in mice carrying an intestinal 
epithelium-specific deletion of RANK, meaning that they lack M cells (Rios et al., 2016). 
Compared to wild type littermates, the Peyer’s patches of these mice display impaired 
particle uptake and reduced numbers of lamina propria IgA-secreting plasma cells. They 
also had lower faecal sIgA concentrations and displayed impaired IgA responses, both 
following oral immunisation with ferritin and following conventionalisation when previously 
germ-free.   
Despite this evidence of the importance of M cells in induction of mucosal immune 
responses, the cellular mechanisms responsible for antigen uptake by M cells remain 
unclear. Certain M cell surface molecules have been shown to act as uptake receptors for 
particular bacteria; for example, GP2 interacting with FimH expressed by S. Typhimurium 
and Escherichia coli (Hase et al., 2009). Other bacterial molecules have been reported to 
mediate preferential targeting of Peyer’s patches but whether they interact specifically with 
M cells, and the molecular identities of their target receptors, are unknown. These include 
the long polar fimbriae of S. Typhimurium (Baumler et al., 1996) and adherent-invasive E. 
coli (Chassaing et al., 2011), and GipA (Vazeille et al., 2016). On the other hand, certain M 
cell molecules have been implicated as uptake receptors but their bacterial interaction 
partners have not been confirmed; for example, cellular prion protein is reported to be 
responsible for uptake of Brucella abortus, possibly via an interaction with bacterial 
surface-expressed heat shock protein 60 (Nakato et al., 2012). Overall, these data support 
the hypothesis that antigen sampling by M cells occurs via specific receptor-mediated 
endocytosis, in contrast to earlier proposals that sampling occurs non-specifically, such as 
by pinocytosis. Despite this, latex beads are used in many studies to model uptake and 
translocation of particulate antigens, raising the question of how this process is mediated 
and whether it accurately recapitulates M cell translocation of bacterial antigens.  
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1.4.4.2. Transcytosis of antigens 
Several studies have suggested that M cells transcytose various antigens, including non-
opsonised and sIgA-bound antigens, by different pathways. Evidence for reverse 
transcytosis of sIgA-bound antigens comes from studies showing selective binding, uptake 
and transport of sIgA by rabbit, mouse and human M cells (Mantis et al., 2002). Reverse 
sIgA transcytosis could facilitate delivery of many different antigens to the GALT. Rochereau 
et al provided evidence that Dectin-1 acts as a receptor for sIgA, with Siglec-5 also playing 
an important role (Rochereau et al., 2013). 
The mechanisms of apical to basolateral antigen transcytosis by M cells have been 
minimally characterised. Antigens are presumed to be transcytosed via the vesicular system 
(Rios et al., 2016); several studies have observed vesicle-bound antigens within M cells, 
including Mycobacterium tuberculosis (Nair et al., 2016), labelled protein tracers (Neutra et 
al., 1987) and E. coli (Roberts et al., 2010). Translocation to underlying dendritic cells has 
been reported to occur in as little as 10 minutes after addition of bacteria to the lumen 
(Sakhon et al., 2015). To date, the only available studies investigating the molecular 
regulation of transcytosis have been conducted in cell line models of the FAE. Using the 
Caco-2 human carcinoma cell line, one study found that expression of constitutively active 
SRC family tyrosine kinase, haematopoietic cell kinase (HCK) increased the rate of 
transcytosis of polystyrene microspheres, while expression of a dominant negative form 
blocked transcytosis (Asai and Morrison, 2013). In addition, the authors found that HCK 
expression is regulated by SpiB and that forced expression of SpiB or a related transcription 
factor, EHF, was sufficient to enhance transcytosis. The lack of progress in identifying 
regulators of M cell transcytosis is largely due to the difficulty in obtaining sufficient 
quantities of M cells to conduct rigorous biochemical studies.  
An alternative proposed mechanism of antigen transport across the FAE is the extension of 
dendrites via M cell-specific pores into the intestinal lumen by Peyer’s patch dendritic cells 
(Lelouard et al., 2012). Such extensions were observed in both mouse and rabbit Peyer’s 
patches and involved recruitment of epithelial cellular adhesion molecule and junctional 
adhesion molecule A to the pore-forming membrane of the M cell. Imaging suggested that 
the dendritic cells were capable of phagocytosing microspheres and live S. Typhimurium 
from the luminal surface of the epithelium, before withdrawing into the sub-epithelial 
dome. Previously, studies have demonstrated dendritic cells extending periscope-like 
tendrils between cells of the villus intestinal epithelium to sample luminal antigens 
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(Rescigno et al., 2001). This report highlights another route of antigen translocation in 
which M cells may be involved.  
1.4.4.3. Basolateral antigen handling and interaction with Peyer’s patch immune cells 
M cells are in close contact with immune cells, some even residing within the deep pocket 
formed within the M cell basolateral surface (Mabbott et al., 2013). This spatial 
arrangement is proposed to facilitate efficient transfer of translocated antigens between M 
cells and antigen-presenting cells; however, little is known about these processes. Ohno 
and colleagues showed that CXCL16 is expressed highly in the FAE compared to the villus 
epithelium and that its receptor, CXCR6/Bonzo, is upregulated on the surface of certain 
CD4+ T cells in the Peyer’s patch (Hase et al., 2006). Their findings suggest that CXCL16 
promotes migration of activated T cells to the sub-epithelial dome. The uncleaved form of 
CXCL16 also acts as a cell adhesion molecule, raising the possibility that it may contribute 
both to immune cell homing to the vicinity of M cells and their direct interaction with M 
cells.  
Recently, microvesicles have been described that are shed by M cells into the sub-epithelial 
space (Sakhon et al., 2015). In this study in mice, microvesicle release occurred 
constitutively and independently of particle translocation. Microvesicles were rapidly taken 
up by dendritic cells, where they frequently co-localised with transcytosed bacteria 
supplied to the intestinal lumen. The number and size of microvesicles appeared to be 
regulated by the type of bacteria supplied and by pro-inflammatory signals such as TLR2 
activation. The authors speculate that transcytosed bacteria are released from M cells 
inside the microvesicles, suggesting a possible pathway by which antigens may be delivered 
to antigen presenting cells. 
1.4.5. Role of M cells in disease  
1.4.5.1. Targeting of M cells by enteropathogens 
The same adaptations that enable M cells to perform their primary role of immune 
surveillance also make them vulnerable to targeting by enteropathogens seeking to invade 
the intestinal epithelium (Miller, 2007). The reduced or absent mucus layer covering the 
FAE allows close contact between luminal microbes and M cells. As discussed above, M cells 
also express molecules on their apical surfaces that act as receptors for bacterial antigens; 
for example, GP2, which interacts with bacterial fimbrial adhesion H (FimH), a component 
of type I pili (Hase et al., 2009). Finally, the transcytotic ability of M cells means that they 
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are specialised for transporting intact particles and even whole bacteria across the 
epithelium.  
The importance of M cells in the initiation of infection is demonstrated by the fact that 
infection with several enteric pathogens is impaired in M cell-deficient mice. In CCR6-
deficient mice, which have reduced M cell numbers, infection with Y. enterocolitica was 
blocked (Westphal et al., 2008). Additionally, infection with mouse mammary tumour virus 
was greatly reduced in mice lacking M cells as a result of the absence of B cells (Golovkina 
et al., 1999). An in vitro study in a cell line model indicated that the fungal pathogen 
Candida albicans selectively invades M cells (Albac et al., 2016). Interestingly, prion 
infection is also blocked in the absence of M cells and enhanced when M cell numbers are 
inflated (Donaldson et al., 2012, 2016). A number of other pathogenic agents have also 
been reported to preferentially infect Peyer’s patches rather than villus epithelium, 
including Listeria monocytogenes (Chiba et al., 2011), Mycobacterium avium subspecies 
paratuberculosis (Ponnusamy et al., 2013) and S. Typhimurium (Clark et al., 1994; Baumler, 
Tsolis and Heffron, 1996). Elsewhere, a lack of M cells in the airways was shown to prevent 
disseminated M. tuberculosis infection, suggesting that exploitation of M cells as a route of 
entry may be common to all mucosal surfaces (Nair et al., 2016). 
As described previously, S. Typhimurium is also able to stimulate enterocytes in crypts in 
the vicinity of lymphoid follicles to adopt an M cell-like phenotype (Tahoun et al., 2012). 
Bacterial effector protein SopB was shown to be responsible for the increase in M cell 
numbers by inducing expression of both RANK and RANKL and driving Wnt/β-catenin 
signalling. SopB is a phosphoinositide phosphatase that is injected into host cells via a type 
III secretion system and regulates many cellular pathways. Although the authors do not 
demonstrate that this process contributes to increased infectivity of S. Typhimurium, this is 
likely given the evidence for its selective invasion of M cells. M cell differentiation is 
therefore a further pathway exploited by pathogens to promote their own invasion.  
1.4.5.2. Involvement of M cells in inflammatory conditions 
There is some evidence suggesting a role for M cells in inflammatory intestinal conditions, 
such as inflammatory bowel disease. Firstly, the initial lesions observed in the development 
of Crohn’s disease tend to occur in the FAE overlying lymphoid follicles (Gullberg and 
Söderholm, 2006). An increase in M cell numbers in the colon has also been recorded in 
mouse models of colitis triggered by both dextran sodium sulphate and Citrobacter 
rodentium (Bennett et al., 2016). It is notable that certain cytokines that promote M cell 
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differentiation, such as TNF-α and LT-β, are also drivers of inflammation. Although it had no 
effect alone on M cell differentiation, TNF-α was found to enhance M cell differentiation 
stimulated by RANKL (Wood et al., 2016). Many patients  with inflammatory bowel disease 
(IBD) have elevated TNF-α and anti-TNF-α antibodies are commonplace in IBD treatment 
(Jones-Hall and Nakatsu, 2016). These data indicate a close relationship between M cells 
and inflammation. It is unclear, however, whether expansion of the M cell population in 
response to inflammatory signals promotes resolution by enhancing immune regulation, or 
whether more M cells allowing bacteria greater access to the mucosa could sustain and 
exacerbate inflammation. In support of the latter, increased translocation of both non-
pathogenic and adherent-invasive E. coli has been observed in the mucosa of Crohn’s 
patients (Keita et al., 2008). 
1.4.5.3. Targeting M cells for oral vaccine development 
Vaccination can offer a highly effective method of disease prevention. Most currently used 
vaccines are given parentally; however, development of successful oral vaccines is desirable 
for ease of administration and induction of protective immune responses at the mucosal 
surfaces, the initiation sites of most infections (Kim and Jang, 2014). Development of oral 
vaccines has been hampered by the challenge of efficient delivery of antigens to the GALT 
and requirement for an adjuvant that can overcome the tendency to develop tolerance to 
orally encountered antigens. M cells are of interest to this field because it is thought that 
their transcytotic ability could be exploited to aid antigen delivery. As a result, efforts have 
been made to combine vaccines with M cell ligands, including UEA-1 (Du et al., 2018) and 
the antigen-binding region of anti-GP2 (Shima et al., 2014). These conjugates showed 
increased efficacy compared to the same molecules lacking the M cell-targeting regions. 
Improved characterisation of M cell-specific markers and function is driving further efforts 
in this area. 
1.4.6. In vitro models for studying M cells  
1.4.6.1. Cell line models 
Progress in understanding of M cell biology has been severely limited by the challenging 
nature of studying native M cells in vivo in humans or animal models. In response, efforts 
have been made to develop suitable in vitro models. The first of these was described over 
two decades ago by Kernéis et al, who cultured the human colonic carcinoma Caco-2 cell 
line on the lower surface of Transwell inserts with primary murine Peyer’s patch B cells in 
the upper chamber of the insert (Kernéis et al., 1997). Although derived from a colorectal 
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adenocarcinoma, Caco-2 cells adopt a phenotype more similar to that of small intestinal 
enterocytes when grown beyond confluence, forming a polarised monolayer with apical 
microvilli, tight junctions and expression of brush border enzymes (Sambuy et al., 2005). 
This configuration allows the B cells to move through the pores of the Transwell filter and 
make direct contact with the Caco-2 cells. The authors observed a number of M cell-like 
phenotypic changes in the co-cultured Caco-2 cells, including redistribution of villin from 
the apical surface, irregular microvilli and increased translocation of both latex beads and 
live Vibrio cholerae. Further characterisation of this model also found reduced expression of 
alkaline phosphatase and increased apical α5β1 integrin on co-cultured Caco-2 cells (Tyrer 
et al., 2002).  
The model developed by Kernéis et al was later modified to avoid the need for access to 
primary lymphocytes by using the human Burkitt’s lymphoma Raji B cell line instead 
(Gullberg et al., 2000). In this version, the Raji B lymphoid cells and Caco-2 cells were 
physically separated by culturing the Caco-2 cells on the upper surface of the Transwell 
insert and placing the Raji cells in the lower chamber. This separation allowed the model to 
be used to study genes expressed specifically in the M-like cells (Lo et al., 2004). The 
authors again observed cells with disorganised microvilli and demonstrated downregulation 
of alkaline phosphatase and increased transcytosis of inert particles. M cell conversion was 
reportedly enhanced in a variation on this model, where inserts were inverted following 
seeding and adherence of Caco-2 cells to allow direct contact between epithelial cells and 
Raji B cells (des Rieux et al., 2007; Ahmad et al., 2017). The use of a Caco-2 sub-clone, 
C2BBe1 cells, has also been reported to increase the efficiency of M cell conversion 
(Masuda et al., 2011).  
A major advantage of these Transwell-based systems is the ease of investigating 
translocation across the epithelium due to the separated apical and basolateral 
compartments. This has been exploited to characterise factors that regulate particle 
transcytosis by M cells, including physical properties of the particles (des Rieux et al., 2005), 
cellular and bacterial receptors (Tyrer et al., 2006; Tahoun et al., 2011), and dietary 
components (Roberts et al., 2010, 2013). More recently, the model has been adapted to 
use murine (Gonzalez-Hernandez et al., 2013) and bovine (Miyazawa et al., 2010) intestinal 
epithelial cell lines and to include mucus-secreting, goblet cell-differentiated HT-29-MTX 
cells (Lesuffleur et al., 1990), to more accurately reflect in vivo conditions (Schimpel et al., 
2014; Araújo et al., 2016).  
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While the Caco-2/B cell co-culture system presents several advantages, its usefulness has 
been limited by variability and doubts over its physiological relevance. A comparison of 
gene expression in Caco-2 cells cultured with and without Raji cells revealed that co-culture 
alters expression of around 100 genes; however, on validation of co-localisation with UEA+ 
M cells in murine and human FAE, most of the genes investigated did not show M cell-
specific expression, although some were expressed throughout the FAE but not in villus 
epithelium (Lo et al., 2004). Notably, several important M cell-associated genes, including 
Spib, Gp2, Tnfaip2 (encoding TNFaip2 or M-Sec), Ccl9 (encoding CCL9), Marcksl1 (encoding 
MRP) and Prnp (encoding prion protein), have been found by microarray expression 
profiling not to be upregulated in co-cultured Caco-2 cells (Mabbott et al., 2013). Together, 
these data suggest that the transcriptome of Caco-2 cells in the co-culture model does not 
fully recapitulate that of Peyer’s patch M cells, although they do recapitulate certain 
phenotypic and functional characteristics of the FAE.  
1.4.6.2. Enteroid model 
Around the time of the discovery that RANKL is necessary and sufficient to induce M cell 
differentiation in mice (Knoop et al., 2009), a novel method of culturing primary intestinal 
stem cells was described (Sato et al., 2009). This followed from the discovery that leucine-
rich-repeat-containing G-protein-coupled receptor 5 (Lgr5)+ cells located at the base of 
small intestinal crypts were the stem cells that populated the intestinal epithelium and gave 
rise to all epithelial lineages (Barker et al., 2007). To generate these cultures, intestinal 
crypts containing Lgr5+ intestinal epithelial stem cells are isolated from primary tissue and 
suspended in a 3D matrix with a cocktail of specific factors that mimic the stem cell niche. 
Proliferation of the stem cells generates a spheroid with a polarised epithelium surrounding 
a hollow lumen that is equivalent to the intestinal lumen (Sato et al., 2009). Daughter cells 
undergo differentiation into all the major epithelial cell lineages and the activity of stem 
cells forms crypt regions with stem cells and Paneth cells at their base. As in vivo, cells are 
shed from the villus regions into the enteroid lumen. The technique has since been 
extended to different regions of the gastrointestinal tract and other organs, including 
stomach (Barker et al., 2010), colon (Sato, Stange, et al., 2011), liver (Huch et al., 2015) and 
brain (Lancaster et al., 2013). 
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Figure 1.6. Establishment and growth of enteroid cultures from mouse small intestine. Crypts 
are isolated from mouse small intestine and embedded in Matrigel matrix, which is 
subsequently overlaid with media supplemented with EGF, R-spondin-1 and Noggin to mimic 
the stem cell niche. Bright field and cartoon images show growth of a single stem cell-
containing crypt into a 3D enteroid. Soon after seeding, the crypt mouth closes to form a 
continuous epithelium around a central lumen. Over a matter of days, the proliferative activity 
of stem cells causes buds to form and cells differentiate into all major epithelial lineages, 
including Paneth, goblet and enteroendocrine cells. Accumulation of dead cells in the lumen 
makes it appear dark.  Scale bars represent 100 μm.  
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It was soon confirmed that application of RANKL in this system induced differentiation of M 
cells, which are otherwise absent from the enteroids (de Lau et al., 2012; Rios et al., 2016). 
The gene expression profile of M cells induced by RANKL in enteroids showed upregulation 
of 164 genes in common with in vivo Peyer’s patch M cells. Genes that showed the greatest 
upregulation in both include Spib, Gp2, Ccl9, Anxa5, Umod, Prnp, Ccl20 and Siglec5. Other 
genes previously identified as M cell-associated – Marcksl1 and Tnfaip2 – were also 
upregulated in RANKL-treated enteroids (Wood, Rios and Williams, 2016).  RANKL also 
increased the number of UEA-binding cells and induced uptake of beads (de Lau et al., 
2012). These data indicate that the M cells in the enteroid model closely resemble Peyer’s 
patch M cells. Since these initial studies in enteroids derived from mice, generation of M 
cells in a RANKL-dependent manner has also been demonstrated in human-derived 
enteroids grown both as 3D cultures and as 2D monolayers (Rouch et al., 2016). Again, M 
cells induced by RANKL in human enteroids showed increased expression of Spib and Gp2 
and enhanced uptake of beads and S. Typhimurium.  
Although relatively novel, the enteroid M cell model has already proved a useful tool for 
identifying factors that regulate M cell differentiation. Evidence from human-derived 
enteroids suggested that Wnt signalling primes epithelial cells for M cell differentiation, 
since a low dose of Wnt3a also increased expression of Spib and Gp2, although the increase 
was much smaller than with RANKL treatment (Rouch et al., 2016). In murine enteroids, 
TNF-α was shown to promote M cell differentiation by synergising with RANKL to induce 
NF-κB subunits, RelB and NF-κB2 (Wood, Rios and Williams, 2016). So far, no studies have 
utilised the 3D enteroid model to investigate bacterial-M cell interactions. This is an exciting 
goal as the 3D structure of the enteroids mimics the tissue architecture of crypts and villi 
found in vivo, making them a highly physiological model. Unfortunately, this increased 
complexity also means that the luminal compartment is only accessible by microinjection, 
which is technically challenging and not amenable to high throughput approaches.  
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Table 1.2. Models used to study M cells. 
 Transwell co-
culture 
Enteroid 
 
2D enteroid M cell-dense 
mouse model 
 
In vivo/ in 
vitro 
In vitro 
 
In vitro In vitro In vivo 
Species Human 
 
Mouse or human Human Mouse 
Epithelial 
component 
Caco-2 cell 
line 
Primary 
enterocytes 
derived from 
intestinal epithelial 
stem cells 
Primary 
enterocytes 
derived from 
intestinal 
epithelial stem 
cells 
Intestinal 
epithelium in 
vivo 
Stimulating 
factors 
Undefined 
factors 
secreted by 
Raji cells 
RANKL RANKL RANKL (via 
intraperitoneal 
injection) 
M cell 
characteristics 
reproduced 
Morphological 
features; 
transcytosis of 
beads, various 
bacteria and 
viruses 
Expression of SpiB, 
GP2, MRP, annexin 
V, TNFaip2; uptake 
of beads; 
morphological 
features not 
assessed 
Expression of 
SpiB, and GP2; 
uptake of 
beads and S. 
Typhimurium; 
morphological 
features not 
assessed 
Morphological 
features; 
increased UEA-
binding and 
expression of 
SpiB and GP2; 
uptake of beads 
and bacteria 
Advantages Ease of 
investigating 
transcytosis 
using 
Transwell 
system 
Mimics 3D 
intestinal structure; 
allows isolation of 
epithelial 
compartment or 
addition of specific 
immune cells via 
co-culture; 
primary, 
untransformed 
cells; can be made 
from many species 
(including human) 
Primary, 
untransformed 
cells; ease of 
investigating 
transcytosis 
using 
Transwell 
system; allows 
isolation of 
epithelial 
compartment 
Most 
physiologically 
relevant; 
contains all 
epithelial, 
mesenchymal 
and immune 
compartments 
Limitations Dubious 
physiological 
relevance 
Lumen only 
accessible by 
microinjection 
No 3D 
structure 
Species barrier 
if interested in 
human biology; 
highly complex 
Citation (Kernéis et al., 
1997; 
Gullberg et 
al., 2000; des 
Rieux et al., 
2007) 
(de Lau et al., 2012; 
Rios et al., 2016) 
(Rouch et al., 
2016) 
(Knoop et al., 
2009; 
Donaldson et 
al., 2016) 
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1.5. Hypothesis  
Enteroid cultures are a highly physiologically relevant model of the small intestinal epithelium, 
closely reproducing many structural and functional characteristics of the small intestinal 
epithelium in vitro. Enteroids may therefore be an informative system in which to investigate 
aspects of intestinal biology that have previously proved challenging to study, such as 
epithelial barrier function. With this in mind, development of this thesis has been driven by 
several hypotheses: 
1. Given previous evidence that regional identity is intrinsically programmed in intestinal 
stem cells, enteroids derived from different segments of the small intestine may retain 
region-specific characteristics in culture. 
 
2. Enteroids may be used to assay changes in epithelial permeability in response to various 
stimuli, including dietary components. 
 
3. Since M cells have been shown to differentiate from intestinal stem cells in response to 
the cytokine, RANKL, enteroids represent a suitable model in which to expand the M cell 
population, enabling a reductionist approach to identifying epithelium-intrinsic and -
extrinsic factors that regulate M cell differentiation and to characterising bacterial 
interactions with M cells. 
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1.6. Aims  
 
1. To further evaluate the ability of 3D, adult mouse stem cell-derived enteroid cultures to 
accurately reproduce their tissue of origin, including region-specific characteristics of the 
small intestine.  
 
2. To develop an assay to measure epithelial permeability in 3D enteroid cultures that can 
be used to evaluate potential effects of bacteria and dietary components on intestinal 
epithelial barrier function.  
 
3. To further characterise the RANKL-induced M cell enteroid model by quantifying the 
effect of exogenous RANKL on non-M cell epithelial cell lineages. 
 
4. To investigate the role of alternative pathway NF-κB signalling in RANKL-induced M cell 
differentiation in enteroids.  
 
5. To develop an assay in which to investigate interactions of particles and bacteria with M 
cells in the enteroid model.  
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Chapter 2 
 
Methods 
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2.1. Materials  
Unless otherwise specified, all general chemical reagents were obtained from Sigma-Aldrich 
(Gillingham, UK). Plastics for mammalian cell culture were supplied by Corning (Amsterdam, 
The Netherlands). Transwell inserts were from Millipore Ltd (Watford, UK). Plastics used for 
solid agar and broth bacterial culture were from Greiner Bio-One (Gloucestershire, UK). 
BactoTM agar, yeast extract and tryptone used in bacterial cultures were obtained from BD 
Biosciences (Oxford, UK). All materials used for transmission electron microscopy (TEM) were 
supplied by Agar Scientific (Stansted, UK) or TAAB Laboratories Equipment (Aldermaston, UK). 
Recombinant murine epidermal growth factor (EGF), Noggin and R-spondin-1 were obtained 
from Bio-techne (Abingdon, UK). Recombinant murine RANKL was obtained from BioLegend 
(London, UK).  
2.2. Mice 
Wild type C57BL/6 and BALB/c controls were obtained from Charles River (Margate, UK). 
Transgenic Nfkb2-/- mice maintained on a C57BL/6 background were kindly provided by Jorge 
Caamaño (University of Birmingham, UK) via Mark Pritchard (University of Liverpool, UK) 
(Caamaño et al., 1998). Relb-/- mice were bred on a 129/B6 background and back-crossed onto 
a C57BL/6 background (Weih et al., 1995). All mice were maintained under specific pathogen-
free conditions in the Biomedical Services Unit at the University of Liverpool. Mice were 
maintained under UK Home Office licences in the Biomedical Services Unit at the University of 
Liverpool. Schedule 1 sacrifices were performed either by cervical dislocation or CO2 
inhalation. 
2.3. Genotyping of enteroid cultures obtained from Nfkb2-/- and Relb-/- mice 
Genomic DNA was extracted from Nfkb2-/- enteroid cultures by hot alkaline lysis. Samples were 
lysed in base solution (25 mM NaOH, 0.2 M EDTA, pH 12.0) for 30 minutes at 95°C. Lysates 
were neutralised with an equal volume of neutralising solution (40 mM Tris-HCl, pH 5.0). 
Polymerase chain reaction (PCR) was performed using GoTaq G2 Green 2X Master Mix 
(Promega, Southampton, UK) and primers specific for either the wild type or knockout alleles 
of the Nfkb2 gene. Primer sequences are shown in Table 2.1. Wild type alleles are 
characterised by a 230-base pair (bp) amplicon, whereas Nfkb2 null alleles give rise to a 120 bp 
product (Figure 2.1). PCR was performed using a Multigene Optimax thermal cycler (Labnet 
Internatinal, New Jersey, USA) with the cycling conditions as detailed in Table 2.2. PCR 
products were separated in a 1.5% w/v agarose gel (UltraPure agarose, Invitrogen, 
Loughborough, UK) in 1X Tris-acetate-EDTA (TAE) buffer containing 1X SYBR Safe DNA gel stain 
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(Invitrogen) at 100 V. Bands were visualised using a Universal Hood II transilluminator (BioRad, 
Watford, UK). 50 bp GeneRuler DNA ladder (Thermo Fisher Scientific, Loughborough, UK) was 
used to determine the product size.  
 
Table 2.1. Sequences of primers used for Nfkb2-/- genotyping PCR. 
Primer 
 
Sequence (5’-3’) 
Common forward GCCTGGATGGCATCCCCG 
WT-specific reverse GTTTGGGCTGTTCCACCA 
Null-specific reverse CCAGACTGCCTTGGGAAA 
  
 
Table 2.2. Cycling conditions used for Nfkb2-/- genotyping PCR. 
Temperature (°C) 
 
Time (s) Cycles 
95 60 1 
95 20 
35 55 90 
72 60 
72 120 1 
 
 
 
 
Figure 2.1. Representative image of Nfkb2-/- genotyping PCR products separated by gel 
electrophoresis in a 1.5% w/v agarose gel to validate genotype of Nfkb2-/- enteroids. Ladder is 
GeneRuler 50 bp DNA ladder (Thermo Fisher Scientific).  
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Relb transgenic mice were routinely genotyped for breeding purposes by Dr Katie Lloyd 
(University of Liverpool, UK). Genomic DNA was extracted from ear notches by incubating 
tissue in 20 μL DNAreleasy (Anachem, Leicester, UK) at 75°C for 5 minutes, followed by 96°C 
for 2 minutes. Two PCR reactions were performed per sample using ThermoPrime ReddyMix 
master mix (Thermo Fisher Scientific) with two primer sets: one specific for the wild type Relb 
gene, one specific for the Relb-/- locus. Primer sequences are shown in Table 2.4. The wild type 
gene gives rise to a product of 357 bp, while the null allele generates a product of 225 bp. 
Cycling conditions used for PCR are shown in Table 2.4. Gel electrophoresis of PCR products 
was performed as above for Nfkb2-/- genotyping. Only tissue from confirmed Relb-/- mice was 
used to establish enteroid cultures. 
 
 
 
Table 2.3. Sequences of primers used for Relb genotyping PCR. 
Primer 
 
Sequence (5’-3’) 
WT-specific forward GTGGTGCCCGGGAATAGGATTGCT 
WT-specific reverse CCATTTTGCTCTGGGTCTGTGTCT 
Relb null-specific forward CATCGACGAATACATTAAGGAGAACGG 
Relb null-specific reverse AAATGTGTCAGTTTCATAGCCTGAAGAACG 
 
 
 
Table 2.4. Cycling conditions used for Relb genotyping PCR. 
Temperature (°C) 
 
Time (s) Cycles 
95 120 1 
95 60 
35 60 90 
72 60 
72 300 1 
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Figure 2.2. Representative image of Relb genotyping PCR products separated by gel 
electrophoresis in 1.5% w/v agarose gels. Upper gel shows products from PCR with primers 
for wild type Relb; lower gel shows products from PCR with primers for Relb null allele. 
Reactions for the same mouse are in matched lanes in each gel. Ladder is Hyperladder IV (100 
bp, Bioline, London, UK). Labels beneath indicate genotype of each animal as shown by the 
two PCRs.  
 
2.4. Enteroid culture 
2.4.1. Crypt isolation 
Enteroid cultures were derived from the following mouse strains: C57BL/6, BALB/c, Nfkb2-/- 
and Relb-/-. To establish cultures, a 3-5 cm section of small intestine from either the proximal 
or distal region was flushed with ice cold phosphate buffered saline (PBS, pH 7.4) and opened 
longitudinally. The tissue was cut into approximately 1 cm lengths and washed by agitating 
with ice-cold PBS. Tissue was incubated in chelation buffer (2 mM 
ethylenediaminetetraacetic acid (EDTA)/PBS) on a rolling platform at 4°C for 30 minutes. 
Tissue was briefly agitated by hand to facilitate detachment of some villous material. 
Chelation buffer was removed and replaced with shaking buffer (43.3 mM sucrose, 59.4 mM 
sorbitol/PBS) and tissue was agitated by hand until crypts were released from the tissue. The 
solution was filtered using a 70 μm cell strainer on ice and the filter was washed with further 
ice-cold shaking buffer. The filtrate was centrifuged at 200 x g for 10 minutes at 4°C and 
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supernatant carefully removed. Pelleted crypts were re-suspended in ice-cold Matrigel 
(Corning), containing EGF, Noggin and R-spondin-1 (at final concentrations of 50 ng/mL, 100 
ng/mL and 500 ng/mL, respectively; all R&D Systems, Abingdon, UK) and 50 μL of this 
suspension was plated per well in a 24-well plate. Matrigel was allowed to polymerise for at 
least 10 minutes at 37°C then 500 μL minigut media was added to cover the Matrigel domes. 
Minigut media consisted of phenol red-free Dulbecco’s Modified Eagle Medium (DMEM)/F12 
(Thermo Fisher Scientific) with 25 mM HEPES buffer, 4.5 mM L-glutamine, 1X N-2 
supplement, 1X B-27 supplement and 100 μg/mL primocin (Invivogen, Toulouse, France). 
Media was replaced after 3-4 days with fresh minigut media supplemented with 50 ng/mL 
EGF, 100 ng/mL Noggin and 500 ng/mL R-spondin-1. 
2.4.2. Maintenance of enteroid cultures 
Media on enteroids was replaced every 3-4 days with fresh minigut medium supplemented 
with 50 ng/mL EGF, 100 ng/mL Noggin and 500 ng/mL R-spondin-1. Cultures were passaged 
every 7 days by removing medium and pipetting up and down with ice-cold PBS to break up 
Matrigel dome. Enteroids were mechanically disrupted by passing vigorously through a 27G 
needle and resuspended in fresh Matrigel supplemented with growth factors, as for initial 
establishment of cultures. The splitting ratio was 1:3-1:4. Matrigel was re-plated in pre-
warmed 24-well plates, allowed to polymerise and overlaid with 500 μL minigut medium. 
2.4.3. Cryopreservation and thawing  
Matrigel was disrupted mechanically as for passaging by pipetting up and down with ice-cold 
PBS but was not passed through a syringe. Enteroids were centrifuged and resuspended in 
minigut medium supplemented with 10% v/v foetal bovine serum (FBS), 10% v/v dimethyl 
sulfoxide (DMSO). Cryovials were cooled gradually for 2 hours-overnight to -80°C in a 
Nalgene Mr Frosty freezing container, before being transferred to liquid nitrogen. To 
reinstate cultures stored in liquid nitrogen, frozen enteroids were thawed rapidly in a 37°C 
water bath, centrifuged for 30 seconds at 100 x g, washed once in cold, sterile PBS, and 
resuspended in Matrigel supplemented with growth factors, as described for initial 
establishment of cultures.  
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2.5. Culture of cell lines 
2.5.1. Caco-2 cells 
Caco-2 cells (ATCC HTB-37) were kindly provided by Dr Andrea Davies (University of 
Liverpool, UK). This is an adherent colonic epithelial cell line derived from a human colon 
carcinoma (Sambuy et al., 2005). Once they have formed a confluent monolayer, Caco-2 cells 
undergo spontaneous differentiation and display many characteristics of polarised absorptive 
enterocytes typical of the small intestine, including a brush border. Caco-2 cells were 
maintained in high-glucose DMEM supplemented with 10% v/v FBS, 100 U/mL penicillin and 
100 μg/mL streptomycin.  
2.5.2. Raji B cells 
Raji B cells (ATCC #CCL-86; Middlesex, UK) are a non-adherent human cell line derived from a 
Burkitt’s lymphoma and are used as a model of human B lymphocytes. Cells were maintained 
in suspension culture in Roswell Park Memorial Institute-1640 (RPMI-1640, Thermo Fisher 
Scientific) medium supplemented with 10% v/v FBS, 100 U/mL penicillin, 100 μg/mL 
streptomycin and 4 mM L-glutamine. Cells were maintained at 37°C in a humidified 
atmosphere of 5% CO2, 95% air. Cells were passaged every 3-4 days by removing two thirds 
of the cell suspension and replacing with fresh medium.  
 
Since factors secreted by Raji B cells have been shown to convert Caco-2 cells to an M cell-
like phenotype (Gullberg et al., 2000), Raji B-conditioned medium was produced to 
investigate whether it would also convert epithelial cells in enteroids. For production of Raji B 
cell-conditioned medium, 3 x 105 cells/mL were seeded in DMEM supplemented with 10% 
FBS and 8 mM L-glutamine. After 5 days, cell suspension was centrifuged at 2000 x g for 5 
minutes to remove cells and cell debris and culture medium was stored at -80°C. Control 
medium (without Raji B cells) was kept under identical conditions in parallel tissue culture 
flasks in the incubator and processed as above for conditioned medium.  
 
2.6. Co-culture of enteroids and Raji B lymphocytes 
Raji B cells were co-cultured with enteroids to assess whether B cells would induce conversion 
of intestinal epithelial cells to M cells. Raji B cells were not passaged during the 2 days prior to 
the experiment. Murine enteroids were passaged at day 7 and re-seeded in 50 μL Matrigel in a 
24-well plate as per normal maintenance. Raji B cells were harvested by centrifugation (300 x 
g, 5 minutes) and resuspended in minigut medium at a density of 2 x 105 cells/mL. Once 
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polymerised, Matrigel droplets were overlaid with 0.5 mL Raji cell suspension so that each well 
contained ~1 x 105 cells. On day 3 of co-culture, Raji B cells were resuspended by gentle 
aspiration and removed, and replaced with fresh lymphocytes (again, 1 x 105 cells/well), or 
they were allowed to settle and only the culture medium was replaced. On day 6, culture 
medium and cells were removed and enteroids were harvested for RNA extraction to analyse 
expression of M cell-associated genes.   
 
2.7. Immunohistochemical analysis of epithelial cell markers 
2.7.1. Harvesting, fixation, paraffin-embedding and preparation of enteroid 
sections 
Medium was removed and Matrigel domes were washed once with ice-cold, sterile PBS. 
Matrigel was dissociated by adding 0.4 mL of Cell Recovery Solution (Corning) over the dome 
and incubating on a shaking platform for 45 minutes at 4°C. Enteroids were fixed with 2% w/v 
PFA in PBS for 30 minutes at room temperature. Enteroids were isolated by allowing to settle 
or by centrifuging at 100 x g for 30 seconds. Supernatant was removed as far as possible and 
enteroids were re-suspended in 75-200 μL Richard-Allan Scientific HistoGel Specimen 
Processing Gel (Thermo Fisher Scientific), depending on number of enteroids. A pellet was 
made with the HistoGel and allowed to cool and set, before being placed into a Histosette II 
histology cassette (Simport Scientific, Quebec, Canada). Cassettes were stored in 70% v/v 
ethanol in H2O for at least 2 hours. Samples were processed by dehydrating through a series 
of graded ethanol from 70-100%, then cleared by overnight incubation in xylene, followed by 
three incubations of 5 minutes in fresh xylene. Finally, infiltration of samples with paraffin 
wax was achieved by incubating for 2 and then 3 hours in wax at 60°C. Processed pellets 
were embedded in paraffin wax in peel-a-way embedding moulds (Simport Scientific) to 
make blocks. Sections of 4 μm were cut using an RM2255 microtome (Leica Microsystems, 
Milton Keynes, UK). Sections were placed onto glass slides pre-coated with 3-
aminopropyltriethoxysilane (APES) and incubated in a dry oven at 37°C for at least 10 hours.  
2.7.2. Fixation, embedding and preparation of mouse small intestine sections 
Preparation of intestinal tissue blocks was performed by Dr Carrie Duckworth (University of 
Liverpool, UK) according to the gut bundling method (Williams et al., 2016). Small intestine 
from C57BL/6 mice was removed immediately after sacrifice, flushed using a 23 G syringe 
with ice-cold PBS and incubated in formalin (3.75% w/v formaldehyde in PBS) for 24 hours at 
room temperature to fix. The small intestine was then divided into proximal, middle and 
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distal thirds and each was cut into approximately 1 cm lengths. Segments were arranged in 
parallel inside a loop of micropore tape and placed into histology cassettes. Samples were 
processed as described previously and paraffin-embedded so that cross-section of the lumen 
was parallel with the resulting block face. As above, 4 μm sections were cut using the 
RM2255 microtome, collected on slides pre-coated with APES and dried.  
2.7.3. Immunohistochemical analysis of paraffin-embedded sections 
Sections were deparaffinised in xylene and re-hydration was begun in 100% ethanol. 
Endogenous tissue peroxidase activity was blocked by placing sections in 3% hydrogen 
peroxide in methanol for 10 minutes. Rehydration of sections was completed through a 
graded series of alcohols from 100% to 70%. Antigen retrieval was then performed by 
heating sections in 10 mM sodium citrate buffer (pH 6) for 20 minutes. After cooling 
gradually over 20 minutes, sections were washed in Tris-buffered saline (TBS; 20 mM Tris, 
150 mM NaCl, pH 7.4) containing 0.1% Tween-20 (TBST) and blocked with 2.5% v/v 
appropriate serum for 30 minutes at room temperature in a humidified chamber. Primary 
antibodies (diluted in 2.5% serum at titres described in Table 2.5) were applied overnight at 
4°C or for 2 hours at room temperature. Sections were washed in TBST and detection of 
primary antibodies was performed using ImmPRESS horse radish peroxidase (HRP) polymer 
detection kit appropriate for the species of the primary antibody (Vector Laboratories, 
Peterborough, UK). The HRP-conjugated polymer reagent was applied for 30 minutes at 
room temperature. Following further washes in TBST, sections were incubated for 
approximately 6 minutes in the dark with a solution of 0.7 mg/mL 3,3’-diaminobenzidine 
(DAB), 2 mg/mL urea hydrogen peroxide, 60 mM Tris buffer. Sections were counterstained 
with haematoxylin, dehydrated, and mounted with distyrene-plasticiser-xylene (DPX) 
mountant (Sigma-Aldrich). 
 
Table 2.5. Details of primary antibodies used for immunohistochemical analysis. 
Target 
 
Antibody and supplier Species & specificity Titre  
Lysozyme (Lyz) Dako, A0099 Rabbit anti-human/mouse 1:3500 
Trefoil factor 3 (TFF3) Santa Cruz, sc-18272 Goat anti-mouse polyclonal 1:500 
Chromogranin A (CgA) Abcam, ab15160 Rabbit anti-mouse/human 1:800 
Active caspase 3 R&D Systems, AF835 Rabbit anti-human/mouse 1:800 
DCLK1 Abcam, ab31704 Rabbit anti-mouse 1:500 
SpiB Bio-techne, AF7204 Sheep anti-mouse 1:25 
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2.8. Immunofluorescence staining of tight junction proteins in Caco-2 cell 
monolayers  
Following fixation by incubating with 4% w/v methanol-free paraformaldehyde (PFA; TAAB 
Laboratories Equipment) in PBS for 10 minutes at room temperature, Caco-2 cells cultured on 
13 mm glass coverslips were washed three times with PBS. Cell membranes were then 
permeabilised by incubating with 0.2% Tween-20, 0.5% Triton X-100 in PBS for 30 minutes at 
4°C. Non-specific binding sites were blocked by incubating cells with 3% w/v bovine serum 
albumin in PBS for 1 hour at room temperature. Primary antibodies were applied to cell 
monolayers overnight at 4°C diluted in 1% w/v bovine serum albumin in PBS at the dilutions 
indicated in Table 2.6. Cells were washed three times with PBS and incubated with Hoechst-
33342 diluted 1:5000 in PBS for 5 minutes at room temperature. After three further washes, 
coverslips were mounted on glass slides using mounting medium (4 mM Mowiol 4-88 with 
2.5% 1,4-diazabicyclo[2.2.2]octane (DABCO)). Slides were examined and images captured using 
a Zeiss LSM 800 microscope and Zen Blue software. Identical laser power and gain settings 
were used for each sample.  
 
Table 2.6. Details of primary antibodies used for immunofluorescence analysis. 
 
 
2.9. Quantitative RNA analysis 
Medium was removed and Matrigel domes were washed once with ice-cold, sterile PBS. Since 
Matrigel is manufactured from mouse tumour cells, it is likely to contain RNA. As a result, it is 
essential that Matrigel is removed from enteroid samples as completely as possible prior to 
analysis. Matrigel was dissociated by adding 0.4 mL of Cell Recovery Solution over the dome 
and incubating on a shaking platform for 45 minutes at 4°C. Enteroids were isolated from this 
suspension by centrifuging at 200 x g for 10 minutes and removing supernatant. Enteroids 
were washed once in ice-cold PBS and centrifuged at 300 x g for 5 minutes at 4°C. PBS was 
removed as far as possible and RNA was either extracted immediately or enteroid pellets were 
Target 
 
Antibody and supplier Species & specificity Titre  
Zonula occludens 1 
(ZO-1) 
Thermo Fisher Scientific, 61-
7300 
Rabbit anti-human 1:50 
Occludin  Abcam, ab31721 Rabbit anti-human 1:500 
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stored at -80°C. Enteroids were disrupted and cells lysed by resuspending in Buffer RLT and 
bead beating in a TissueLyser II at 30 Hz for 30 seconds with a 5 mm stainless steel bead, then 
rotating tubes and repeating (all Qiagen, Manchester, UK).  
Total RNA was extracted using the RNeasy minikit and purified using the RNase-free DNase set 
(both Qiagen). Equal amounts of RNA from the same experiment (up to 1 μg) were reverse 
transcribed using the RT2 First Strand kit (Qiagen) and cDNA was stored at -80°C.  
Quantitative PCR (qPCR) was performed according to manufacturer’s instructions using SYBR 
green I master (Roche, Welwyn Garden City, UK) and manufacturer-verified RT2 primer assays 
for Gapdh, Gp2, Spib and Tnfrsf11a (Qiagen, details in Table 2.7) in a LightCycler 480 (Roche). 
Cycling conditions used are detailed in Table 2.8. Amplification of a single, specific amplicon 
was confirmed from melt curves. Where no threshold cycle (CT) value was detected 
consistently, an arbitrary value of 40 was assigned (McCall et al., 2014). Due to consistent non-
detection of certain gene products in control samples, data was analysed by the ΔCT method 
(Schmittgen and Livak, 2008) where the CT value of the gene of interest was normalised to that 
of the housekeeping gene, Gapdh and are expressed as 2-ΔCT. Gapdh mRNA levels were 
unchanged in experimental samples compared to controls.   
 
 
Table 2.7. Primers used for qPCR. †Reference position refers to a position contained within 
the sequence of the amplicon relative to the start of the relevant RefSeq sequence (as Qiagen 
do not make public exact primer sequences). 
Gene name 
 
Full name 
 
RefSeq 
Accession no. 
 
Reference 
position† 
Source Catalogue 
no. 
Gapdh Glyceraldehyde-3-
phosphate 
dehydrogenase 
NM_008084 478 Qiagen PPM02946E 
Spib Spi-B transcription 
factor 
NM_019866 635 Qiagen PPM04709A 
Gp2 Glycoprotein 2 NM_025989 1444 Qiagen PPM29342A 
Tnfrsf11a  TNF receptor 
superfamily, 
member 11a 
(Rank) 
NM_009399 1353 Qiagen PPM03749F 
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Table 2.8. Cycling conditions used for qPCR. 
Step  
 
Number of 
cycles 
Target temperature 
(°C) 
 
Hold time 
(00:00:00) 
Ramp rate 
(°C/s) 
Denaturation 1 95 00:10:00 4.4 
Amplification 50 95 00:00:15 1 
60 00:01:00 1 
Melt curve 1 60 00:00:15 4.4 
95 - 0.03 
 
 
2.10. Assessment of epithelial permeability in enteroids using luminally 
microinjected fluorescent dextrans 
To investigate permeability of the intestinal epithelium under several different conditions, an 
assay was established using enteroids, based on an experiment described previously to 
evaluate intestinal permeability in response to bacterial infection (Leslie et al., 2015). 
Enteroids were seeded in Matrigel as described above on 13 mm glass coverslips in 24-well 
plate. On day 3-5 post-passage, coverslips were removed from wells. Only enteroids with an 
apparently undisrupted epithelium were selected for injection. Microinjection was performed 
using a Femtojet microinjector and Injectman micromanipulator (both Eppendorf, Stevenage, 
UK). A mixture containing 5 mg/mL 4 kDa fluorescein isothiocyanate-conjugated dextran (FD4, 
Sigma-Aldrich) and 1 mg/mL 10 kDa Alexa Fluor 594-conjugated dextran (Thermo Fisher 
Scientific) in H2O was injected into the central lumen of 2-7 enteroids per well (Figure 2.3). 
Micropipettes used were made from borosilicate glass capillaries with a 1 mm outer diameter 
and 0.58 mm internal diameter (Harvard Apparatus, Edenbridge, UK) using a DMZ Universal 
electrode puller (Zeitz Instruments, Martiensried, Germany) with the settings detailed in Table 
2.9. Matrigel domes were washed twice in warm PBS and returned to complete medium.  
Microinjected enteroids were incubated at 37°C for 3.5 hours as luminal dextran levels were 
determined to stabilise by this time after a large initial decrease, presumably due to leakage 
from the puncture site (Figure 2.4). Enteroids were then imaged using a BX51 epifluorescence 
microscope (Olympus, Southend-on-Sea, UK). This was taken as time zero (t0) and the same 
enteroids were then imaged at hourly intervals, for up to 4 hours (t4). For each enteroid, bright 
field and red and green fluorescence images were collected. Exposure settings were adjusted 
for each enteroid at t0 and kept constant for all subsequent images of that enteroid. Analysis 
was performed using ImageJ 1.48v software (Schneider, Rasband and Eliceiri, 2012). Bright 
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field and fluorescence images were synchronised and the perimeter of each enteroid was 
defined from the bright field image for each time point. The mean pixel intensity within this 
area was measured and expressed as a percentage of the mean pixel intensity for that 
enteroid at t0.  
 
 
Figure 2.3. Microinjection of FD4 into enteroid lumen. Upper panel: bright field images 
showing enteroids within the Matrigel during microinjection. The microcapillary can be seen 
entering from the left. Lower panel: left image is a bright field image of an enteroid following 
luminal microinjection with FD4. Right image shows FD4 fluorescence inside the same 
enteroid.  
 
 
Table 2.9. Settings used to pull microcapillaries for microinjection of enteroids.  
Parameter 
 
Value 
Heat for glass softening, H 400 
Preliminary pull, F(TH) O3O 
Distance threshold for elongation, s(TH) O22 
AD 12O 
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Figure 2.4. Quantification of loss of luminal fluorescence from enteroids following 
microinjection with FD4. N = 2, n = 3-4 enteroids per group. Error bars represent standard 
deviation (SD). 
 
2.11. Analysis of enteroid swelling 
Based on an assay previously used to investigate CFTR activity in enteroids (Dekkers et al., 
2013), the surface area of enteroids in bright field images was used to assess enteroid swelling. 
Enteroids were seeded in 25 μL Matrigel in 48-well plates and overlaid with 200 μL complete 
minigut medium. Experiments were performed on the second day post-seeding. Bright field 
images were collected of 5-8 enteroids per well prior to incubation with treatments and then 
at 0.5, 1, 2, 3 and 4 hours post-treatment. The cystic fibrosis transmembrane conductance 
regulator (CFTR) is expressed on the apical membrane of enterocytes and is the major 
regulator of intestinal fluid secretion. CFTR-mediated secretion of chloride ions results in 
movement of sodium ions and water into the intestinal lumen in response to the change in 
electrochemical and osmotic gradients (Saint-Criq and Gray, 2017). Forskolin has previously 
been shown to induce enteroid swelling by activating CFTR-dependent movement of fluid into 
the lumen (Dekkers et al., 2013) and was therefore used as a positive control (5 μM, Sigma-
Aldrich). CFTR-dependent swelling was blocked by pre-incubation of enteroids for 3 hours with 
50 μM CFTR-inh-172 (Bio-techne), a selective CFTR inhibitor (Ma, Thiagarajah, et al., 2002; 
Dekkers et al., 2013). CFTR-inh-172 produces rapid, reversible and voltage-independent 
inhibition of Cl- secretion via the CFTR and is known to prevent intestinal fluid secretion 
induced by cholera toxin (Ma, Thiagarajah, et al., 2002). Enteroid perimeter was specified for 
each image and its area was determined using ImageJ software. Mean enteroid area at each 
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time point was normalised to mean enteroid area of that group at the first time point prior to 
treatment.  
 
2.12. Transmission electron microscopy 
2.12.1. Fixation and processing 
2.12.1.1. Enteroids 
All preparation of samples and imaging was carried out in the Biomedical Electron 
Microscopy Unit at the University of Liverpool, UK. Enteroids were harvested for 
transmission electron microscopy (TEM) on day 3 post-seeding, Matrigel was dissociated by 
incubation with Cell Recovery Solution for 45 minutes on ice with shaking. Enteroids were 
washed once with ice-cold PBS and fixed in 2.5% w/v glutaraldehyde in 0.1 M phosphate 
buffer (PB, 0.1 M Na2HPO4, 0.1 M Na2H2PO4, pH 7.4) in a PELCO BioWave Pro+ Microwave 
Tissue Processing System (Ted Pella Inc., California, USA). The fixation programme was 20 
Hg and 100 W for 1 minute on, 1 minute off, 1 minute on. Enteroids were then washed at 
least 3 times with 0.1 M PB and post-fixed and stained with reduced osmium (2% w/v OsO4 
in double distilled H2O (ddH2O) with 1.5% w/v potassium ferrocyanide) in the BioWave for 
20 seconds on, 20 seconds off, 20 seconds on, 20 seconds off at 20 Hg and 100 W. All stains 
were filtered with a 0.22 μm syringe filter prior to use.  
 
Incubation with the mordant 1% w/v thiocarbohydrazide in ddH2O was performed for 5 
minutes at room temperature. A second osmium staining was then performed with 2% w/v 
osmium in ddH2O in the Biowave (20 Hg, 100 W, 20s on-20s off-20s on-20s off) before an 
overnight incubation at 4°C in aqueous 1% w/v uranyl acetate.  
 
The following day, enteroids were stained with lead aspartate (0.02 M lead nitrate in 0.03 
M aspartic acid in ddH2O, pH 5.5) for 30 minutes at room temperature. Enteroids were 
dehydrated through a graded series of ethanol (70-100%) and then acetone (100%). Resin 
infiltration was performed in 1:1 mixture of 100% acetone and Epon 812 hard premixed 
resin kit (TAAB Laboratories Equipment) for 30 minutes, followed by two 30-minute 
infiltration steps in 100% hard resin. Finally, enteroids were embedded in hard resin in a 
flexible plastic dish and polymerised at 60°C in a dry oven for at least 48 hours. 
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2.12.1.2. Intestinal tissue  
Intestinal tissue samples approximately 1 mm3 in size were dissected from the proximal or 
distal ends of the small intestine of a C57BL/6 mouse. Samples were washed gently in ice-
cold PBS and fixed temporarily in 4% w/v PFA and 2% w/v glutaraldehyde in 0.1 M PB, pH 
7.4. As soon as possible, samples were transferred to 2.5% w/v glutaraldehyde in 0.1 M PB 
and fixed in the Biowave using the fixation programme. Samples were incubated in the 
fixative overnight at room temperature. After washing in 0.1 M PB, samples were stained 
with reduced 2% w/v OsO4 in the Biowave and washed again. Samples were stained again 
with 2% w/v OsO4 in ddH2O in the Biowave, washed, and incubated overnight at 4°C in 1% 
w/v uranyl acetate in ddH2O. The following day, samples were washed and sequentially 
dehydrated through a graded series of ethanol (70-100%) and then acetone (100%), each 
for 10 minutes. Resin infiltration was performed for 30 minutes each in 2:1, 1:1, 1:2, 1:3 
solutions of acetone: medium resin. After two 30-minute incubations in 100% resin, 
samples were embedded in 100% resin and polymerised at 60°C in a dry oven for at least 48 
hours. 
2.12.2. Preparation of blocks and sectioning 
Excess resin was trimmed away using a hacksaw and razor blade, then the blocks were 
mounted on a cryopin using super glue or epoxy resin. Block faces with dimensions of 350 x 
350 μm were cut using a glass knife on an UC6 ultramicrotome (Leica Microsystems) and 
then 70-80 μm thick sections were cut using a diamond knife (Diatome, Switzerland). 
Sections were collected on copper grids (TAAB), which were prepared by coating with 0.3% 
w/v pioloform (polyvinyl butyral), and left to dry for at least 24 hours.  
2.12.3. Post-staining of small intestinal tissue sections 
To gain additional contrast, intestinal tissue sections prepared as described above were post-
stained for 5 minutes at room temperature with 4% w/v uranyl acetate in ddH2O, followed by 
washing in three separate baths of ddH2O. Sections were then incubated for 5 minutes with 
Reynolds’ lead citrate (TAAB), washed again, and dried at room temperature.  
2.12.4. Transmission electron microscopy 
Sections were imaged at 100-120 kV in a Tecnai G2 Spirit BioTWIN transmission electron 
microscope (FEI, Cambridge, UK) using analySIS 3.2 software (FEI) and Gatan Microscopy 
Suite software (Gatan, California, USA).  
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2.13. Statistical analysis 
All statistical analyses were performed using Prism 6 (Version 6.01; GraphPad Software, Inc, 
California, USA). Data values in the text are expressed as mean ± standard error of the mean 
(SEM). N values refer to the number of independent experiments performed; n values refer to 
the number of replicates for individual experimental groups. Data sets exhibiting a normal 
distribution, as assessed using a Shapiro-Wilk normality test, were analysed using unpaired 
Student t-tests or one-way analysis of variance (ANOVA, to compare more than two sample 
groups) followed by multiple pairwise comparisons. Data that was not normally distributed 
were analysed using non-parametric tests, such as Mann-Whitney test. Spearman correlation 
coefficients were used to assess correlation between two measured variables. The threshold 
used to determine statistical significance was p < 0.05.  
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Chapter 3 
 
Location-specific characteristics 
of enteroids derived from murine 
proximal or distal small intestine 
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3.1. Introduction  
The small intestine is largely anatomically and physiologically similar in both humans and mice, 
making the mouse a good model for many aspects of human intestinal biology (Nguyen et al., 
2015; Hugenholtz and de Vos, 2018). In both species, the small intestine begins after the 
pyloric sphincter and ends at the ileocaecal junction. Along its cephalocaudal axis, the small 
intestine is divided into three regions – the duodenum, jejunum and ileum – which have 
distinct functions and must cope with different physiological challenges. Briefly, the duodenal 
epithelium produces digestive enzymes and bicarbonate, the latter of which contributes to 
neutralising the gastric chyme to support the former in breaking down macromolecular 
nutrients. Absorption of certain essential nutrients, such as the minerals iron and calcium, also 
begins in the duodenum. The majority of nutrient and water absorption occurs in the jejunum. 
Here, the epithelium expresses many brush border nutrient-specific transporters, such as the 
sodium-coupled glucose and neutral amino acid symporters (Bröer, 2008; Chen, Tuo and Dong, 
2016). In the ileum, absorption of key fat- and water-soluble vitamins occurs (Reboul and 
Borel, 2011; Said, 2011) and bile salts are reabsorbed (Dawson and Karpen, 2015). As a result, 
the epithelium varies between these regions. Differences are observed in expression of 
enzymes (Bosse et al., 2006) and transporters (Mutch et al., 2004; Anderle et al., 2005), size of 
villi, distribution of different epithelial cell types (Bosse et al., 2006; Kim and Ho, 2010; Bevins 
and Salzman, 2011), and in the level of mucus secretion (Kim and Ho, 2010).  
 
Regionalisation of the small intestine along the cephalocaudal axis is controlled by a few key 
transcription factors. The most important in this context are considered to be pancreatic and 
duodenal homeobox 1 (PDX1), GATA4 and GATA6.  
 
PDX1 has been shown to be important in specifying the duodenum (Thompson, DeLaForest 
and Battle, 2018). PDX1 expression is required for expression of duodenum-specific genes, 
such as the enterocyte marker alkaline phosphatase 3 and proximal enteroendocrine cell 
marker, gastric inhibitory peptide (Chen et al., 2009). Expression of PDX1 also represses genes 
that encode duodenal enzymes, such as lactase and sucrose isomaltase.   
 
GATA4, in both mice and humans, is expressed by the epithelium of both duodenum and 
jejunum but not the ileum (Bosse et al., 2006). The essential role of GATA4 in patterning the 
divide between jejunum and ileum is revealed by the fact that intestinal epithelium-specific 
deletion of Gata4 during development results in a shift towards a more ileal phenotype 
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(Thompson, DeLaForest and Battle, 2018). In the Gata4-knockout jejunum, genes specific to 
jejunal enterocytes are repressed and ileal-specific genes, such as Slc10a2 (encoding the apical 
sodium bile acid transporter, ABST), are enhanced (Bosse et al., 2006; Battle et al., 2008; 
Walker, Thompson and Battle, 2014). Gata4-/- mice demonstrate the importance of 
regionalisation in determining function, as they exhibit reduced absorption of fats. 
Reciprocally, experimental expression of GATA4 in the mouse ileum causes a shift towards a 
jejunal expression profile (Thompson et al., 2017).  
 
GATA6, a related transcription factor, is expressed along the whole length of the small 
intestinal epithelium and appears to be involved in determining small intestinal as opposed to 
colonic identity in these cells. Deletion of GATA6 in the intestinal epithelium causes the ileal 
epithelium to adopt a more colonic phenotype (Beuling et al., 2011; Walker et al., 2014), with 
impaired differentiation of Paneth and enteroendocrine cells (Beuling et al., 2011). Similar 
consequences are only seen in the jejunum and duodenum if both GATA6 and GATA4 are 
deleted simultaneously (Beuling et al., 2011). This suggests that GATA4 and GATA6 perform 
distinct roles in patterning the small intestinal epithelium, with GATA4 specifying the jejunal-
ileal transition and GATA6 contributing to ileal identity, at least in part by repressing colon-
specific genes.   
 
Although these transcriptional regulators of regional specialisation along the small intestine 
have begun to be understood, it remained unclear how regional identity is specified in terms of 
intestinal epithelial stem cell biology (Middendorp et al., 2014). One possibility is that stem 
cells receive locational signals from their local microenvironment, for example from 
neighbouring mesenchymal cells. Alternatively, regional identity might be intrinsically 
programmed in the stem cell. Evidence from enteroid models indicates that the latter is most 
likely true (Middendorp et al., 2014; Kraiczy et al., 2017). Enteroids are three dimensional (3D), 
ex vivo cultures of primary intestinal stem cells. This culture technique was first described by 
Clevers and colleagues (Sato et al., 2009; Sato and Clevers, 2013) and has already seen huge 
uptake by researchers studying development and normal physiology of the small intestine, as 
well as intestinal disease and host-pathogen interactions (Bartfeld, 2016; Dedhia et al., 2016; 
Fatehullah, Tan and Barker, 2016; Hill and Spence, 2016; In et al., 2016; Dutta, Heo and 
Clevers, 2017). Enteroids may be established from adult intestinal stem cells and passaged for 
long term maintenance by regularly disrupting the structures and re-seeding the fragments. 
The stem cells are maintained by a cocktail of growth factors and proliferate to form a 
continuous epithelial monolayer that encloses a central lumen, with distinct crypt-like buds 
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forming with stem cells at their bases. Enteroids established in this way contain only epithelial 
cells, including all major intestinal epithelial lineages (Sato et al., 2009).  
 
A key study comparing the transcriptomes of murine enteroids established from duodenum, 
jejunum or ileum to their parent tissues showed that region-specific gene expression was 
largely retained in vitro, despite the absence of extrinsic locational cues from surrounding 
mesenchymal cells (Middendorp et al., 2014). Intrinsic locational identity appears to be 
programmed epigenetically, as enteroids established from adult human ileum and colon 
exhibit stable, distinct patterns of DNA methylation, which are very similar to those of their 
parent tissues (Kraiczy et al., 2017). These epigenetic modifications were found to regulate 
expression of region-specific genes, including FABP6 and MUC5B. Methylation profiles of 
different segments within the small intestine have not been compared.   
 
In this chapter, the terms ‘proximal’ and ‘distal’ are used to refer to the segments of the 
murine small intestine from which enteroid cultures were established. For proximal enteroids, 
the first 3-6 cm segment of intestine directly after the pyloric sphincter were used; this likely 
includes the duodenum but also jejunum, as the duodenum in mice is very short (Williams et 
al., 2016). Distal enteroids were derived from a 3-6 cm section of small intestine up to, and 
directly adjacent to, the caecum.  
 
3.2. Hypothesis  
Enteroids derived from different regions of the mouse small intestine retain location-specific 
characteristics of their parent tissues in culture, despite the absence of extrinsic positional 
cues. 
 
3.3. Aims  
1. To assess whether enteroids derived from proximal and distal regions of mouse small 
intestine retain morphological differences in culture. 
 
2. To compare the distribution of different epithelial cell types in proximal and distal 
murine small intestine and to assess whether differences in cell type distributions are 
maintained in enteroid cultures derived from these regions. 
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3. To assess for any differences in epithelial permeability of proximal and distal small 
intestine using the enteroid model. 
 
3.4. Methods  
Enteroid culture 
Enteroids were established from proximal and distal regions of the small intestine of wild type 
C57BL/6 mice. The method used is described in detail in Section [Methods .4]. Briefly, a section 
of small intestine 3-6 cm long was taken from either directly after the pyloric sphincter 
(proximal) or directly before the caecum (distal).  The tissue was washed and intestinal crypts 
were isolated by incubating with EGTA, followed by agitating vigorously. Crypts were 
embedded in Matrigel, which was allowed to set before being covered with culture medium. 
The essential growth factors, R-spondin 1, Noggin and EGF were supplied in the culture 
medium. Enteroids used for experiments were of passage 1-25. 
Quantification of epithelial cell types by immunohistochemistry 
For immunohistochemical analysis, enteroids were cultured for 6 days after passage. The 
Matrigel was then dissociated and the enteroids were fixed with paraformaldehyde and 
paraffin embedded. Sections were stained with antibodies against prominent markers of the 
different epithelial cell types present in the small intestine: trefoil factor 3 (TFF3; goblet cells) 
(Kim and Ho, 2010), lysozyme (Lyz; Paneth cells) (Sato, van Es, et al., 2011), chromogranin A 
(CgA; enteroendocrine cells) (Engelstoft et al., 2015) and doublecortin-like kinase 1 (DCLK1; 
tuft cells) (Middelhoff et al., 2017). See Section [Methods .7] for a detailed description of this 
technique. Cell types were quantified as a percentage of the total cells per enteroid section. 
Sections of C57BL/6 mouse tissue from the same regions of the small intestine from which 
enteroids were derived were stained in parallel. In intestinal tissues, the number of each cell 
type was quantified as a percentage of the total number of cells observed in each crypt-villus 
axis. 
Transmission electron microscopy (TEM) 
Enteroids were harvested on day 3 post-passage. Matrigel was dissociated and enteroids were 
fixed and processed for TEM as detailed in Section 2.12.  
Assessment of epithelial permeability in enteroids 
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Differences in the epithelial permeability of the proximal and distal small intestine were 
investigated by microinjecting FD4 into the lumen of enteroids derived from either region. 
Since enteroids vary in size, each enteroid was injected until it began to swell rather than with 
a fixed volume. The luminal fluorescence of injected enteroids was visualised using an 
epifluorescence microscope at hourly intervals following injection and bright field images were 
collected in parallel. To monitor loss of fluorescence from the lumen, the perimeter of each 
enteroid was specified using ImageJ software and the mean fluorescence intensity of pixels 
within this area was determined. To adjust for differences in starting fluorescence intensity 
within each microinjected enteroid (i.e. due to differences in volume of FD4 injected), the 
values for each enteroid were normalised against its starting value.  
 
3.5. Results 
3.5.1. Enteroids derived from proximal and distal small intestine exhibit similar 
patterns and rate of growth once established 
Enteroid cultures established from crypts that were isolated from proximal and distal regions 
of the small intestine showed similar growth patterns (Figure 3.1 A). Both proximal and distal 
enteroids showed clear increases in size from day 3-7 post-passage (Figure 3.1 B). Enteroid 
area measured on days 5 and 7 was normalised to day 3 to negate any differences in the size 
of fragments generated during passage. During the course of the experiment, the observed 
areas of proximal enteroids varied between 0.005-0.180 mm2, while distal enteroids were 
between 0.007-0.267 mm2. Similar increases in size were observed for proximal and distal 
enteroids on days 5 and 7 post-seeding when normalised to enteroid size on day 3.  
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Figure 3.1. Growth of enteroids derived from proximal and distal small intestine. (A) 
Representative bright field images of enteroids established either from the proximal or distal 
region of the small intestine of a C57BL/6 mouse. Images captured on days 3, 5 and 7 post-
seeding do not necessarily show the same enteroid at each time point. Scale bars represent 
200 μm. (B) Quantification of mean area of proximal and distal enteroids at 3, 5 and 7 days 
post-seeding. Data are shown relative to mean area on day 3 to control for possible differences 
in size of fragments seeded. Across all time points, range of observed enteroid areas was 
0.005-0.180 mm2 (proximal) and 0.007-0.267 mm2 (distal).  For proximal cultures, N = 2 
cultures established from different mice, n = 21-46 enteroids; for distal cultures, N = 3, n = 14-
60. Error bars represent SEM.    
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3.5.2. Enteroids derived from proximal and distal small intestine exhibit location-
specific morphological characteristics 
Under normal conditions, it is apparent by light microscopy that enteroids derived from 
proximal and distal small intestinal tissue tend to have a different appearance (Figure 3.2 A). 
The morphological differences are difficult to quantify. Whereas the basolateral aspect of 
enteroids derived from proximal small intestine tends to have a smooth appearance, the 
basolateral aspect of the epithelium of distal enteroids has a more “raspberry-like” or ruffled 
appearance, particularly in the crypt bud regions. The difference in appearance is maintained 
over the course of many passages.  
Efforts were made to quantify these morphological differences by evaluating enteroid 
circularity (a measure of how similar the overall enteroid shape is to a perfect circle, which 
would give a value of 1.0; Figure 3.2 B) and the number of buds per enteroid (Figure 3.2 C). 
Distal enteroids showed a trend towards higher mean circularity, indicating that they tend to 
be more round overall, but this did not reach significance. On day 3, the mean number of 
buds per enteroid was lower on in distal compared to proximal enteroids but by day 5 they 
were approximately equal.  
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Figure 3.2. Location-specific morphological characteristics of enteroids. (A) Representative 
bright field images of enteroids derived from either proximal or distal small intestine of 
C57BL/6 mice. Full arrows indicate areas of where characteristic ‘raspberry-like’ appearance 
of basolateral aspect of epithelium of distal enteroids is noticeable. Arrow heads indicate 
Paneth cells. All scale bars represent 100 μm. Inset boxes show 2X (upper panel) or 1.7X 
(lower panel) magnified parts of the images. (B) Quantification of enteroid circularity from 
bright field images. For proximal enteroids, N = 2 independent enteroid cultures derived from 
different mice, n = 21-46 enteroids; for distal enteroids, N = 3, n = 13-60. (C) Mean number of 
buds per enteroid. For proximal enteroids, N = 2, n = 28-44; for distal enteroids, N = 3, n = 15-
57. All error bars represent SEM.   
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To assess any differences in the ultrastructure of the epithelium, enteroids derived from the 
different regions of the small intestine were also analysed by transmission electron 
microscopy. Sections from throughout the enteroid were analysed, including within a crypt 
bud and from the villus region (Figure 3.3 A). In sections taken from towards the crypt base, 
enterocytes had short, irregular microvilli on their apical surface (Figure 3.3 B). In contrast, 
enterocytes in the villus regions exhibited long, regular microvilli that were very similar in 
appearance to those visualised on enterocytes in small intestinal tissue samples. 
Paneth, goblet and enteroendocrine cells were identified by their characteristic features in 
enteroids derived from both regions (Figure 3.4 A & B). Paneth cells contain many large, 
densely staining cytoplasmic granules towards their apical surface. Goblet cells are named for 
their distinctive goblet-like shape and feature a large theca of mucus-containing vesicles 
towards their apical surface. Finally, enteroendocrine cells were identifiable by the small, 
darkly staining granules found basolateral to the cell nucleus.    
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Figure 3.3. Analysis of murine enteroids by transmission electron microscopy. (A) Schematic 
showing the orientation of enteroids within the resin in relation to the block face from which 
sections are cut. Lower image schematic demonstrates the cross-sectional view of a crypt 
visible in sections. (B) TEM images demonstrating the different regions of an enteroid, moving 
from the crypt base up along the crypt-villus axis. L, lumen; E, enterocyte; P, Paneth cell.  
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Figure 3.4. Identification by TEM of epithelial cell types in murine enteroids. TEM images of 
enteroids fixed on day 3 post-seeding an. Images show representative examples of the major 
intestinal epithelial cell types, Paneth cells, goblet cells and enteroendocrine cells. (A) Lower 
magnification and (B) higher magnification views of cell-specific morphology. L, lumen; N, 
nucleus.   
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In sections of tissue derived from proximal and distal small intestine, the luminal surface of 
enterocytes was found to be packed with long, regular microvilli (Figure 3.5 A). As expected, 
enterocytes were thin and columnar, with the nuclei located basally (Figure 3.5 B). This was 
closely mirrored by the epithelium of enteroids derived from both proximal and distal 
regions. Within crypt regions, the lumen was small in diameter and the apical surface of 
epithelial cells displayed short, irregular microvilli (Figure 3.6 A & B). In contrast, the lumen 
was expanded in the villus region and microvilli were long and regular, much more closely 
resembling those in the tissue (Figure 3.6 C & D).  
 
 
Figure 3.5. Ultrastructure of the murine small intestinal epithelium in vivo. Representative 
TEM images of (A) an overview of the epithelium and (B) the apical surface of enterocytes of 
proximal and distal small intestine from a C57BL/6 mouse. Microvilli are present on the apical 
surface. N, nucleus. 
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Figure 3.6. Ultrastructure of the crypt and villous regions of enteroids derived from proximal 
and distal murine small intestine.  (A & B) Representative TEM images of (A) an overview of 
the crypt epithelium and (B) the apical surface of crypt epithelial cells in an enteroid derived 
from either proximal or distal small intestine of a C57BL/6 mouse. Paneth cells are present in 
the images of the proximal enteroid and enteroendocrine cells are visible in the overview of 
the distal enteroid epithelium. (C & D) Representative TEM images of (C) an overview of the 
epithelium and (B) the apical surface of epithelial cells in the villous regoin of enteroids 
established from either proximal or distal small intestine of a C57BL/6 mouse. L, lumen; N, 
nucleus; P, Paneth cell; E, enteroendocrine cell.   
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3.5.3. Location-specific distribution of epithelial cell types in small intestinal tissue 
It has been suggested that GATA4 alters cell fate specification as part of its role in regulating 
specialisation of the small intestine along the cephalocaudal axis (Bosse et al., 2006), 
although this has not been comprehensively investigated. Immunohistochemical analysis was 
therefore performed on sections of tissue and enteroids derived from proximal and distal 
small intestine to compare the distribution of epithelial cell types. Tissue samples were 
derived from three different wild type C57BL/6 mice and enteroid samples were from 
cultures generated from three different mice. Cell types examined were Paneth, goblet, 
enteroendocrine and tuft cells, using the markers Lyz, TFF3, CgA and DCLK1, respectively. 
Individual cell types were quantified as a percentage of total cells per crypt-villus axis or per 
enteroid section. 
As expected, Paneth cells were observed exclusively at the crypt bases in tissue sections and 
were frequently observed within the crypt buds of enteroids (Figure 3.7 A). The percentage 
of Paneth cells was significantly larger in distal compared to proximal small intestinal tissue 
by 2.9% ± 0.4% (mean ± SEM; p < 0.01; Figure 3.7 B). In enteroids, Paneth cells represented a 
larger proportion of total cells by 7.8% ± 3.9%, although this difference did not reach 
significance.  
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Figure 3.7. Quantification of Paneth cells in tissue and enteroids derived from proximal and 
distal mouse small intestine. (A) Representative images showing immunohistochemical 
staining of lysozyme (Lyz), an anti-microbial peptide stored in Paneth cell granules. Staining 
was performed on paraffin-embedded sections of tissue and enteroids derived from proximal 
and distal small intestine. Scale bars = 50 μm. (B) Quantification of number of Paneth cells per 
crypt-villus axis in intestinal tissue and per complete enteroid section. For intestinal tissue: N = 
3, n = 30 crypt-villus axes. For enteroids: N = 3, n = 20-31 enteroid sections. Unpaired two-
tailed t-test, **p < 0.01, n.s. non-significant. Error bars represent SEM.  
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Immunohistochemical staining revealed goblet cells distributed throughout the small 
intestinal epithelium in both tissue and enteroid sections (Figure 3.8 A). The percentage of 
goblet cells was significantly greater in both distal tissue and enteroids compared to their 
proximal equivalents, by 7.4% ± 0.7% and 6.3% ± 2.0% respectively (p < 0.001 and p < 0.05; 
Figure 3.8 B). The proportion of goblet cells in each region was closely matched between 
enteroids and their parent tissues. Goblet cells represented 14.2% ± 1.9% of cells in distal 
enteroids compared to 16.6% ± 0.6% in distal small intestine. In proximal samples, goblet 
cells represented 7.9% ± 0.3% of cells in enteroids compared to 9.2% ± 0.3% in proximal 
tissue.  
Enteroendocrine cells were observed throughout the crypt and villous epithelium in both 
tissue and enteroids (Figure 3.9 A). In small intestinal tissue, enteroendocrine cells were 
significantly more abundant in the proximal compared to the distal region, by 0.4% ± 0.1% (p 
< 0.05; Figure 3.9 B). Although not statistically significant, the same trend was observed in 
enteroids derived from these tissues; enteroendocrine cells constituted 5.8% ± 0.6% of total 
cells in proximal enteroids and 4.5% ± 1.4% in distal enteroids.  
Tuft cells were identified along the length of the crypt-villus axis in tissue from both proximal 
and distal small intestine (Figure 3.10 A). In enteroids, tuft cells again did not localise 
specifically to either crypt or villous regions. Tuft cells were the least abundant cell type; 
many enteroid sections did not contain any DCLK1-expressing cells. They appeared to be 
equally distributed in proximal and distal regions, representing 1.3% ± 0.3% of cells in 
proximal and only 0.6% ± 0.02% in distal small intestine (Figure 3.10 B). The percentage of 
tuft cells was 0.5% ± 0.1% in proximal enteroids and 0.8% ± 0.2% in distal enteroid cultures. 
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Figure 3.8. Quantification of goblet cells in tissue and enteroids derived from proximal and 
distal mouse small intestine. (A) Representative images showing immunohistochemical 
staining of goblet cell marker TFF3. Staining was performed on paraffin-embedded sections of 
tissue and enteroids derived from proximal and distal small intestine. Scale bars = 50 μm. (B) 
Quantification of number of goblet cells per crypt-villus axis in intestinal tissue and per 
complete enteroid section. For intestinal tissue: N = 3 mice, n = 30 crypt-villus axes. For 
enteroids: N = 3, n = 20-31 enteroid sections. Unpaired two-tailed t-test, ***p < 0.001, *p < 
0.05. Error bars represent SEM.   
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Figure 3.9. Quantification of enteroendocrine cells in tissue and enteroids derived from 
proximal and distal mouse small intestine. (A) Representative images showing 
immunohistochemical staining of CgA, a marker of enteroendocrine cells. Staining was 
performed on paraffin-embedded sections of tissue and enteroids derived from proximal and 
distal small intestine. Scale bars = 50 μm. (B) Quantification of number of enteroendocrine 
cells per crypt-villus axis in intestinal tissue and per complete enteroid section. For intestinal 
tissue: N = 3 mice, n = 30 crypt-villus axes. For enteroids: N = 3, n = 16-35 enteroid sections. 
Unpaired two-tailed t-test, *p < 0.05, n.s. non-significant. Error bars represent SEM. Y-axis 
scaled for comparison of Figures 3.7-10. 
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Figure 3.10. Quantification of tuft cells in tissue and enteroids derived from proximal and 
distal mouse small intestine. (A) Representative images showing immunohistochemical 
staining of tuft cell marker DCLK1. Staining was performed on paraffin-embedded sections of 
tissue and enteroids derived from proximal and distal small intestine. Scale bars = 50 μm. (B) 
Quantification of number of enteroendocrine cells per crypt-villus axis in intestinal tissue and 
per complete enteroid section. For intestinal tissue: N = 3 mice, n = 27-30 crypt-villus axes. For 
enteroids: N = 3, n = 23-36 enteroid sections. Unpaired two-tailed t-test, n.s. non-significant. 
Error bars represent SEM. 
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3.5.4. Relationship between enteroid size and frequency of different epithelial cell 
types 
Certain cell types are found in specific regions of the intestinal epithelium; for example, 
Paneth cells migrate to the crypt base as they differentiate and are not generally found 
within the villus epithelium. Enteroids likely contain a proportionally larger crypt region than 
is found in intestinal tissue and this effect should be greater in smaller enteroids. As a result, 
it might be expected that there is a relationship between enteroid size and its percentage 
composition of certain cell types. Such a relationship might bias the quantification of cell 
types if one group of enteroids tended to be smaller or larger than the other. To test this, the 
percentage of each cell type was compared with the total number of cells within the enteroid 
section and the non-parametric Spearman’s rank correlation coefficient was calculated 
(Figure 3.11 and Table 3.1). Most comparisons, however, showed Spearman rs values close to 
zero, which suggests that there is little correlation between enteroid size and its percentage 
of each cell type. The only exception to this was for goblet cells in distal enteroids, where the 
Spearman rs value of -0.416, and a p value < 0.05 suggest a moderate, but significant, 
negative correlation that is not explained by random variation.  
 
 
 
Figure 3.11. Relationship between enteroid size and frequency of different epithelial cell 
types. Comparison of the proportion of Paneth, goblet, enteroendocrine and tuft cells per 
enteroid section with the total number of cells in that section for enteroids derived from 
proximal and distal SI. Each dot represents one scored enteroid section (see Table 3.1 for the 
total numbers of sections scored for each sample, pooled from 3 independent experiments). 
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Table 3.1. Relationship between enteroid size and frequency of different epithelial cell types. 
Results from calculation of the non-parametric Spearman correlation coefficient (rs) between 
the total cells per enteroid section with the percentage of each cell type present (as shown in 
Figure 3.8). N, total number of enteroid sections scored, pooled from 3 independent enteroid 
cultures.  
  Paneth cells 
  
Goblet cells Enteroendocrine cells 
  
Tuft cells 
Proximal 
  
Distal Proximal Distal Proximal Distal Proximal Distal 
N (number 
of enteroid 
sections 
scored) 
80 70 79 68 91 91 77 73 
Spearman’s 
rs 
  
-0.204 -0.209 0.090 -0.416 0.098 0.043 -0.102 0.131 
95% 
confidence 
intervals 
-0.411-
0.023 
  
-
0.429-
0.034 
-0.141-
0.311 
-0.600 -0.117-
0.303 
-0.170-
0.253 
-0.325-
0.132 
-
0.109-
0.356 
p value 
(two-
tailed) 
  
0.070 0.082 0.431 <0.001 0.357 0.685 0.379 0.271 
 
 
 
3.5.5. Epithelial permeability of enteroids derived from proximal and distal small 
intestine 
No difference was observed in the permeability of the epithelium of enteroids derived from 
proximal and distal regions of the small intestine (Figure 3.12). In untreated enteroids from 
both origins, a gradual decrease in the mean fluorescence intensity within the lumen was 
measured to a level approximately 80% of the starting fluorescence (100%). Both sets of 
enteroids responded similarly to treatment with 2 mM EGTA, showing significant, rapid 
reductions in mean luminal fluorescence intensity (p < 0.05; ANOVA). In both cases, this 
effect reached a plateau following a decrease of approximately 50% compared to the starting 
fluorescence.  
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Figure 3.12. Epithelial permeability of enteroids derived from proximal and distal small 
intestine. (A) Representative fluorescence images of FD4-injected proximal and distal 
enteroids following treatment with 2 mM EGTA as indicated. Right-most panels show bright 
field images of enteroids 4 h post-treatment. (B) Quantification of the mean fluorescence 
intensity within the enteroid lumen at the indicated time points post-treatment. Mean 
intensity at each time point is shown relative to the starting mean intensity for each enteroid 
at 0 h (set to 100%). (C) Area under the curve analysis of the curves shown in (A). One-way 
ANOVA, ***p < 0.001, n.s. not significant, N = 4 (except groups marked #, where N = 5 and ~, 
where N = 3), n = 2-7 enteroids per group. (D) Quantification of changes in mean total enteroid 
area during the permeability assays. All error bars represent SEM. 
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3.6. Summary of results 
1. Mouse enteroids derived from proximal and distal regions of the small intestine exhibit 
distinct gross morphologies but similar patterns of growth. 
 
2. No differences were observed between the appearance of individual enterocytes nor 
the epithelium as a whole in enteroids derived from proximal and distal murine small 
intestine.  
 
3. Mouse enteroids contain all the major epithelial cell types found in vivo. Although the 
absolute percentages of each cell type differ in some cases between tissue and 
enteroids, the pattern of differences between proximal and distal small intestinal tissue 
is maintained in enteroids derived from these regions.  
 
4. Enteroids derived from proximal and distal small intestine display very similar levels of 
epithelial permeability.  
 
3.7. Discussion 
Enteroid cultures offer an exciting new model for investigating many aspects of the small 
intestine, from development to infection and ageing (Bartfeld, 2016; Dedhia et al., 2016; Huch 
et al., 2017; Hu et al., 2018). The usefulness of this model has already been demonstrated in 
numerous recent studies. Thorough characterisation of this model system is therefore 
essential to understand the extent to which in vitro enteroids mimic conditions in vivo. The 
small intestine exhibits specialisation along its length to allow different regions to perform 
distinct functions. Tissue derived from the duodenum therefore exhibits different 
characteristics in terms of tissue architecture, but perhaps more importantly, in terms of gene 
expression and physiological function. Despite this, many publications currently do not specify 
from which region of the small intestine enteroids have been generated.  
Here, we present evidence that regional specificity is retained in enteroid cultures. This is in 
support of a previous report that regional identity is encoded intrinsically in epithelial stem 
cells of the adult small intestine (Middendorp et al., 2014). The authors demonstrated that 
location-specific transcriptomes were maintained in intestinal stem cells cultured as enteroids 
in the absence of tissue-derived cues. We find that enteroids derived from proximal and distal 
regions of the mouse small intestine show similar patterns of growth. At the ultrastructural 
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level, the cells in these cultures appear similar; however, we observe consistent differences in 
the gross morphology of these cultures. Importantly, we confirm that the distribution of 
differentiated epithelial cell lineages differs between proximal and distal tissue in vivo and that 
these differences are generally reflected in enteroids.  
In our studies, we observe that the epithelium consistently has a different gross morphology 
when viewed by bright field microscopy, depending on whether enteroids are derived from 
proximal or distal small intestine. In distal enteroids, the epithelium frequently appears more 
bunched, giving the overall enteroid a raspberry-like appearance. The reason for this is 
unclear. As expected, we do not find notable variation in the ultrastructure of the epithelium 
in proximal and distal enteroids. It is therefore possible that the cause may be the different 
proportions of epithelial cell types found in proximal and distal enteroids. 
The proportions of Paneth and goblet cells are shown here to be significantly larger in distal 
compared to proximal regions of the mouse small intestine in vivo. This is in support of 
previous reports that goblet cells become more abundant along the intestinal tract, correlating 
with increasing bacterial load towards the colon (Kim and Ho, 2010; Sekirov, Russell and 
Antunes, 2010). As the microbial density increases, there is a greater need for goblet cell-
derived mucus to exclude them from the epithelium. These data also agree with previous 
findings that Paneth cell abundance increases from proximal to distal small intestine (Jones et 
al, 2018, in preparation,). Given that Paneth cells are major producers of antimicrobial 
peptides, it is possible that the observed increase in their numbers is also related to the rise in 
microbial content along the small intestine.   
Our results indicate the same trends in enteroids derived from proximal and distal small 
intestinal tissue, with distal enteroids containing a greater proportion of goblet and Paneth 
cells. In distal enteroids, the distribution of Paneth cells also appeared to be less polarised, 
with Paneth cells found along the length of crypt buds rather than only at the crypt base. Since 
Paneth cells maintain the stem cell niche (Sato, van Es, et al., 2011), this might indicate that 
stem cells in distal enteroids are also less restricted to the crypt base, which could contribute 
to the trend we observed of distal enteroids towards a more circular morphology.  
We also find the trend for fewer enteroendocrine cells in both tissue and enteroids originating 
from the distal region. Any analysis of different cell types is dependent on the specificity of the 
markers used. Recent findings suggest that, while chromogranin A is expressed strongly in 
enterochromaffin cells, its expression is lower in other types that predominantly produce 
peptide hormones, such as gastric inhibitory peptide (Engelstoft et al., 2015). This may have 
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resulted in an underestimate in our study of the true number of enteroendocrine cells. Current 
evidence indicates, however, that the markers used for the other cell lineages are robust and 
specific.  
These findings indicate that, in addition to location-specific gene expression profiles, enteroids 
also maintain a location-specific composition of epithelial cell types. This is in agreement with 
previous reports that the abundance of goblet and Paneth cells towards the distal small 
intestine (Bosse et al., 2006; Kim and Ho, 2010; Bevins and Salzman, 2011); however, it is not 
known how this is programmed. It seems likely the same factors that regulate other aspects of 
regional identity are involved. Atoh1 is more highly expressed in mouse ileum than jejunum; 
this appears to be repressed by Gata4 since conditional mutation of Gata4 increased Atoh1 
expression in jejunum (Bosse et al., 2006). Since Atoh1 specifies the secretory lineage (Yang et 
al., 2001; see Section 1.1.4), this may represent a mechanism by which the Gata4 gradient 
regulates the increase in Paneth and goblet cells described in distal small intestine.  
Alternatively, local microenvironment-derived signals in the different regions might drive 
immature epithelial cells towards particular lineages. Examples of this phenomenon have been 
described previously, including IL-13-stimulated expansion of the tuft cell population (von 
Moltke et al., 2015) and RANKL expression by mesenchymal cells driving M cell differentiation 
in Peyer’s patches (Nagashima, Sawa, Nitta, Tsutsumi, et al., 2017). Enteroids only contain 
epithelial cells but a situation could be imagined where Wnt3a secretion by Paneth cells might 
promote further Paneth cell differentiation (van Es, Jay, et al., 2005), so that enteroids derived 
from ileal crypts rich in Paneth cells due to other local signals go on to favour Paneth cell 
differentiation. 
Although we find the same pattern of cell type distributions between enteroids and their 
parent tissues, the absolute percentages of these cell types in tissue and enteroids show some 
variation. For example, we find a markedly higher percentage of Paneth and enteroendocrine 
cells per enteroid compared to the number in a crypt-villus axis in vivo. This is likely due to 
overrepresentation of the crypt region in enteroids, although our analysis did not suggest a 
strong relationship between enteroid size and the proportion of most of the cell types we 
examined. Given that the graphs suggest that sections with more cells in total tend to have 
lower percentages of all the cell types, it is possible that there is a non-linear relationship 
between enteroid size and percentage of the different cell types that is not identified by the 
Spearman correlation coefficient. Middendorp and colleagues compared expression profiles of 
enteroid cultures to isolated crypts or villi and found that more of the genes known to be 
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specific to crypts were also expressed in enteroids from the same region, rather than those 
genes specifically expressed in villi (Middendorp et al., 2014). The enteroids we used were 
harvested on day 7 post-seeding; enteroids cultured for longer may contain a larger villus 
region and more closely mimic the lower percentages of Paneth and enteroendocrine cells we 
observed in parallel tissue taken from the intestine. The percentages of goblet and tuft cells, in 
contrast, were very similar in both enteroids and intestinal tissue specimens.  
Greater epithelial permeability has previously been reported in the distal compared to the 
proximal small intestine (Loehry and Parrish, 1970; Ross, Rubin and Deren, 1972; Collins et al., 
2017). This is based, however, on a variety of measurement techniques that may actually refer 
to different definitions of intestinal permeability. Most tests examine flux of a labelled 
molecule, for example a sugar or ion, across the epithelium, either in vivo or in explant tissue 
mounted in Ussing chambers; however, each test may describe a different property of the 
epithelium, since the pathways by which these different molecules cross the epithelium 
probably differ (Bischoff et al., 2014). Here, we were interested in permeability or ‘leakiness’ 
of the epithelium to flux of a large molecule via the paracellular pathway. We observe no 
difference in permeability of the epithelium in proximal and distal enteroids to 4 kDa FITC-
dextran. Most comparable to our data is a report of increasing FITC-dextran flux and 
transepithelial conductance in tissue from duodenum to ileum of BALB/c mice that received a 
sham ovariectomy prior to culture in Ussing chambers. The disparity with our observations 
may arise from differences in the protocols, with data from Ussing chamber experiments 
frequently found not to correlate with other permeability assays (Bischoff et al., 2014).  
An important consideration is that the maintenance of regional identity in enteroid cultures 
may be dependent on culture conditions. The only studies that have previously examined 
regional identity in enteroids used culture conditions very similar to our own for murine 
enteroids, including R-spondin, Noggin and EGF. Other protocols include Wnt through the use 
of conditioned media generated by L-WRN cells, which secrete R-spondin-3, Noggin and Wnt3a 
(Miyoshi and Stappenbeck, 2013). The use of commercial growth media, such as IntestiCult 
(STEMCELL Technologies, Cambridge, UK), for which the formulation is not publicly available, is 
also increasing. Altered growth factor concentrations may affect many aspects of enteroid 
cultures, including their cell type composition and maturity of differentiated cells. Indeed, 
addition of Wnt3a to murine enteroids results in spherical rather than budding enteroids, 
probably due to enhanced proliferation, and expression of differentiation markers, such as 
duodenum-specific Sis (encoding sucrose isomaltase) and ileum-specific Slc10a2, is decreased 
(Middendorp et al., 2014). Regional patterns of Gata4 expression were conserved after Wnt3a 
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treatment, however, suggesting that intrinsic regional programming was preserved 
(Middendorp et al., 2014). Interestingly, intestinal organoids derived from induced pluripotent 
stem cells, another recently developed 3D intestinal model, contain both GATA6+/GATA4+ cells 
and GATA6+/GATA4- cells, indicating that they contain a mixture of cells more similar to either 
duodenum or ileum (Spence et al., 2011). The characterisation performed here may therefore 
not be applicable to enteroids cultured using alternative protocols.  
Overall, the data presented here support a growing body of evidence demonstrating that 
enteroids are a highly physiologically representative model system. They suggest that the 
location within the small intestine from which murine enteroids are derived impacts on their 
physiology and function. The origin of tissue used for establishing enteroids should therefore 
be a consideration in experimental design as different regions may be more appropriate 
depending on the research question. Ideally, future publications should detail the regional 
origin of adult stem cell-derived enteroids as this information may be pertinent to the 
interpretation of results. 
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Chapter 4 
 
Direct effects of gliadin-derived 
peptides on an enteroid model of 
the small intestinal epithelium 
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4.1. Introduction 
Gliadin is the soluble protein component of gluten and is found in cereals including wheat, rye 
and barley (Wieser, 2007). Whereas most dietary proteins are rapidly broken down by 
proteases in the small intestine, gliadin is resistant to digestion because of its high proline 
content (Shan, 2002). As a result, relatively large fragments of gliadin survive digestion and are 
available to interact with the epithelium. Gliadin is pertinent to human health because it 
triggers coeliac disease in a subset of genetically susceptible individuals who carry HLA-DQ2 
and/or HLA-DQ8 risk alleles (Meresse, Malamut and Cerf-Bensussan, 2012). This chronic 
condition causes gastrointestinal symptoms, including diarrhoea, constipation, malnutrition 
and abdominal pain due to bloating (Schuppan, Junker and Barisani, 2009), in addition to 
extra-intestinal symptoms and an increased risk of small bowel cancer and lymphoma (Leffler, 
Green and Fasano, 2015). Coeliac patients usually have elevated serum levels of anti-tissue 
transglutaminase 2 (TG2) and anti-endomysial autoantibodies, which are used as part of 
diagnosis; however, there are also patients who are serologically and histologically negative for 
coeliac disease but who report symptoms shortly after intake of gluten (Rej, Aziz and Sanders, 
2019). This appears to represent a range of disorders, including non-coeliac wheat 
sensitivity/non-coeliac gluten sensitivity (NCWS/NCGS) and wheat-sensitive irritable bowel 
syndrome (IBS). There are several candidates, including gluten, for the causative dietary 
component in these conditions but their pathophysiology is still poorly understood.  
The activities of gliadin-derived peptides in the small intestine are not yet fully understood. 
There is also no consensus on whether or how they access the small intestinal tissue. Based on 
available data, some researchers have suggested that there are two classes of gliadin peptides: 
‘immunogenic’ and ‘cytotoxic’ peptides (Ciccocioppo, Di Sabatino and Corazza, 2005). The 
action of immunogenic peptides is the better understood and accepted. It is known that 
glutamine residues within gliadin peptides are modified by tissue transglutaminase 2 to 
become negatively charged glutamic acid (Di Sabatino et al., 2012). This makes certain 
peptides preferential ligands for the HLA-DQ2 and -DQ8 molecules, which are expressed on 
antigen-presenting cells. The 33-mer fragment, which spans amino acids 56-88, and a 
subsection consisting of amino acids 56-68 (P56-68) are frequently described examples of 
‘immunogenic’ peptides (Shan, 2002). T cells reactive to gliadin peptides in complex with these 
molecules have been detected in coeliac patients (Anderson et al., 2000; Arentz-Hansen et al., 
2000; Camarca et al., 2009). In this way, immunogenic gliadin peptides drive an inflammatory 
adaptive immune response that causes damage to the intestinal epithelium in the form of 
crypt hyperplasia and characteristic villus atrophy.  
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The role and mechanism of action of ‘cytotoxic’ gliadin peptides are less well-defined. The 
archetypal example of a cytotoxic peptide is the fragment spanning amino acids 31-43 (P31-
43). Previous studies examining the actions of P31-43 on the intestinal epithelium have mostly 
been conducted using epithelial cell line models, with effects reported that include 
cytoskeletal rearrangement (Clemente et al., 2003), increased secretion of cytokine IL-15 
(Maiuri et al., 2003), increased expression of tight junction regulator zonulin (Lammers et al., 
2008), and growth-promoting activities via interference with trafficking of epidermal growth 
factor receptor (EGFR) (Barone et al., 2007, 2010, 2011). These reports indicate that gliadin 
P31-43 is capable of activating innate immune pathways in the epithelium, independently of 
adaptive immune activation.  
Given that such cytotoxic activities are not dependent on the adaptive immune system, they 
would be equally relevant to individuals who do not carry coeliac HLA risk alleles. In recent 
years there has been growing interest from clinicians regarding NCWS/NCGS, which is 
characterised by intestinal symptoms similar to those seen in IBS and extra-intestinal 
symptoms that include headaches and fatigue (Volta et al., 2015; Gibson, Skodje and Lundin, 
2017). Furthermore, studies have estimated that one third of IBS patients may be gluten-
sensitive, which could represent an overall prevalence of approximately 3% of the population 
(Catassi et al., 2017).  
No studies have previously been conducted to investigate the effect of gliadin-derived 
peptides in enteroids. In this context, enteroids offer several advantages. Firstly, the enteroid 
epithelium consists of a heterogeneous population of stem cells and differentiated intestinal 
epithelial cells, making it more complex and physiologically representative than 2D intestinal 
cell lines; secondly, enteroids offer the ability to study the epithelium in isolation from immune 
components; thirdly, the 3D structure of enteroids with an enclosed lumen equivalent to the 
gut lumen affords the opportunity to investigate paracellular and transcellular translocation 
across the epithelium, since the apical and basolateral compartments are separated and both 
are accessible (the former albeit via microinjection). 
 
4.2. Hypothesis 
Peptide fragments of α-gliadin will have direct effects on intestinal epithelial homeostasis.  
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4.3. Aim 
To investigate whether peptide fragments of α-gliadin directly modulate the small intestinal 
epithelium in an enteroid model, including: 
1. Perturbation of intestinal epithelial permeability  
 
2. Alteration of intestinal epithelial cell viability and barrier integrity 
 
4.4. Methods 
Enteroid culture 
All experiments in this chapter were performed using enteroids derived from the distal region 
of the small intestine. Enteroids were selected as an appropriate model because coeliac 
disease affects almost exclusively the small intestine. 
Assessment of epithelial permeability in enteroids following incubation with gliadin peptides 
Permeability of the enteroid epithelium following treatment with gliadin peptides was assayed 
using a fluorescent dye-based method based on a previously described method. A detailed 
description of the method may be found in Section 2.10. Briefly, a 4 kDa FITC-conjugated 
dextran (FD4) was microinjected into the lumen of enteroids suspended within a Matrigel 
matrix. Peptide fragments of α-gliadin were then added to the enteroid media. Two gliadin 
peptides (P31-43 and P56-68) were synthesised with N-terminal fluorenylmethyloxycarbonyl 
(Fmoc) protecting group by GenScript (New Jersey, USA) as previous findings from our 
research group had indicated that whole-gliadin peptic-tryptic digest contained unacceptably 
high levels of the endotoxin LPS (personal communication; Dr Carrie Duckworth, University of 
Liverpool, UK) that would have had confounding effects in planned experiments involving co-
culture of enteroids with immune cells, known to be activated by LPS (Alexander and Rietschel, 
2001). The sequences and sizes of synthesised gliadin peptides are described in Table 4.1. 
Fluorescence and bright field images were used to monitor the decreasing intensity of 
fluorescence remaining in the lumen over time.  
 
  
  
107 
 
Table 4.1. Details of the two peptide fragments of α-gliadin synthesised using Fmoc-based 
solid-phase chemistry.   
Peptide Length Amino acid (aa) sequence Molecular weight  
P31-43 13 aa Fmoc-LGQQQPFPPQQPY 1749.93 
P56-68 13 aa Fmoc-LQLQPFPQPQLPY 1791.06 
 
Assessment of epithelial cell viability in response to gliadin peptides  
Cell death by apoptosis was investigated by immunohistochemical staining with an antibody 
specific for the active form of the cysteine-aspartic acid protease, caspase 3. This antibody 
binds the p17 subunit of caspase 3, generated by proteolytic processing of an inactive 
precursor in cells undergoing apoptosis (Han et al., 1997). Enteroids were fixed following 24 
hours of treatment with 100 μg/mL gliadin P31-43 or P56-68. This time point was selected 
because others in our group had previously shown that significant apoptosis is induced in 
enteroids following 24 hours of treatment with another apoptotic stimulus, TNF-α (manuscript 
in preparation, Dr Carrie Duckworth). Paraffin-embedded sections of enteroids were analysed 
by immunohistochemical staining, a detailed protocol for which may be found in Section 2 .7.  
Investigation of the effect of gliadin peptides on tight junction integrity 
Since tight junctions are known to regulate epithelial permeability (Zihni et al., 2016) and 
certain dietary components may regulate intestinal permeability (Ulluwishewa et al., 2011), 
tight junction structure was investigated using immunofluorescence microscopy and TEM 
following exposure to gliadin peptides. Regulation of epithelial permeability can occur through 
redistribution of component proteins away from the tight junction, so localisation of key 
junctional proteins, occludin and ZO-1, was investigated using the Caco-2 cell line. This allowed 
for ease of observation of cell-cell junctions in cells spread out as 2D monolayers.  
Caco-2 cells are a human colon carcinoma colonocyte cell line that undergo differentiation 
when cultured as a monolayer to adopt characteristics similar to those of small intestinal 
enterocytes (Sambuy et al., 2005). Cells were seeded on sterile 13 mm glass coverslips in a 24-
well plate at 2.5 x 105 cells per well and cultured to full differentiation for 15-18 days. Cells 
were incubated with 100 μg/mL gliadin P31-43 or P56-68, or equivalent volume of vehicle 
(0.2% DMSO) for 2 hours at 37°C. Monolayers were then washed twice with warm, sterile PBS 
and fixed with 4% w/v PFA in PBS for 10 minutes at room temperature. Localisation of occludin 
and ZO-1 was then examined by immunofluorescence staining as described in Section 2.8. TEM 
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was performed as described in Section 2.12 and used to examine the ultrastructure of cell-cell 
junctions in enteroids incubated for 2 hours with 100 μg/mL gliadin P31-43 or P56-68.  
Assessment of enteroid swelling as a result of epithelial chloride secretion in response to gliadin 
peptides  
Enteroid swelling was assessed using enteroid surface area – determined from bright field 
microscopy – as a surrogate measure for enteroid volume. This assay is described in detail in 
Section 2.11. On the second day post-seeding, enteroids were incubated with 25-100 μg/mL 
P56-68 or 100 μg/mL P31-43, in the presence or absence of CFTR inhibition by CFTR-inh-172, 
and monitored by bright field microscopy for up to 4 hours. Controls were treated with the 
highest concentration of vehicle (0.3% v/v DMSO).  
For time-lapse videos, enteroids were seeded as above in a 48-well tissue culture plate. On day 
2 or 3 post-seeding, enteroids were treated with vehicle control (DMSO), 100 μg/mL P31-43 or 
100 μg/mL P56-68. Enteroids were observed for at least 12 hours post-treatment using a 
CytoSMART 2 in-incubator imaging system (CytoSMART Technologies, Eindhoven, The 
Netherlands). Images were collected at 5-minute intervals.  
 
4.5. Results  
4.5.1. Gliadin-derived peptide P56-68 appears to increase epithelial permeability in 
enteroids 
4.5.1.1. Baseline epithelial permeability is similar in enteroids derived from wild type 
C57BL/6 and BALB/c mouse strains and transgenic Nfkb2-/- mice 
Differences have been reported in the sensitivity of peritoneal macrophages isolated from 
C57BL/6 and BALB/c mouse strains to gliadin and its peptide fragments, with BALB/c mice 
showing lower responsiveness (Tucková et al., 2002). Nfkb2-/- mice (on a C57BL/6 
background) show reduced sensitivity to permeability-enhancing stimuli, such as LPS and 
TNF (Williams et al., 2013). Epithelial permeability was therefore investigated in untreated 
enteroids derived from each of these three mouse strains to determine any intrinsic 
differences. In all three strains, the amount of FD4 within the lumen remained relatively 
constant over 4 hours, as observed by fluorescence imaging (Figure 4.1 A). No significant 
difference was identified between the areas under the curve (AUC) for enteroids generated 
from each strain, indicating that they exhibit similar rates of loss of luminal fluorescence 
intensity (Figure 4.1 B). 
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Figure 4.1. Enteroids derived from C57BL/6, BALB/c and Nfkb2-/- mouse strains display 
similar levels of epithelial permeability at baseline. (A) Comparison of the loss of fluorescence 
intensity from the lumen of untreated enteroids derived from C57BL/6, BALB/c and Nfkb2-/- 
mice. Error bars represent SEM. (B) AUC analysis of data series shown in (A). No significant 
differences were found as assessed by one-way ANOVA; N = 4, 5, 3 for C57BL/6, BALB/c and 
Nfkb2-/- respectively, n = 2-5 enteroids per group. All error bars represent SEM.   
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4.5.1.2. Gliadin-derived peptide P56-68 appears to increase epithelial permeability in BALB/c 
enteroids 
Given that altered intestinal permeability has been reported in coeliac patients (Schumann 
et al., 2017), the effect of the two 13-aa gliadin peptides, P31-43 and P56-68, on epithelial 
permeability was investigated in murine enteroids to ascertain whether each might affect 
permeability via a direct interaction with the epithelium. In BALB/c enteroids that were 
either untreated, treated with vehicle control (0.2% v/v DMSO), or treated with 100 μg/mL 
P31-43, the amount of FD4 within the lumen remained relatively constant over 4 hours, as 
observed by fluorescence imaging (Figure 4.2 A & B). No significant difference was 
determined between the AUC for enteroids treated with P31-43 compared to vehicle-
treated control enteroids (Figure 4.2 C). As expected, treatment with 2 mM EGTA resulted 
in a rapid loss of fluorescence intensity from the lumen (p < 0.001 compared to untreated 
control; ANOVA, N = 6, n = 2-6 enteroids per group), likely due to its calcium chelating 
activity, which disrupts Ca2+-dependant E-cadherin cell-cell interactions within tight 
junctions (Kim et al., 2011). A significant decrease in AUC, indicating a greater rate of 
fluorescence loss, was also observed in enteroids treated with 100 μg/mL P56-68 compared 
to vehicle control (p < 0.05; ANOVA, N = 6, n = 2-6). Although the magnitude of the effect 
was slightly smaller, the time course of the effect was similar to that observed following 
treatment with 2 mM EGTA. 
4.5.1.3. Gliadin-derived peptide P56-68 appears to increase epithelial permeability in wild 
type C57BL/6 enteroids 
The effect of gliadin P56-68 does not appear to be strain-specific as similar results were 
observed in wild type C57BL/6 enteroids. C57BL/6 enteroids incubated with vehicle control 
(DMSO) or 100 μg/mL P31-43 showed little change in luminal fluorescence intensity over 4 
hours post-treatment (Figure 4.3 A & B). Treatment with both 2 mM EGTA and 100 μg/mL 
P56-68 again caused significant loss of mean FITC fluorescence pixel intensity from the 
enteroids (Figure 4.3 C). This effect was rapid, with the greatest decrease occurring by 2 
hours after treatment. After 2 hours, mean luminal pixel intensity stabilised. The magnitude 
of these changes was similar to those observed in BALB/c enteroids (Figure 4.2). 
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Figure 4.2. Gliadin-derived peptide P56-68 appears to increase epithelial permeability in 
BALB/c enteroids. (A) Representative images showing luminal FD4 fluorescence in enteroids 
derived from BALB/c mice at the indicated time points following treatment with vehicle 
control (0.2% v/v DMSO), 100 μg/mL gliadin P31-43 or P56-68, or 2 mM EGTA. The right-most 
panel shows corresponding bright field images of the enteroids 4 h post-treatment. (B) 
Quantification of the mean fluorescence intensity within the enteroid lumen at the indicated 
time points post-treatment. Intensity at each time point, for each enteroid, was measured 
relative to its intensity at 0 h (set to 100%). (C) Data shown in panel (B) calculated as mean 
area under the curve. Significant differences determined by one-way ANOVA; *p < 0.05, ***p < 
0.001, N = 5 (except groups marked #, for which N = 6), n = 2-6 enteroids per group. All error 
bars represent SEM. 
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Figure 4.3. Gliadin-derived peptide P56-68 appears to increase epithelial permeability in 
C57BL/6 enteroids. (A) Representative images showing luminal FD4 fluorescence in enteroids 
at the indicated time points following treatment with gliadin peptides or 2 mM EGTA. The 
right-most panel shows the corresponding bright field images of enteroids 4 h post-treatment. 
(B) Quantification of the mean fluorescence intensity within the enteroid lumen at the 
indicated time points post-treatment. Intensity at each time point for each enteroid was 
measured relative to its intensity at 0 h (set to 100%). Error bars represent SEM. (C) Data 
shown in panel (B) calculated as mean area under the curve. Significant differences 
determined by one-way ANOVA; *p < 0.05, ***p < 0.001, N = 4 (except group marked with #, 
for which N = 3), n = 2-5 enteroids per group. Error bars represent SEM. 
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4.5.1.4. Gliadin-derived peptide P56-68 appears to increase epithelial permeability in Nfkb2-
/- enteroids 
In enteroids derived from Nfkb2-/- mice bred on a C57BL/6 background, treatment with 100 
μg/mL gliadin P56-68 also resulted in a significant loss of luminal fluorescence intensity 
compared to vehicle control (Figure 4.4 A-C). Whereas mean luminal pixel intensity 
declined to approximately 60% of its initial value in wild type C57BL/6 enteroids, the 
decrease in Nfkb2-/- enteroids was observed to be approximately 70%. The initial rate of 
change in Nfkb2-/-enteroids appeared to be lower, with mean fluorescence intensity only 
beginning to plateau at 4 hours post-treatment rather than 2 hours as seen in wild type 
strains (Figure 4.4 B). Again, 100 μg/mL gliadin P31-43 had no effect on the rate of 
fluorescence loss from the enteroid lumen (Figure 4.4 A-C). Nfkb2-/- enteroids appear to be 
less sensitive to P56-68-induced loss of FD4 fluorescence (Figure 4.4 D). 
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Figure 4.4. Gliadin-derived peptide P56-68 appears to increase epithelial permeability in 
Nfkb2-/- enteroids. (A) Representative images showing luminal FD4 fluorescence in enteroids 
derived from transgenic Nfkb2-/- mice (bred on a C57BL/6 background) at the indicated time 
points following treatment with vehicle control (0.2% v/v DMSO), 100 μg/mL gliadin P31-43 or 
P56-68, or 2 mM EGTA. Right-most images show corresponding bright field images of 
enteroids 4 h post-treatment. (B) Quantification of mean fluorescence intensity within 
enteroid lumen at the indicated time points post-treatment. Intensity at each time point for 
each enteroid was measured relative to its intensity at 0 h (set to 100%). (C) Data shown in 
panel (B) calculated as area under the curve. Significant differences as determined by one-way 
ANOVA; *p < 0.05, ***p < 0.001, N = 4 (except group marked #, for which N = 3), n = 2-7 
enteroids per group. (D) Comparison of luminal FD4 fluorescence in vehicle-treated controls 
and P56-68-treated enteroids derived from C57BL/6 and Nfkb2-/- mouse strains (data from 
panel (B) and Figure 4.3). All error bars represent SEM. 
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4.5.2. Effects of gliadin-derived peptides on epithelial cell viability 
There is a high rate of cell turnover in the intestine, regulated by proliferation, apoptosis and 
cell shedding. In enteroids, shed apoptotic cells are observed to accumulate within the 
enclosed lumen during growth. In enteroids exposed only to 0.2% DMSO vehicle control for 
24 hours, some apoptotic cells – marked by positive staining of active caspase 3 – were 
visualised within the enteroid lumen (Figure 4.5 A). As expected, staining was found 
throughout the cytoplasm of these cells. Some cellular debris was also apparent within the 
lumen, such as cell fragments with no discernible nucleus. Also apparent in the lumen was 
the presence of cell debris, such as cell fragments with no discernible nuclei. Cells positive for 
active caspase 3 were rarely observed within the epithelium of vehicle-treated control 
enteroids. Following treatment for 24 hours with 100 μg/mL gliadin peptides P31-43 (Figure 
4.5 B) or P56-68 (Figure 4.5 C), the number of apoptotic cells within the lumen did not 
appear to be increased across more than 20 enteroid sections. There was also no increase in 
the occurrence of positively stained cells within the epithelium of gliadin peptide-treated 
enteroids compared to vehicle-treated controls. 
Even in untreated enteroids, cells undergoing apoptosis may be observed within the enteroid 
lumen by TEM, having been shed from the epithelium (Figure 4.6 A). Apoptotic cells may be 
distinguished by several features, including: dense cytoplasm, nuclear fragmentation or 
complete breakdown of the nuclear membrane, disintegration of organelles and blebbing of 
the plasma membrane. No evidence of apoptosis was observed within cells of the epithelial 
monolayer of C57BL/6 enteroids incubated for 2 hours with vehicle control, 100 μg/mL 
gliadin P31-43 or 100 μg/mL P56-68 (Figure 4.6 B). In two gliadin peptide-treated enteroids 
observed, the overall structure of the epithelium appeared normal. The nuclear membranes 
remained intact with no signs of increased chromatin condensation. Across the different 
treatments examined, organelles such as mitochondria, endoplasmic reticulum and Golgi 
were visible and displayed normal architecture.   
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Figure 4.5. Effects of gliadin-derived peptides on epithelial cell death as assessed by active 
caspase 3 immunohistochemistry. Representative images of sections of C57BL/6 enteroid 
treated for 24 h with (A) vehicle control (0.2% v/v DMSO), (B) 100 μg/mL gliadin P31-43, or (C) 
100 μg/mL gliadin P56-68 with immunohistochemical staining for active caspase 3. Arrow 
heads indicate examples of individual positively stained cells within the enteroid epithelial 
monolayer. All scale bars = 50 μm.  
  
  
117 
 
 
 
 
Figure 4.6. Enteroids do not show ultrastructural evidence of reduced viability following 
treatment with gliadin peptides. (A) TEM images showing apoptotic cells within the lumen of 
untreated enteroids. In the left image, the apical surface of the epithelium is also visible. (B) 
Representative TEM images of enteroids treated for 2 h with vehicle control or 100 μg/mL 
gliadin peptides P31-43 or P56-68. Left column shows low magnification overviews of the 
epithelium. Middle column shows examples of cell nuclei with a healthy appearance. Right 
column shows high power images of healthy-looking cell nuclei and intact organelles, including 
mitochondria. Arrows indicate healthy-looking organelles, including mitochondria, 
endoplasmic reticulum and Golgi apparatus. All scale bars are as indicated. L, lumen; A, 
apoptotic body; N, nucleus.  
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4.5.3. Effects of gliadin-derived peptides on cell-cell junctions 
4.5.3.1. Gliadin-derived peptides do not alter ultrastructure of cell-cell junctions 
Transmission electron microscopy was used to examine changes to cell-cell junctions in the 
enteroid epithelium in response to gliadin-derived peptides 2 hours post-administration, 
when changes in permeability in response to gliadin P56-68 were apparent (Figure 4.2, 
Figure 4.4). Enteroids derived from both proximal and distal SI were examined by TEM 
following 2 hours of treatment with vehicle, P31-43 or P56-68. Since the crypt and villus 
regions of the intestinal epithelium are structurally and functionally distinct, sections taken 
from both areas of enteroids were examined.  
In all samples, some spaces were observed along the boundary between cells. These were 
flanked by areas of very close contact. In all samples, cells were tightly held together at the 
apical surface of the epithelium, where tight junctions are located (Figure 4.7). No 
differences were observed in the appearance of tight junctions in the enteroids treated 
with gliadin-derived peptides compared to the vehicle control.   
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Figure 4.7. Gliadin-derived peptides do not disrupt ultrastructure of cell-cell junctions. 
Representative TEM images of enteroids following treatment for 2 h with vehicle control (0.2% 
v/v DMSO) or 100 μg/mL gliadin peptides P31-43 or P56-68. As shown in left and right 
columns, cell-cell junctions were examined both in crypt base and villus regions of the 
enteroids. Arrows indicate location of tight junctions. All scale bars correspond to 1 μm. 
 
4.5.3.2. Gliadin-derived peptides do not cause rearrangement of tight junction proteins in 
differentiated Caco-2 cell monolayers 
Tight junctions are known to regulate epithelial permeability (Zihni et al., 2016) and may be 
regulated by redistribution of junctional proteins away from the cell-cell border (Clayburgh 
et al., 2005). Furthermore, rearrangement of the actin cytoskeleton, which also regulates 
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tight junction integrity, has been reported in response to gliadin peptides in rat intestinal 
epithelial (IEC-6) cells (Clemente et al., 2003).  Localisation of key tight junction proteins, 
occludin and zonula occludens 1 (ZO-1), was therefore investigated as a potential 
mechanism for increased epithelial permeability following exposure to gliadin peptides. 
Since it is easier to visualise cell-cell junctions in 2D cell culture, differentiated Caco-2 cell 
monolayers were used. As the monolayer forms, Caco-2 cells undergo differentiation to 
adopt a phenotype similar to that of small intestinal enterocytes. Analysis of monolayer 
transepithelial electrical resistance (TEER) demonstrated that TEER increased over 15-18 
days in culture, consistent with full differentiation of the Caco-2 monolayers (Roberts et al., 
2010) (Figure 4.8).  
Following treatment for 2 hours with vehicle control, 100 μg/mL P31-43 or 100 μg/mL P56-
68, no difference was observed in the localisation of ZO-1 (Figure 4.9 A) or occludin (Figure 
4.10 B). As expected, both ZO-1 and occludin were observed along the cell-cell junctions. 
The distribution pattern of both proteins varied within each treatment group. In some 
regions within in all groups, a double line was visible at the cell-cell junction; in others, the 
smoothness of the line of the cell junctions varied. 
 
 
Figure 4.8. Caco-2 cells differentiate to form intact monolayers as assessed by TEER analysis. 
Transepithelial electrical resistance of Caco-2 cell monolayers cultured on Millicell culture 
inserts for up to 15 days. Background readings recorded from an unseeded insert incubated in 
media were subtracted from the raw TEER values. Values shown are multiplied by the area of 
the Millicell polycarbonate membrane (0.6 cm2). Data represent mean TEER recordings from n 
= 21 cultures. Error bars represent SD. 
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Figure 4.9. Gliadin-derived peptides do not cause rearrangement of ZO-1 in differentiated 
Caco-2 cell monolayers. Confocal microscopy images of immunofluorescent staining of tight 
junction protein, ZO-1, in Caco-2 cell monolayers treated for 2 h with vehicle control or 100 
μg/mL gliadin P31-43 or P56-68. Monolayers were differentiated for 15-18 days prior to 
treatment. Cell nuclei are counterstained with Hoechst-33342 (blue). All scale bars = 10 μm. 
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Figure 4.10. Gliadin-derived peptides do not cause rearrangement of occludin in 
differentiated Caco-2 cell monolayers. Confocal microscopy images of immunofluorescent 
staining of tight junction protein, occludin, in Caco-2 cell monolayers treated for 2 h with 
vehicle control or 100 μg/mL gliadin P31-43 or P56-68. Monolayers were differentiated for 15-
18 days prior to treatment. Cell nuclei are counterstained with Hoechst-33342 (blue). All scale 
bars = 10 μm. 
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4.5.4. Gliadin-derived peptide P56-68 but not P31-43 induced enteroid swelling 
During the permeability experiments described above (Section 4.5.1), it was observed that 
enteroids appeared to swell following treatment with gliadin P56-68. To investigate this 
possible effect, images collected during the experiments on C57BL/6 enteroids (Figure 4.3) 
were re-analysed to evaluate and compare enteroid area. This revealed that there was 
indeed an increase in mean percentage area of enteroids treated with 100 μg/mL P56-68 
compared to vehicle-treated controls. A peak response was observed at around 2 hours post-
treatment (Figure 4.11 A). After 2 hours, mean enteroid area decreased slightly but remained 
elevated above that of controls up to 4 hours post-treatment. This resulted in a significantly 
greater area under the curve for P56-68-treated enteroids compared to vehicle-treated 
controls (p < 0.001; ANOVA, N = 4, n = 2-5 enteroids per group) (Figure 4.11 B). In contrast, 
the mean area of enteroids treated with 100 μg/mL P31-43 did not change over 4 hours. 
Addition of 2 mM EGTA also caused a significant increase in mean enteroid area (p < 0.001, N 
= 4 for untreated control, N = 3 for EGTA, n = 2-5); however, this change was likely caused by 
a different mechanism. Whereas EGTA appeared to cause enterocytes to pull apart, the area 
increase following P56-68 treatment appeared in bright field images to be due to a rise in 
luminal volume of the enteroids.   
4.5.5. Gliadin P56-68 did not significantly decrease total luminal pixel intensity  
Given that altering enteroid area could affect mean pixel intensity, total pixel intensity inside 
the enteroid perimeter was compared, again for data from C57BL/6 enteroids (Figure 4.3). 
Total pixel intensity is equal to enteroid area multiplied by mean pixel intensity of 
fluorescence; it is therefore corrected for changes in enteroid area. Using this measure, no 
significant difference was observed in total pixel intensity within the lumen of C57BL/6 
enteroids incubated with 100 μg/mL gliadin P56-68 over 4 hours (Figure 4.12 A & B). Gliadin 
P31-43 also had no effect on total luminal pixel intensity. 
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Figure 4.11. Gliadin-derived peptide P56-68 but not P31-43 induces enteroid swelling in 
permeability experiments. (A) Mean area of enteroids at the indicated time points following 
treatment with 100 μg/mL gliadin peptides or EGTA. Area refers to surface area determined 
from the enteroid perimeter in bright field images. Values were calculated relative to the area 
of each enteroid at 0 h, which was set to 100%. (B) Area under the curve was analysed for the 
data series shown in panel (A). Each symbol represents the mean of an independent 
experimental repeat. Significant differences were determined using one-way ANOVA; ***p < 
0.001, N = 3-4, n = 2-5 enteroids per group. Error bars represent SEM.    
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Figure 4.12. Gliadin-derived peptide P56-68 does not significantly decrease total luminal 
pixel intensity. (A) Change in total pixel intensity within the enteroid lumen following 
treatment with gliadin peptides or EGTA. Total pixel intensity was calculated as the product of 
the enteroid area and the mean pixel intensity within this area. Values for each enteroid were 
calculated relative to the starting total pixel intensity of that enteroid at 0 h. Error bars 
represent SEM. (B) Area under the curve was analysed for the curves shown in (A). Each 
symbol represents the mean of an independent experimental repeat. No significant 
differences were observed using one-way ANOVA with selected pairwise comparisons of 
means using Bonferroni t-tests; N = 3-4, n = 2-5 enteroids per group.  
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4.5.6. Gliadin P56-68 but not P31-43 induces swelling of BALB/c and Nfkb2-/- 
enteroids 
When images from permeability assays of BALB/c enteroids were reanalysed to examine the 
change in enteroid area, a significant increase in enteroid area was found following 
treatment with both 2 mM EGTA and 100 μg/mL gliadin P56-68 compared to untreated and 
vehicle controls respectively. This resulted in a significantly greater calculated area under the 
curve for both P56-68-treated and EGTA-treated enteroids compared to respective controls 
(both p<0.001; ANOVA, N=6 versus controls N=5, with n=2-6 enteroids per group) (Figure 
4.13 A & B). In Nfkb2-/- enteroids, 2 mM EGTA also caused a significant increase in enteroid 
area (one-way ANOVA to compare AUC of EGTA-treated enteroids versus untreated controls; 
p < 0.001, N = 4 versus controls N =3, n = 2-7 enteroids per group) (Figure 4.14 A & B). A 
trend towards increased mean area was observed in Nfkb2-/- enteroids treated with 100 
μg/mL gliadin P56-68 but this difference was not statistically significant.  
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Figure 4.13. Gliadin P56-68 but not P31-43 induces swelling of BALB/c enteroids. (A) Analysis 
of the change in area of BALB/c enteroids during permeability experiments described in Figure 
4.2. (B) Area under the curve analysis of the time courses shown in (A). Each symbol represents 
the mean of one independent biological experiment. Statistical differences were seen using 
one-way ANOVA; ***p < 0.001, N = 5 separate experimental cultures (except for groups 
marked #, for which N = 6), n = 2-6 enteroids per group. All error bars represent SEM.  
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Figure 4.14. Gliadin P56-68 but not P31-43 induces swelling of Nfkb2-/- enteroids. (A) Analysis 
of the change in area of Nfkb2-/- enteroids during permeability experiments described in Figure 
4.4. (B) Area under the curve calculated for the data series shown in panel (A). Each symbol 
represents the mean of one independent biological experiment. Statistical differences were 
seen using one-way ANOVA; ***p < 0.001, N = 4 separate experimental cultures (except for 
groups marked #, for which N = 3), n = 2-7 enteroids per group. All error bars represent SEM.  
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4.5.7. Gliadin P56-68 induces enteroid swelling due to CFTR-dependent fluid 
secretion 
4.5.7.1. Gliadin P56-68 induces enteroid swelling  
To investigate the effect of gliadin P56-68 on enteroid swelling in isolation from the 
potentially confounding effects of microinjecting fluid into the enteroid lumen, C57BL/6 
enteroids were treated on day 2 post-seeding with vehicle (0.2% v/v DMSO) or increasing 
concentrations of P56-68. Enteroids were tracked by bright field microscopy over 4 hours 
(Figure 4.15 A). Enteroid surface area was used as a surrogate measure of enteroid volume. 
Control enteroids treated with vehicle showed almost no change in area over 4 hours post-
treatment. In contrast, treatment with P56-68 dramatically increased mean percentage 
enteroid area. Swelling was rapid, being morphologically noticeable at 30 minutes post-
treatment (Figure 4.15 B). The increase in mean enteroid area after 30 minutes was dose-
dependent. Enteroid area peaked after around 1 hour post-treatment, reaching a plateau 
for up to 4 hours. The mean area of enteroids treated with 50 μg/mL or 100 μg/mL P56-68 
increased by around 50-55% compared to pre-treatment, the peak increase in the area of 
enteroids treated with 25 μg/mL P56-68 was approximately 35%. Analysis of the area under 
the curve revealed significant differences compared to vehicle with 25, 50 and 100 μg/mL 
P56-68 (all p < 0.001; ANOVA, N = 3, n = 5-8 enteroids per group) (Figure 4.15 C).  
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Figure 4.15. Gliadin P56-68 induces enteroid swelling. (A) Representative bright field images 
of C57BL/6 enteroids at the indicated time points following treatment with vehicle or 25-100 
μg/mL gliadin P56-68. (B) Mean enteroid area. Error bars represent SEM. (C) Area under the 
curve analysis of the curves shown in (B). One-way ANOVA with Bonferroni correction, ***p 
<0.001, N = 3, n = 5-8 enteroids per group. Error bars represent SEM.  
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4.5.7.2. Enteroid swelling induced by P56-68 is similar to that induced by forskolin 
Swelling of enteroids has been described previously in response to forskolin (Dekkers et al., 
2013). This effect was replicated following treatment of C57BL/6 enteroids on day 2 post-
passage with 5 μM forskolin (Figure 4.16 A). Forskolin induced a rapid increase in mean 
percentage enteroid area that was apparent within 0.5 hours and peaked by 1 hour. This 
increase in enteroid area was sustained for the duration of the experiment (up to 4 hours, 
Figure 4.16 B). This resulted in a significantly greater area under the curve for forskolin-
treated enteroids compared to vehicle-treated controls (p < 0.001, ANOVA; N = 3, n = 5-8 
enteroids per group, Figure 4.16 C). The time course of forskolin-induced enteroid swelling 
was therefore very similar to that induced by gliadin P56-68. The magnitude of the effect 
was also almost identical, with both resulting in a peak increase in mean enteroid area of 
approximately 50-55%.  
Forskolin-induced swelling is due to activation of the CFTR, a chloride ion channel known to 
be expressed on the apical membrane of intestinal epithelial cells (Saint-Criq and Gray, 
2017). Secretion of chloride ions into the lumen creates an electrochemical and osmotic 
gradient, drawing sodium ions and water into the lumen (Saint-Criq and Gray, 2017). In 
enteroids, this results in swelling as the lumen is enclosed. The involvement of CFTR in this 
effect was confirmed by pre-incubation of the enteroids with 50 μM CFTR-inh-172, a 
specific inhibitor of CFTR (Thiagarajah et al., 2004; Dekkers et al., 2013). Enteroids pre-
treated with CFTR-inh-172 alone showed no change in area, while CFTR-inh-172 
significantly reduced the swelling induced by addition of 5 μM forskolin (p < 0.01 when 
comparing AUC of mean percentage area for enteroids treated with forskolin and CFTR-inh-
172 versus those treated with forskolin alone; ANOVA, N = 3, n = 5-8 enteroids per group) 
(Figure 4.16 C). 
4.5.7.3. Enteroid swelling induced by P56-68 is mediated by CFTR activation 
Inhibition of CFTR by pre-incubation with 50 μM CFTR-inh-172 completely abolished the 
increase in enteroid area induced by 100 μg/mL P56-68 (Figure 4.17 A-C). The extent of 
protection was greater than that afforded by CFTR-inh-172 when used to block forskolin-
induced swelling.  
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Figure 4.16. Enteroid swelling induced by P56-68 is similar to that induced by forskolin. (A) 
Representative bright field images of enteroids at the indicated time points following 
treatment with vehicle control (0.3% DMSO), CFTR-inh-172 (a selective CFTR inhibitor), 
forskolin alone or forskolin and CFT-172-inh. To block apical chloride channel ion secretion, 
enteroids were pre-incubated with 50 μM CFTR-inh-172 for 3 h prior to addition of gliadin 
peptides; CFTR-inh-172 was present for the duration of the experiment. Forskolin was used at 
dose of 5 μM. (B) Mean area of treated enteroids determined from specifying enteroid 
perimeter in bright field images. Error bars represent SEM. (C) Area under the curve analysis of 
the data series shown in panel (B). Significant differences were observed using one-way 
ANOVA with selected pairwise comparisons of treatment means using Bonferroni t-tests; ***p 
< 0.001, **p < 0.01, N = 3, n = 5-8 enteroids per group. Error bars represent SEM. 
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Figure 4.17. Enteroid swelling induced by P56-68 is mediated by CFTR activation. (A) 
Representative bright field images of C57BL/6 enteroids over 4 h post-treatment with vehicle 
control (0.3% DMSO) or 100 μg/mL gliadin P56-68, both with and without the apical chloride 
channel inhibitor CFTR-inh-172 (at 50 μM). Scale bars = 50 μm. (B) Quantification of mean 
enteroid percentage area following the treatments described in panel (A). Error bars = SEM. (C) 
Area under the curve calculated for the data series shown in panel (B). Significant differences 
determined by one-way ANOVA with selected pairwise comparisons of treatment means using 
Bonferroni t-tests; ***p < 0.001, N = 3, n = 5-8 enteroids per group. Error bars = SEM. 
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4.5.7.4. Gliadin P31-43 does not induce enteroid swelling 
No change in mean enteroid area was recorded in enteroids treated with 100 μg/mL gliadin 
P31-43 compared to vehicle control (Figure 4.18 A-C). There was also no change in enteroid 
area following treatment with combination of gliadin P31-43 in the presence of 50 μM 
CFTR-inh-172. 
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Figure 4.18. Gliadin P31-43 does not induce enteroid swelling. (A) Representative bright field 
images of C57BL/6 enteroids following treatment with vehicle control (DMSO), 100 μg/mL 
gliadin P31-43, or 100 μg/mL P31-43 with 50 μM CFTR-inh-172. Scale bars = 50 μm. (B) 
Quantification of enteroid area following the treatments described in (A). Error bars = SEM. (C) 
Area under the curve analysis of (B). Error bars = SEM. No significant differences observed 
using one-way ANOVA; N = 3, n = 6-8 enteroids per group.  
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4.5.8. P56-68-induced enteroid swelling is maintained for approximately 4 hours 
Time-lapse microscopy using a CytoSMART in-incubator bright field microscope showed that 
enteroids treated with vehicle (0.2% v/v DMSO) remained a consistent size over the course of 
12 hours (Figure 4.19 A). In contrast, 100 μg/mL gliadin P56-68 rapidly induced swelling, 
which was noticeable by 10 minutes post-treatment (Figure 4.19 B). Enteroid lumens 
remained enlarged for approximately 4 hours, then decreased in size again (visible decrease 
at 6 hours) Following this, enteroids generally remained at this smaller size until at least 12 
hours post-treatment. Around 11-12 hours post-treatment, some enteroids appeared to re-
swell, albeit to a much lesser degree. Gliadin P31-43 had no dynamic effect on enteroid area 
(Figure 4.19 C).  
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Figure 4.19. P56-68-induced enteroid swelling is maintained for approximately 4 h. Still 
images taken from 12-h time-lapse videos captured using a CytoSMART in-incubator bright 
field microscope. Images show C57BL/6 enteroids treated at 0 h with (A) vehicle control 
(0.2% v/v DMSO), (B) 100 μg/mL gliadin P56-68, or (C) 100 μg/mL gliadin P31-43. Arrow 
heads indicate examples of individual enteroids that showed an obvious swelling response. 
Inset images in (B) show 2X magnified images of 100 μg/mL gliadin P56-68-induced enteroid 
swelling. 
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4.5.9. Gliadin P56-68 causes luminal swelling, cell stretching and flattening of 
microvilli 
Unlike the normal monolayer epithelium observed in vehicle-treated (0.2% v/v DMSO) 
control enteroids (Figure 4.20 A & B), parts of the lumen were observed by TEM to be greatly 
engorged in those enteroids fixed following 2 hours of treatment with 100 μg/mL gliadin 
peptide P56-68 (Figure 4.20 C-F). The epithelium of this P56-68-treated enteroid was seen to 
be both thinner and stretched (Figure 4.20 C-E). Cells were markedly elongated laterally. In 
the area when the lumen was expanded, apical-basolateral diameter measured in P56-68-
treated epithelial cells was 4.0 μm ± 0.96 μm (mean ± SEM; diameter measurements taken at 
6 sites in 4 different images of the stretch area). In contrast, the mean apical-basolateral 
diameter of vehicle-treated control epithelial cells was 17.5 μm ± 1.5 μm (SD, 1 cell measured 
in 4 images of different areas of the enteroid). Of note too, the apical surface of P56-68-
treated enteroid epithelial cells appeared almost devoid of microvilli, with only very small, 
irregular wrinkles visible (Figure 4.20 E). In other regions of the same enteroid where no 
swelling of the lumen was apparent, the apical surface of enterocytes appeared normal, with 
regular-length microvilli evident (Figure 4.20 F).  
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Figure 4.20. Gliadin P56-68 causes luminal swelling, cell stretching and flattening of 
microvilli. (A & B) TEM images of a control enteroid showing (A) an overview of the typical 
appearance of the epithelium and (B) a close-up of microvilli on the apical surface of 
enterocytes. (C-F) Images of an enteroid treated for 2 h with 100 μg/mL P56-68. (C &D) Areas 
of the enteroid where the lumen is enlarged and cells are stretched thin. (E) A stretched 
enterocyte. (F) Apical surface of enterocytes in a different part of the same enteroid where 
normal microvilli are still present. Arrows indicate the apical surface of the cell where microvilli 
are almost absent. L, lumen; N, nucleus.  
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4.6. Summary of results 
 
1. A peptide fragment of α-gliadin spanning amino acids 56-68 rapidly induced increased 
secretion of fluid into the enteroid lumen. The increase in luminal volume peaked 
around 1 hour after exposure and enteroid area reduced after approximately 4 hours.  
 
2. Enteroid swelling induced by gliadin P56-68 occurred in a dose-dependent manner. The 
magnitude of the effect was similar with both 50 and 100 μg/mL gliadin P56-68, 
although a clear effect was still observed with 25 μg/mL gliadin P56-68.  
 
3. Increased intra-enteroid luminal fluid secretion caused by gliadin P56-68 was due to 
activation of the CFTR, a chloride channel expressed on the apical surface of 
enterocytes.  
 
4. The swelling response induced by gliadin P56-68 is likely specific to its amino acid 
sequence, as an otherwise identical size peptide, P31-43 with a different amino acid 
sequence, had no effect on fluid secretion.  
 
5. Neither gliadin peptide was observed to affect enterocyte cell viability or integrity of 
tight junctions.   
 
4.7. Discussion 
Gluten, and therefore also gliadin, is a common dietary component for the majority of the 
world’s population, being present in foodstuffs made from wheat, barley and rye. Although 
most dietary proteins are thought to be biologically inert in the gut lumen, gliadin is an 
example of a protein that interacts with the intestinal wall and has profound 
pathophysiological consequences in the form of coeliac disease. Although symptoms of coeliac 
disease can be successfully avoided by removing gluten from the diet, up to two thirds of 
patients do not adhere, possibly due to the negative impact on quality of life through social 
isolation and increased food expense (Barratt, Leeds and Sanders, 2011). As a result, many 
people find it difficult to adhere to a gluten-free diet. In some cases, patients may not respond 
or become refractory to a gluten-free diet (McAllister, Williams and Clarke, 2018). The 
condition is also believed to be under-diagnosed, especially in individuals who suffer mainly 
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extra-intestinal symptoms. It is therefore desirable to understand the pathophysiology of this 
common disease. While great progress has been made in understanding the immunological 
events that drive the inflammatory response observed in coeliac disease, many aspects of the 
pathophysiology of the condition remain poorly understood, in particular the putative direct 
effects of gliadin-derived peptides on the intestinal epithelium. The studies presented here, 
using stem cell-derived 3D enteroid cultures, provide evidence that gliadin-derived peptides 
may indeed directly impact on the physiology of the epithelium, in the absence of an adaptive 
immune response.  
We show that a 13-amino acid peptide (P56-68) constituting a fragment of α-gliadin, rapidly 
enhances apical fluid secretion (secondary to apical chloride secretion) by intestinal epithelial 
cells. This effect is dose-dependent, with a highly significant swelling response generated with 
25 μg/mL gliadin P56-68. It is difficult to quantify the concentration of this gliadin peptide 
present in the gut lumen in vivo following the ingestion of a gluten-containing meal. This 
concentration would be dependent on many factors, including the amount of food consumed, 
the gluten content of the food and the extent to which this particular peptide was generated 
from digestion of the gliadin present. One study using an antibody-based test to measure the 
concentration of gluten-derived peptides in urine detected peptides in all subjects on a gluten-
containing diet at concentrations up to 604 ng/mL (Moreno et al., 2017). In one patient, 
approximately 15 ng/mL gluten-derived peptides were detected in the urine following 
consumption of a single 25 mg oral dose of gluten. Symptoms have been reported in coeliac 
patients after oral challenge with just milligram daily doses of gluten (Hischenhuber et al., 
2006). Given that one slice of bread contains around 8 g gluten and that these peptides are 
resistant to digestion, it is not unreasonable to suggest that gluten concentration in the gut 
could reach concentrations in the microgram range, as used in this study.  
Our data show that the swelling induced by gliadin P56-68 is mediated by CFTR activity. The 
CFTR is a major anion channel expressed at the apical membrane of enterocytes throughout 
the small intestinal epithelium, with capacity for regulated secretion of chloride and 
bicarbonate ions, whose activity is the main regulator of apical fluid secretion (Field, 2003; 
Jakab, Collaco and Ameen, 2011; Saint-Criq and Gray, 2017). CFTR activation is triggered by 
elevated intracellular cyclic adenosine monophosphate (cAMP) and results in secretion of 
anions, mainly chloride ions, into the intestinal lumen, with sodium ions following via the 
paracellular pathway down the resulting electrochemical gradient and water following by 
osmosis.  
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Whilst in this study we do not address the upstream mechanism of P56-68-mediated CFTR 
activation, CFTR can be activated in many ways, including phosphodiesterase inhibition, 
inhibition of CFTR-interacting proteins, or stimulation of adenylate cyclase (Moon et al., 2015). 
Hyperactivation of the CFTR, for example by cholera toxin-mediated activation of adenylate 
cyclase, can result in diarrhoea as too much fluid is secreted and overtakes the reabsorbing 
capacity of the colon (Lencer and Tsai, 2003). Secretory diarrhoea is also an adverse effect of 
many drugs, including irinotecan and zidovudine, which inhibit cAMP secretion via the CFTR-
interacting protein MRP and cause increased local cAMP (Moon et al., 2015). There are 
therefore myriad pathways by which gliadin P56-68 could activate the CFTR.  
A very recent publication reports that gliadin-derived peptide P31-43 inhibits CFTR activity, 
reportedly mediated by direct binding of P31-43 to one of the CFTR intracellular nucleotide 
binding domains (Villella et al., 2019). Together, the findings suggest that P31-43-mediated 
inhibition of CFTR drives epithelial stress and activation of TG2, the enzyme responsible for the 
deamidation of gliadin peptides that promotes presentation to the adaptive immune system. 
Evidence was also described of elevated baseline inflammation in the small intestines of CFTR-
deficient mice (either CFTR knockout or mutated), which was augmented following oral gliadin 
administration. In contrast to P31-43, no inhibition of forskolin-induced CFTR activity was 
reported in Caco-2 cells following 3 hours of treatment with an α-gliadin peptide consisting of 
amino acids 57-68, which is very similar to P56-68. Although it is difficult to compare this with 
our own study given the different time points and methodologies, the report of direct binding 
and regulation of the CFTR by a gliadin-derived peptide is certainly intriguing. This study 
provides evidence of a peptide similar in size and amino acid composition to P56-68 directly 
regulating CFTR activity.  
From the study presented here, it is not clear whether gliadin P56-68 acts on a cell surface 
receptor or whether it enters the epithelial cells and interacts with a target inside the cells. 
Several previous studies have indicated that gliadin-derived peptides are taken up by intestinal 
epithelial cells via endocytosis (Friis et al., 1992; Ménard et al., 2012; Zimmermann et al., 2014; 
Barone and Zimmer, 2016). Endocytosis is the suggested mechanism, since uptake was 
reduced by methyl-β-cyclodextin, a general inhibitor of endocytosis (Schumann et al., 2008; 
Caputo et al., 2010; Zimmermann et al., 2014); however, some reports suggest there may be 
differences between the precise mechanisms of endocytosis of P31-43 and P56-68. Uptake of 
gliadin-derived peptides has also been shown in biopsies from both healthy individuals and 
those with coeliac disease. One study demonstrated uptake of synthetic gliadin peptides in 
biopsies from patients with active coeliac disease (Ménard et al., 2012), while a second 
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reported greater uptake in coeliac patients compared to controls following in vivo challenge 
with digested gliadin (Friis et al., 1992). This indicates that both cell surface receptors and 
molecules inside the cell are possible targets for P56-68 in activating the CFTR. 
One potential limitation of our study is that gliadin peptides were delivered to the basolateral 
rather than the apical surface of the intestinal epithelium. In vivo, the initial exposure of the 
intestinal epithelium to dietary gliadin would be at the apical surface; however, presentation 
of gliadin peptides at the basolateral surface is also likely to occur, perhaps especially in coeliac 
patients in whom defects in epithelial barrier integrity have been reported (van Elburg et al., 
1993; Heyman et al., 2012). It is probable that gliadin peptides translocate across the 
epithelium in order to encounter antigen-presenting cells in the lamina propria and drive the 
adaptive immune response observed in coeliac disease. Translocation of gliadin peptides has 
been reported in several studies using epithelial cell lines (Schumann et al., 2008; Bethune et 
al., 2009). In a macaque model of gluten sensitivity, translocation of gliadin peptides was 
found only in gluten-sensitive animals (Bethune et al., 2008; Mazumdar et al., 2010), while 
translocation was only observed in duodenal biopsies derived from patients with active coeliac 
disease (Matysiak-Budnik et al., 2008). A role for the transferrin receptor in transporting 
gliadin peptides as a complex with secretory IgA, in a retrograde manner from apical to basal 
compartments, has also been proposed (Matysiak-Budnik et al., 2008). As mentioned 
previously, increased permeability of the intestinal epithelium has also been reported during 
coeliac disease (van Elburg et al., 1993; Heyman et al., 2012), presenting another route by 
which gliadin peptides may access the basolateral surface.  
In our studies, analysis of total FD4 pixel intensity during permeability assays indicated that the 
effect of gliadin P56-68 on mean FD4 pixel intensity was largely explained by its effect on 
enteroid swelling, there was still a slight, non-significant trend towards greater loss of FD4 in 
the P56-68 group. This suggests that this peptide could also have a small effect on epithelial 
permeability, perhaps contributing to the barrier dysfunction already reported in coeliac 
patients (van Elburg et al., 1993; Heyman et al., 2012).  
A further aspect for consideration is whether the synthetic gliadin peptides undergo 
modification by TG2 in our system. In vivo, glutamine residues within gliadin peptides are 
deamidated to glutamic acid by TG2; the resulting negative charge makes them ideal ligands 
for the HLA-DQ2/8 molecules. TG2 is expressed in the lamina propria and expression in the 
small intestinal epithelium has been reported to increase in active coeliac disease (Esposito et 
al., 2003). The level of TG2 expression in normal intestinal epithelium has not been well 
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defined. In this study, we did not assess whether TG2 is present in enteroid cultures. The 
peptides used in this study both contain multiple glutamine residues that are potential sites for 
TG2 activity. If TG2 is present, it is possible that the peptides may undergo modification in the 
cultures, which would increase the physiological relevance of this model.  
The aim of our study was to use enteroids to model gliadin-associated pathophysiological 
epithelial responses, so a key question is the physiological relevance of our findings to 
conditions of gluten sensitivity in humans. Abnormal activation of the CFTR by gliadin P56-68 in 
vivo could cause excess fluid secretion into the lumen of the small intestine. It is conceivable 
that this could contribute to bloating and abdominal pain, commonly reported symptoms of 
coeliac disease, NCWS and many cases of IBS. Although the colon has a significant capacity for 
reabsorbing water (up to 1.5 L), it can be overwhelmed (Debongnie and Phillips, 1978), for 
instance in the case of CFTR hyperactivation and fluid secretion caused by enterotoxic 
pathogens such as Vibrio cholerae (Thiagarajah, Donowitz and Verkman, 2015). The action of 
gliadin P56-68 could therefore contribute to diarrhoea, another key symptom of coeliac 
disease, NCWS and diarrhoea-associated IBS (IBS-D) (Cooper et al., 1980; Wald, 2012; Murray, 
Frey and Oliva-Hemker, 2018). If so, our data demonstrating enteroid swelling in response to 
gliadin-derived peptides suggest a possible diagnostic test for gluten-sensitive IBS or NCWS.  
We demonstrated that enhanced fluid secretion triggered by gliadin P56-68 resulted in 
distension of the intestinal epithelium and disruption of normal microvilli morphology. Since 
the role of microvilli is to increase the surface area of the epithelium, such an effect in vivo 
could play a role in reduced nutrient absorption. Although largely attributable to villus 
flattening and damage caused by ongoing inflammation, nutrient malabsorption is a common 
problem in coeliac patients.  
The vast majority of coeliac patients are carriers of the HLA-DQ2/8 alleles whereas the 
C57BL/6 mice from which our enteroids were derived were not genetically susceptible to 
gluten sensitivity. Our findings are therefore relevant to both coeliac and non-coeliac 
individuals but may be a better model of NCWS than coeliac disease. It has been suggested, 
however, that direct effects of gliadin-derived peptides on the intestinal epithelium may have 
a role in coeliac disease, particularly in its early stages. Only a small proportion of those who 
carry HLA-DQ2/8 develop coeliac disease and many other genetic loci have been linked to 
coeliac disease risk (Abadie et al., 2011), including NFKB2 and multiple other NF-κB-related 
genes (Fernandez-Jimenez et al., 2014). Other coeliac-associated loci include genes related to T 
and B cell function, as well as intestinal barrier function. It is therefore possible that genetic 
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variants could make certain individuals more susceptible to direct effects of gliadin peptides, 
such as P56-68, on the epithelium. This could contribute to an individual’s risk of developing 
coeliac disease, or indeed, NCWS.  
We did not find evidence of cytotoxic effects induced by gliadin P31-43, including no increase 
in cell shedding into the lumen, in caspase 3-positive staining, or in localisation of tight 
junction proteins. This is in agreement with previous findings from our group showing that 
enteroid circularity does not increase following treatment with synthetic gliadin peptides P31-
43 or P56-68 for 24 or 48 hours (personal communication, Andra Vaida and Dr Carrie 
Duckworth, University of Liverpool). Enteroid circularity is a morphological measure 
determined from the enteroid perimeter in bright field images; it has been shown by our group 
to correlate positively with the number of caspase 3-positive cells and is thus a crude measure 
of enteroid viability. Previous studies have reported alterations of the actin cytoskeleton 
(Clemente et al., 2003), growth factor-like effects due to interfering with trafficking of the 
EGFR (Barone et al., 2007, 2010, 2011), IL-15 secretion (Maiuri et al., 2003) and expression of 
tight junction regulators (Lammers et al., 2008). In contrast, Cerf-Bensussan and colleagues 
stated that “several unpublished studies including ours have not been able to demonstrate a 
direct effect of p31-43 or the longer p31-49 peptide on either epithelial lines or leucocytes” 
(Heyman et al., 2012). One possible explanation is that most of these studies were performed 
on cell lines, which can show marked variation in phenotype between different laboratories.  
The results presented here also highlight the importance of choice of experimental model 
system. The unique properties of enteroid cultures made it possible to observe the swelling 
response induced by gliadin P56-68. The self-organisation of enteroids to form distinct basal 
and luminal compartments makes them ideal models in which to investigate factors affecting 
secretion into the lumen. This would not have been possible using a 2D cell culture, even a 
Transwell system, where the apical and basolateral compartments are separated but not 
restricted in volume. In contrast in enteroids, the closed nature of the lumen means that even 
small changes in the lumen volume may be detected as a change in enteroid area.  
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Chapter 5 
 
Characterisation of an enteroid 
model of M cells and the FAE   
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5.1. Introduction 
M cells are specialised epithelial cells restricted spatially to the follicle-associated epithelium of 
the intestine, which overlies tertiary lymphoid follicle, such as Peyer’s patches in the distal 
small intestine and mucosal lymphoid follicles of the colon (Ohno, 2016). Although details of 
the underlying mechanisms remain poorly understood, several studies have indicated that M 
cells have the ability to take up particles, bacteria and viruses from the gut lumen and 
translocate them to the basolateral surface of the epithelium (des Rieux et al., 2005; Keita et 
al., 2008; Hase, Kawano, et al., 2009; Roberts et al., 2010; Nakato et al., 2012; Rios et al., 
2016). From here, antigens are thought to be transferred to antigen presenting cells, such as 
dendritic cells, macrophages and intraepithelial lymphocytes, thereby facilitating generation of 
immune responses by the gut-associated immune system to antigens present in the gut lumen 
(Mabbott et al., 2013; Rios et al., 2016).   
Given that they represent only a tiny fraction of epithelial cells in the small intestine, M cells 
are challenging to study in vivo. Whilst 2D transformed cell line co-culture models have 
supported key biological insights into M cell biology, they also have significant limitations in 
terms of reproducibility, inconsistencies in M cell function, time to develop and cost (Kernéis et 
al., 1997; Gullberg et al., 2000; Schulte et al., 2000; Martinez-Argudo, Sands and Jepson, 2007). 
Development of 3D in vitro models to facilitate the study of M cells is therefore desirable. 
Understanding of M cell biology has recently been advanced by the finding that RANKL, a 
cytokine belonging to the TNF super family, is necessary and sufficient for M cell 
differentiation (Knoop et al., 2009). Since then, RANKL has been shown to stimulate expansion 
of the M cell population even in enteroids, which are devoid of immune cells (de Lau et al., 
2012). In vivo, M cells are restricted to the FAE because their differentiation is driven by a 
subset of RANKL-expressing mesenchymal cells that reside in the sub-epithelial dome 
(Nagashima et al., 2017a; Nagashima et al., 2017b). RANKL-stimulated enteroids therefore 
present a novel model of the FAE in which to investigate M cell biology; however, this model 
has not so far been fully characterised. 
RANKL induces upregulation of an M cell ‘master transcription factor’, SpiB, which in turn 
drives expression of several M cell-associated genes, including GP2 (de Lau et al., 2012; Wood, 
Rios and Williams, 2016). RANKL is known to activate NF-κB signalling via TRAF signalling 
molecules (Wong et al., 1998); however, the relative requirement for classical versus 
alternative NF-κB signalling pathways and their distinct NF-κB subunits (Vallabhapurapu and 
Karin, 2009) in M cell differentiation is unclear. NF-κB subunits RelA and RelB are essential for 
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development of Peyer’s patches in mice (Alcamo et al., 2002; Yilmaz, 2003), although their 
precise roles in M cell differentiation are unknown. M cell differentiation was recently found to 
proceed normally in c-Rel-deficient mice (Sehgal et al., 2017).  
Previous work has also implicated B cells in M cell differentiation. For instance, work in our 
research laboratory, and by others, has described a model where Caco-2 human colon 
carcinoma cells are cultured in the presence of B cells, stimulating the Caco-2 cells to adopt an 
M cell-like phenotype (Kernéis et al., 1997; Gullberg et al., 2000; des Rieux et al., 2007; Man et 
al., 2008; Roberts et al., 2010). These cells demonstrate increased expression of M cell markers 
(Gullberg et al., 2000), M cell-like ultrastructural changes and translocation of beads and 
bacteria (Roberts et al., 2010, 2013). The identity of the Raji B cell-derived factors responsible 
for driving this phenotypic change have, however, proved difficult to identify (Gullberg, 2005). 
Other evidence supporting a role for B cells in M cell differentiation includes the proximity of 
the FAE to the lymphoid follicle and reports that mice deficient in B cells have fewer M cells 
(Golovkina et al., 1999; Ebisawa et al., 2011).  
 
5.2. Hypothesis 
Stimulation of enteroids with RANKL to induce M cell differentiation will cause perturbations in 
the differentiation of other epithelial cell types. Differentiation of M cells induced by RANKL 
requires NF-κB2 alternative pathway signalling and may be promoted by B cell-derived factors.  
 
5.3. Aims 
1. To characterise the effects of exogenous RANKL on differentiation of M cells in an 
enteroid model. 
 
2. To investigate the role of NF-κB alternative pathway in M cell differentiation. 
 
3. To characterise the effect of RANKL on other aspects of enteroid structure and 
composition. 
 
4. To investigate the effects of B cells and B cell-derived factors on differentiation of M 
cells. 
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5.4. Methods 
Enteroid culture  
Since most Peyer’s patches are located in the terminal ileum, all enteroids used in this chapter 
were derived from the distal region of murine small intestine, unless otherwise stated. To 
investigate the role of alternative pathway signalling in M cell differentiation, enteroids were 
established from two mouse strains carrying knockouts of key alternative pathway proteins. 
Nfkb2-/- mice (on a C57BL/6 background), carrying a germ line mutation of the Nfkb2 gene, 
have decreased numbers of B cells in their spleen, bone marrow and lymph nodes, in addition 
to altered structure of secondary lymphoid organs (Caamaño et al., 1998).  
Relb-/- mice, carrying  a germ line mutation of the Relb gene, display multiple abnormalities, 
including smaller body mass, inflammatory responses in multiple organs and splenomegaly 
(Weih et al., 1995). They were bred by crossing heterozygous animals and offspring were 
genotyped in our laboratory by PCR prior to use in experiments (see Section 2.2 for details). All 
other enteroids used in this chapter were established from mice of the C57BL/6 strain. 
Stimulation of M cell differentiation by RANKL  
To induce M cell differentiation, enteroids were treated with 200 ng/mL recombinant murine 
RANKL at the time of passage. This dose was selected as it has previously been demonstrated 
to induce robust upregulation of Spib and other M cell-associated genes in enteroid cultures 
(de Lau et al., 2012; Rouch et al., 2016). Enteroids were exposed to RANKL for either 3 or 6 
days, as indicated. For 6-day treatments, RANKL was added again on day 3, ie. when culture 
medium was replaced. The effect of RANKL on the growth and gross morphology of enteroids 
was assessed using bright field microscopy.  
Quantitative analysis of M cell-associated gene expression 
Changes in gene expression in enteroids as a result of RANKL treatment were detected by 
qPCR. A detailed description of the procedure may be found in Section 2.9. Briefly, Matrigel 
was dissociated and enteroids were washed and collected by centrifugation. Total RNA was 
extracted and contaminating DNA was removed by DNase treatment. RNA was then reverse 
transcribed to cDNA and qPCR was performed with SYBR green, using validated primers 
specific for mouse Spib, Gp2 and Rank. Amplification of a single, specific amplicon was 
confirmed from melt curves. Gp2 expression in untreated controls was consistently 
undetectable across independent repeats, indicating that Gp2 is truly unexpressed in these 
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samples. In these cases, an arbitrary value of 40 was imputed (McCall et al., 2014). To reduce 
bias introduced by normalising experimental samples to these imputed Gp2 control CT values, 
data were analysed using the dCT method rather than the ddCT method. CT values for target 
genes were normalised to the housekeeping gene, Gapdh, and are expressed as 2-ΔCT 
(Schmittgen and Livak, 2008). Statistical tests were not performed given that Gp2 was not 
measurable in untreated controls. Gapdh mRNA levels were similar in experimental samples 
and controls.   
Immunohistochemical analysis of effect of RANKL epithelial cell lineage markers and SpiB  
For immunohistochemical analysis, enteroids were treated for 6 days starting from day 0 post-
passage. Enteroids were then fixed and processed to generate paraffin-embedded sections as 
described in Section 2.7.  
Comparing epithelial permeability in control versus RANKL-treated enteroids  
The assay used to evaluate epithelial permeability in control and RANKL-treated enteroids was 
similar to that described in Section 2.10. Enteroids were treated on the day of seeding with 
200 ng/mL RANKL. On day 3 post-seeding, a 50:50 mixture of FD4 and AlexaFluor 594-
conjugated 10 kDa dextran were microinjected into the enteroid lumen. Instead of allowing 3.5 
hours for luminal FD4 to stabilise, images were captured every hour, starting 1 hour post-
injection. Image analysis was performed as described in Section 2.10 using ImageJ software.  
Production of Raji B cell-conditioned medium 
Since B cells have been reported to promote M cell differentiation (Kernéis et al., 1997), Raji B 
cell-conditioned medium was generated and incubated with enteroids to investigate whether 
factors secreted by B cells could induce upregulation of M cell-associated genes. Raji B cells are 
a non-adherent human Burkitt’s lymphoma cell line (Karpova et al., 2005). Raji B cell-
conditioned media and control media was produced by culturing Raji cells in suspension in 
DMEM supplemented with 10% v/v FBS and 8 mM L-glutamine for 5 days, then collecting 
media and removing cells and cell debris by centrifugation. Control media was incubated in 
tissue culture flasks, at the same time and under the same conditions, but without cells. 
Conditioned or control medium was incubated with enteroids at a dilution of 50% v/v in 
normal minigut medium from day 0 post-passage. The resulting medium was supplemented 
with 50 ng/mL EGF, 100 ng/mL Noggin and 500 ng/mL R-spondin-1, as in complete minigut 
medium. Medium was replaced on day 3 post-passage and enteroids were harvested for RNA 
extraction on day 6 post-passage.   
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Co-culture of Raji B cells and enteroids 
For co-culture of enteroids with Raji B cells, 1 x 105 cells per well were added to the culture 
medium overlying enteroid cultures. Various co-culture conditions were assessed: Raji B cells 
were added on either day 0 or day 3 post-seeding. On day 3 post-seeding, either Raji cells and 
culture medium were replaced, or the original cells were kept and only the medium was 
replaced. Enteroids were harvested on day 6 for RNA extraction by removing Raji cells and 
dissociating Matrigel.  
 
5.5. Results   
5.5.1. Effect of RANKL on enteroid growth and morphology 
Treatment with 200 ng/mL RANKL had no apparent effects on the growth of enteroids 
(Figure 5.1). Enteroids grow at a similar rate to controls and reached a similar size. Both 
RANKL-treated and control enteroids display the expected budding morphology. 
 
 
Figure 5.1. Effect of RANKL on enteroid growth. Representative bright field images of 
enteroids derived from a C57BL/6 mouse treated with 200 ng/mL recombinant murine RANKL. 
Images were captured on days 3, 5 and 7 post-seeding. RANKL treatment was on day 0. Scale 
bars represent 100 μm.   
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5.5.2. Effect of RANKL on M cell-associated gene expression in wild type enteroids 
5.5.2.1. Distal enteroids 
To confirm whether exogenous RANKL induces M cell differentiation, expression of Spib and 
Gp2 were analysed following incubation of distal C57BL/6 enteroids with 200 ng/mL RANKL. 
After 3 days, Spib expression relative to Gapdh showed a trend to increase in RANKL-
treated enteroids compared to controls in each independent experiment, although the size 
of the increase showed considerable variation and this difference did not reach significance 
(Figure 5.2 A). Gp2 mRNA was consistently not detected in control enteroids, whereas it 
was detected in enteroids treated with RANKL. Again, this effect was variable and did not 
reach significance.  
Incubation of distal enteroids with 200 ng/mL RANKL over a longer period – for 6 days from 
passage – resulted in significant upregulation of both Spib and Gp2 expression, with Gp2 
transcripts again undetectable in control enteroids (Figure 5.2 B). In contrast, no significant 
difference was found in the level of Rank expression between controls and RANKL-treated 
enteroids.  
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Figure 5.2. Effect of RANKL on M cell-associated gene expression in wild type distal 
enteroids. (A) Quantification by qPCR of the expression of M cell-associated genes, Spib and 
Gp2, in enteroids derived from distal small intestine of C57BL/6 mice treated for 3 d with 200 
ng/mL RANKL. Addition of RANKL to enteroid cultures was at the time of seeding. N = 3, n = 3-5 
wells enteroids pooled for each condition. (B) Quantification by qPCR of the expression of M 
cell-associated genes, Spib, Gp2 and Rank, in C57BL/6 enteroids on day 6 of treatment with 
200 ng/mL RANKL. RANKL was added to enteroid cultures at the time of seeding. N = 7, except 
for Rank, for which N = 3, n = 3-5 wells enteroids pooled for each condition. All data measured 
by qPCR were normalised to the housekeeping gene Gapdh and are represented as 2-ΔCT. Gp2 
transcript was undetected in all untreated samples at both time points. Error bars represent 
SEM. 
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5.5.2.2. M cell differentiation in proximal enteroids 
Whilst the majority of Peyer’s patches are known to be located in the terminal ileum (Ohno, 
2016), proximal intestinal epithelial cells were used to investigate whether they were also 
capable of supporting M cell differentiation. Expression of M cell-associated genes in 
response to 200 ng/mL RANKL was therefore analysed in enteroids derived from proximal 
murine small intestine. After 6 days incubation with RANKL, relative expression of both Spib 
and Gp2 was increased compared to untreated control enteroids (Figure 5.3). The increase 
relative to Gapdh was at least as great, particularly for Gp2, as was seen under the same 
conditions in distal enteroids.  
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Figure 5.3. RANKL induces upregulation of M cell-associated genes in wild type proximal 
enteroids. Quantification of mRNA levels of M cell-associated genes in enteroids derived from 
C57BL/6 murine proximal small intestine on day 6 post-treatment with 200 ng/mL RANKL. 
Enteroids were first treated with RANKL at the time of seeding. Data measured by qPCR were 
normalised to the housekeeping gene Gapdh and are represented as 2-ΔCT. Gp2 transcript was 
undetected in all untreated samples. N = 3 independent enteroid cultures derived from 
different mice. Error bars represent SEM. 
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5.5.1. Effect of RANKL on expression of M cell marker SpiB 
Expression of SpiB was investigated at the protein level by immunohistochemical staining. 
The specificity of the anti-SpiB antibody was validated in small intestinal tissue from a 
C57BL/6 mouse containing a Peyer’s patch and follicle-associated epithelium (Figure 5.4 A). 
No SpiB-positive cells were visible in control sections (where the staining protocol was 
performed in the absence of the primary anti-SpiB antibody). Cells with nuclear staining were 
observed in the dome-like follicle-associated epithelium overlying Peyer’s patches, where M 
cells are known to be located. In contrast, no positively stained nuclei were observed within 
the epithelium of neighbouring villi.  
SpiB-positive cells were extremely rare in untreated enteroids harvested on day 6 post-
seeding (Figure 5.4 B). In enteroids treated with 200 ng/mL RANKL on the day of seeding, 
cells with positive nuclear staining were observed. SpiB-positive cells were dispersed 
throughout the epithelium in both crypt and villus regions of the enteroids, rather than 
exhibiting any pattern of polarisation or clustering. Quantification of SpiB-positive cells 
revealed that RANKL treatment resulted in a significant increase in the percentage of SpiB-
positive cells per enteroid section from 0.1% ± 0.03% (mean ± SEM) in untreated controls to 
14.0% ± 4.6% with RANKL (Figure 5.4 C). Efforts to quantify GP2 expression using an anti-GP2 
antibody (clone 2F11-C3; MBL International, Massachusetts, USA) did not result in clear, 
specific staining. Furthermore, efforts to quantify expression and localisation of Spib and Gp2 
expression using the RNAscope in situ hybridisation assay (Advanced Cell Diagnostics, 
California, USA) also did not generate a sufficiently strong signal to allow quantification. 
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Figure 5.4. Effect of RANKL on expression of M cell marker SpiB in enteroids. (A) Validation of 
the specificity of the anti-SpiB antibody used. Sections of C57BL/6 mouse small intestine 
containing Peyer’s patches or neighbouring villus tissue were stained with and without anti-
SpiB antibody. Scale bars = 100 μm. (B) Representative images of immunohistochemical 
staining for SpiB in sections of enteroids that were untreated or treated for 6 d with 200 ng/mL 
RANKL. Scale bars = 50 μm. (C) Quantification of SpiB-positive cells as a proportion of the total 
cells per enteroid section. Unpaired t-test, *p < 0.05, N = 3 independent enteroid cultures 
derived from 3 different mice, n = 20-27 enteroid sections per treatment. 
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5.5.2. Ultrastructural effects of RANKL on enteroids 
Peyer’s patch M cells in vivo have characteristic features visible only by electron microscopy, 
such as altered apical microvilli and a basolateral pocket in which lymphocytes are frequently 
observed (Owen and Jones, 1974). While the enteroid model used here did not contain 
immune cells because it is established from epithelial stem cells, both proximal and distal 
C57BL/6 enteroids incubated for 3 days with or without 200 ng/mL RANKL were analysed by 
TEM for evidence of changes towards an M cell phenotype. In crypt and villous domains, the 
epithelium of proximal (Figure 5.5 A) and distal (Figure 5.5 B) enteroids treated with RANKL 
showed a similar overall structure as observed in control enteroids (see Figure 3.3 for further 
images). Treatment with RANKL clearly did not induce M cell differentiation in all cells within 
the enteroid epithelium as other differentiated cell types, including Paneth and 
enteroendocrine cells, were apparent (Figure 5.6).   
In some areas of RANKL-treated enteroids, epithelial cells exhibited densely packed, regular 
microvilli typical of those found on mature villous enterocytes in vivo (Figure 5.7 A). Given 
that the appearance of microvilli in control enteroids appeared to vary between crypt and 
villous regions, identification of cells with altered apical microvilli proved somewhat 
challenging. Several examples, however, were observed of enterocytes with microvilli that 
were shorter, more irregular, or even absent, than the surrounding cells, which featured 
well-developed microvilli as described above (Figure 5.7 B).  
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Figure 5.5. Treatment with RANKL does not cause overt structural changes in enteroids. TEM 
images of (A) proximal and (B) distal enteroids treated for 3 days with 200 ng/mL RANKL. L, 
lumen; N, nucleus; A, apoptotic body. 
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Figure 5.6. Enteroids treated with RANKL still contain other differentiated epithelial cell 
types. TEM images of (A) a Paneth cell and (B) a goblet cell in a distal enteroid treated for 3 
days with 200 ng/mL RANKL. L, lumen; N, nucleus.  
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Figure 5.7. Evidence of cells with an M cell phenotype in enteroids treated with RANKL. TEM 
images of proximal and distal enteroids treated for 3 days with 200 ng/mL RANKL showing (A) 
cells with normal microvilli on the apical surface and (B) examples of cells with microvilli that 
appear short and irregular, typical of murine M cells. Arrowheads indicate the apical surface of 
cells with M cell-like appearance. L, lumen; A, apoptotic body.  
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5.5.3. Effect of RANKL on frequency of other epithelial cell types 
5.5.3.1. Paneth cells 
Given the observation that other epithelial lineages are still present in RANKL-treated 
enteroids (Figure 5.6) and that increased differentiation of M cells must impact on the 
proportion of the other cell types, the distribution of epithelial cell types was analysed by 
immunohistochemistry following RANKL treatment. The presence of Paneth cells in both 
untreated and enteroids exposed to 200 ng/mL RANKL for 6 days was confirmed by 
immunohistochemical staining (Figure 5.7 A). The proportion of cells within each enteroid 
that were Paneth cells was significantly lower in RANKL-treated enteroids than in controls 
(Figure 5.8 B). In untreated enteroids the mean proportion of cells represented by Paneth 
cells was 7.8% ± 1.4%, whereas this was reduced to 2.4% ± 0.4% following RANKL 
treatment. 
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Figure 5.8. Effect of RANKL treatment on frequency of Paneth cells in enteroids. (A) 
Representative images of immunohistochemical staining for lysozyme (Lyz; a marker for 
Paneth cells) in sections of enteroids that were untreated or treated for 6 d with 200 
ng/mL RANKL. Scale bars represent 50 μm. (B) Quantification of Paneth cells as a 
proportion of the total cells per enteroid section. Unpaired t-test, *p < 0.05. N = 3 
independent enteroid cultures derived from 3 different mice, n = 21-29 enteroid sections. 
Y-axis scaled for comparison of Figures 5.8-11.  
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5.5.3.2. Goblet cells 
Goblet cells were present in control enteroids and in those treated with RANKL (Figure 5.9 
A). Quantification of the proportion of goblet cells per enteroid section indicated a trend 
towards fewer goblet cells in enteroids treated with RANKL compared to untreated 
controls, although this did not reach statistical significance (Figure 5.9 B). Untreated 
enteroids contained 9.3% ± 2.4% goblet cells on average, while those treated with RANKL 
contained 5.3% ± 0.96% goblet cells.  
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Figure 5.9. Effect of RANKL treatment on frequency of goblet cells in enteroids. (A) 
Representative images of immunohistochemical staining for trefoil factor 3 (TFF3; a marker for 
mucus-secreting goblet cells) in sections of enteroids that were untreated or treated for 6 d 
with 200 ng/mL RANKL. Scale bars represent 50 μm. (B) Quantification of goblet cells as a 
proportion of the total cells per enteroid section. Unpaired t-test, n.s. not significant. N = 3 
independent enteroid cultures derived from 3 different mice, n = 26-34 enteroid sections. Y-
axis scaled for comparison of Figures 5.8-11.  
  
169 
 
5.5.3.3. Enteroendocrine cells 
Enteroendocrine cells were apparent in both untreated and RANKL-treated enteroids 
(Figure 5.10 A). The mean percentage of the epithelium made up of enteroendocrine cells 
in untreated enteroids was 1.9% ± 0.4% (Figure 5.10 B). This was similar to the percentage 
of enterocytes identified as enteroendocrine cells in enteroids stimulated with RANKL (2.6% 
± 1.7%). No significant difference was found between the proportions of enteroendocrine 
cells in the two groups.   
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Figure 5.10. Effect of RANKL treatment on frequency of enteroendocrine cells in enteroids. 
(A) Representative images of immunohistochemical staining for chromogranin A (CgA; a 
marker of enteroendocrine cells) in sections of enteroids that were untreated or treated for 6 
d with 200 ng/mL RANKL. Scale bars represent 50 μm. (B) Quantification of enteroendocrine 
cells as a proportion of the total cells per enteroid section. Unpaired t-test, n.s. not significant. 
N = 3 independent enteroid cultures derived from 3 different mice, n = 20-34 enteroid 
sections. Y-axis scaled to allow comparison of Figures 5.8-11. 
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5.5.3.4. Tuft cells 
Although they occur infrequently, tuft cells were identified in both untreated controls and 
in those treated with RANKL (Figure 5.11 A). No significant difference was found between 
the proportions of enterocytes represented by tuft cells in untreated and treated enteroids 
(Figure 5.11 B). In untreated controls, the percentage made up by tuft cells was 1.1% ± 
0.02%; in enteroids exposed to RANKL, the percentage was 0.95% ± 0.21%.  
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Figure 5.11. Effect of RANKL treatment on frequency of tuft cells in enteroids. (A) 
Representative images of immunohistochemical staining for doublecortin-like kinase 1 (DCLK1; 
a marker for mature tuft cells) in sections of enteroids that were untreated or treated for 6 d 
with 200 ng/mL RANKL. Scale bars represent 50 μm. (B) Quantification of tuft cells as a 
proportion of the total cells per enteroid section. Unpaired t-test, n.s. not significant. N = 3 
independent enteroid cultures derived from 3 different mice, n = 21-26 enteroid sections. Y-
axis scaled for comparison of Figures 5.8-11. 
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5.5.4. Effect of RANKL on epithelial permeability in enteroids 
A slightly reduced TEER value – an indicator of epithelial permeability – has been reported 
following stimulation of Caco-2 cells are induced by Raji B cells to adopt an M cell-like 
phenotype (Roberts et al., 2010). To examine this in RANKL-treated M cell-rich enteroids, 
permeability of the epithelium to luminally microinjected FD4 was assessed. Both untreated 
controls and enteroids treated with 200 ng/mL RANKL, added on the day of seeding, showed 
a similar pattern of gradual loss of luminal FD4 (Figure 5.12 A). This was contrasted by the 
marked increase in the rate of FD4 loss caused by treatment with 2 mM EGTA at 3 hours 
post-injection. No change was observed in the area of either untreated or RANKL-treated 
enteroids (Figure 5.12 B). This confirms that any change in mean luminal pixel intensity was 
due to loss of luminal FD4 rather than due to a change in enteroid area. 
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Figure 5.12. Effect of RANKL on epithelial permeability in enteroids. (A) Epithelial 
permeability of C57BL/6 enteroids treated with 200 ng/mL RANKL for 3 d from the day of 
seeding was compared to that of untreated enteroids by assessing decline in mean 
fluorescence intensity within the enteroids. Following microinjection of FD4 into the enteroid 
lumen, enteroids were monitored over 7 h. Mean luminal pixel intensity at each time point is 
shown relative to the intensity 1 h post-injection, which was set to 100%. Some untreated 
enteroids were exposed to 2 mM EGTA 3 h post-injection. N = 4 independent experiments 
using enteroids derived from 3 different mice, n = 2-7 enteroids per group. Error bars 
represent SEM. (B) Analysis of change in enteroid area throughout the experiment detailed in 
(A). Data is shown as the percentage change relative to the starting area for each enteroid. 
Error bars represent SEM. 
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5.5.1. Role of alternative pathway NF-κB signalling in M cell differentiation 
Enteroid cultures were established from Nfkb2-/- mice bred on a C57BL/6 background. Nfkb2-
/- enteroids showed normal appearance and growth (Figure 5.13 A). Following 6 days of 
treatment with 200 ng/mL RANKL, Nfkb2-/- enteroids showed a slight, but non-significant, 
increase in expression of Spib mRNA (Figure 5.13 B). This was approximately 24 times smaller 
than the increase found in wild-type C57BL/6 enteroids following the same treatment ((an 
increase in expression of Spib relative to Gapdh of 0.006 in Nfkb2-/- enteroids compared to 
0.091 in wild type enteroids; Figure 5.2 A). There was also a very slight increase in expression 
of Gp2 in RANKL-treated compared to untreated Nfkb2-/- enteroids but, again, this increase 
was smaller than that seen in wild type C57BL/6 enteroids (Figure 5.13 C).  
To investigate the role of the alternative NF-κB pathway signalling protein subunit RelB in M 
cell differentiation, we established enteroids from Relb-/- mice bred on a C57BL/6 
background. Relb-/- enteroids displayed a normal gross morphology and growth (Figure 5.14 
A). Treatment of Relb-/- enteroids with 200 ng/mL RANKL for 6 days from the day of seeding 
resulted in a slight but non-significant increase in levels of Spib mRNA (Figure 5.14 B). This 
increase was notably much less than was observed in C57BL/6 enteroids treated with the 
same concentration of RANKL (an increase in expression of Spib relative to Gapdh of 0.007 in 
Relb-/- enteroids compared to 0.091 in wild type enteroids; Figure 5.2 A). Gp2 mRNA was 
undetectable in both untreated and RANKL-treated enteroids (Figure 5.14 C).  
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Figure 5.13. Role of NF-κB2 in M cell differentiation in enteroids. (A) Bright field images of 
untreated Nfkb2-/- enteroids on day 6 post-passage. Scale bars = 200 μm. (B & C) 
Quantification of (A) Spib and (B) Gp2 mRNA levels in enteroids derived from distal small 
intestine of Nfkb2-/- mouse bred on a C57BL/6 background on day 6 post-treatment with 200 
ng/mL RANKL. Enteroids were first treated with RANKL at the time of seeding. Data measured 
by qPCR were normalised to the housekeeping gene Gapdh and are represented as 2-ΔCT. Gp2 
transcript was undetected in all untreated samples. N = 3 independent enteroid cultures 
derived from different mice; enteroids from 3 wells were pooled for each condition. Error bars 
represent SEM. Y-axes scaled for comparison with Figure 5.2 B. 
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Figure 5.14. Role of RelB in M cell differentiation in enteroids. (A) Bright field images of Relb-/- 
enteroids on day 3 post-passage. Scale bars = 200 μm. (B & C) Quantification of (B) Spib and (C) 
Gp2 mRNA levels in enteroids derived from distal small intestine of Relb-/- mice bred on a 
C57BL/6 background on day 6 post-treatment with 200 ng/mL RANKL. Enteroids were first 
treated with RANKL at the time of seeding. Data measured by qPCR were normalised to the 
housekeeping gene Gapdh and are represented as 2-ΔCT. Gp2 transcript was undetected in all 
untreated samples. N = 3 independent enteroid cultures derived from different mice. Error 
bars represent SEM. Y-axes scaled for comparison with Figure 5.2 B. 
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5.5.1. Role of B cells in M cell differentiation 
Enteroids cultured for 6 days after seeding with a 50:50 ratio of normal enteroid medium and 
conditioned medium from Raji B cell cultures showed no induction of either Spib or Gp2 
expression (Figure 5.15 A & B). This was in comparison to enteroids cultured with a 50:50 
ratio of enteroid medium and control medium that had been incubated under the same 
conditions but without Raji B cells.  
To investigate the effects of B cells on M cell differentiation, C57BL/6 enteroids were co-
cultured with Raji B cells. The Raji cells were added to the medium overlying the Matrigel 
droplet containing the enteroids. Raji cells were observed to cluster around the periphery of 
the Matrigel but did not migrate into the Matrigel (Figure 5.16 A). Co-culture with the Raji B 
cells appeared to induce increased expression of Spib mRNA, although this response showed 
large variability and did not reach significance (Figure 5.16 B). This was observed after both 3 
and 6 days of co-culture. No change was found in the expression of Gp2 mRNA in enteroids 
following co-culture with Raji B cells for either 3 or 6 days (Figure 5.16 C). Gp2 mRNA was 
virtually undetectable in all groups, although was detected in positive control samples 
treated for 6 days with 200 ng/mL RANKL (Figure 5.2 B). 
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Figure 5.15. Effect of B cell-secreted factors on M cell differentiation in enteroids. 
Quantification of (A) Spib and (B) Gp2 mRNA in enteroids derived from distal small intestine of 
C57BL/6 mice. Enteroids were exposed to 50% control media or 50% Raji B cell-conditioned 
media for 6 days from the day of seeding. Data measured by qPCR were normalised to the 
housekeeper gene Gapdh and are represented as 2-ΔCT. Gp2 transcript was undetected in all 
untreated samples. N = 3 independent enteroid cultures derived from different mice. Error 
bars represent SEM. 
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Figure 5.16. Effect of B cells on M cell differentiation in enteroids. (A) Representative bright 
field image showing the enteroid-Raji B cell co-cultures, with Raji B cells (arrow head) seen in 
the media overlying enteroids (arrows) within a droplet of Matrigel (M). Image captured on 
day 6 of co-culture. Scale bar = 200 μm. (B & C) Quantification of mRNA levels of M cell-
associated genes (B) Spib and (C) Gp2 in enteroids derived from distal small intestine of 
C57BL/6 mice on day 6 post-seeding. Enteroids were cultured with 1 x 105 Raji B cells either 
from the day of seeding with no replacement of Raji cells, from the day of seeding with 
replacement of Raji cells on day 3 post-seeding, or with addition of Raji cells on day 3. Data 
measured by qPCR were normalised to the housekeeping gene Gapdh and are represented as 
2-ΔCT. Gp2 transcript was undetected in all untreated samples. N = 3 independent enteroid 
cultures derived from different mice; enteroids from 3 wells were pooled for each condition. 
Error bars represent SEM. 
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5.6. Summary of results 
1. RANKL induces M cell differentiation in wild type C57BL/6 mouse enteroids, as shown by 
upregulation of Spib and Gp2 expression and increased expression of SpiB at the protein 
level.  
 
2. The frequency of Paneth and goblet cells is reduced in enteroids treated with RANKL, 
while enteroendocrine cell and tuft cell populations remained constant.  
 
3. Alternative pathway NF-κB signalling is required for RANKL-induced M cell 
differentiation, including a requirement for both NF-κB2 and RelB.  
 
4. B cells are able to induce a limited degree of M cell differentiation, with upregulation of 
Spib but not of Gp2, a marker of mature M cells.  
 
5.7. Discussion 
Understanding the factors regulating M cell differentiation and function is key to gaining 
insight into their role in antigen sampling and induction of intestinal immune responses. This 
will aid development of improved oral vaccines and novel therapies against enteric infections. 
Progress in this area has been hampered by a lack of robust in vitro models of M cells and the 
FAE; however, recent discoveries have identified that the cytokine RANKL upregulates 
expression of Spib, a master transcription factor that drives M cell differentiation (Knoop et al., 
2009; Kanaya et al., 2012). Although the source of RANKL in vivo is specialised mesenchymal 
cells in the sub-epithelial dome of Peyer’s patches, the demonstration that exogenous RANKL 
is sufficient to induce differentiation of M cells in enteroid cultures presents an exciting new 
model of the FAE (de Lau et al., 2012).  
Here, we provide additional evidence in support of these earlier findings, showing in a 
physiologically relevant, 3D model of the small intestinal epithelium – generated from 
intestinal crypt stem cells derived from either the proximal or the more relevant distal region – 
that exogenous RANKL stimulates upregulation of transcription factor Spib and M cell marker 
Gp2. Nuclear SpiB is detected in many cells throughout the epithelium following addition of 
RANKL, demonstrating that upregulated mRNA is translated to increased levels of protein. We 
further characterised the RANKL-stimulated enteroid model, showing that treatment with 
RANKL perturbs the usual distribution of different epithelial cell types found in the enteroid 
  
182 
 
epithelium, resulting in a trend towards fewer TFF3-positive, mucus-secreting goblet cells and 
significantly fewer lysozyme-positive Paneth cells. Upregulation of Spib and Gp2 by RANKL is 
shown to require Nfkb2 and Relb, indicating that alternative pathway NF-κB signalling is 
necessary for M cell differentiation. Finally, a B cell line was also found to be capable of 
stimulating upregulation of Spib but not of Gp2, suggesting that B cells do likely promote M 
cell differentiation but are perhaps not sufficient alone to generate fully mature M cells.  
The data presented here are in agreement with the findings of two previous studies showing 
that RANKL induced upregulation of Spib and Gp2 in murine enteroids (de Lau et al., 2012; 
Rouch et al., 2016). This is further supported by our demonstration that SpiB expression at the 
protein level is also increased and evidence from TEM studies showing individual cells within 
the enteroids that displayed M cell-like characteristics, with irregular apical microvilli. Similar 
findings have been described in the Caco-2 cell line-based model of M cells, where a variable 
number of cells with irregular microvilli were identified following co-culture with Raji B cells 
(Roberts et al., 2010). In their study, Clevers and colleagues also observed increased 
expression of the receptor Rank following RANKL treatment, independently of SpiB (de Lau et 
al., 2012); however, we found no change in the level of Rank mRNA. Elevated levels of RANK 
expression in M cells or the FAE have not been described in other studies.  
In the studies presented here, a large degree of variation was found in the fold changes 
measured in Spib and Gp2 between independent experiments. Likely explanations for this are 
a) variation in enteroid seeding density between individual experiments, which could alter the 
available concentration of RANKL, and b) contamination of RNA samples due to incomplete 
removal of Matrigel. Since Matrigel is produced by murine cells, it is therefore likely to contain 
some mouse RNA.  
Immunohistochemical analysis of SpiB showed that SpiB was essentially absent in untreated 
epithelial cells, whereas SpiB expression was observed in approximately 14% ± 4.6% of cells 
following treatment for 6 days with RANKL. The fact that SpiB was not expressed in all cells, 
despite all cells presumably receiving the same amount of RANKL stimulation, suggests that a 
process of lateral inhibition may be occurring; for example, so that M cells inhibit their 
neighbours from also becoming M cells. Such a mechanism could be a way of limiting the 
number of M cells within the FAE. This is in agreement with previous reports that the 
distribution of M cells in the FAE is spatially regulated so that they are dispersed across the FAE 
rather than forming clusters (Wang et al., 2011; Hsieh and Lo, 2012). Hsieh and Lo observed 
that conditional deletion of either Notch, or its ligand Jagged1, resulted in increased clustering 
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of M cells within the FAE, suggesting that Notch signalling may be involved in patterning of M 
cell distribution via lateral inhibition (Hsieh and Lo, 2012). Notch signalling is known to 
coordinate complex spatial arrangement of cell types during development of other tissues, 
such as in the Drosophila eye disc and mammalian inner ear (Hsieh and Lo, 2012).  
In this respect, RANKL-stimulated enteroids appear to be a good model of the FAE. Here, 
14.0% ± 4.6% of cells within the enteroid epithelium were SpiB-positive following RANKL 
treatment, which is comparable to the approximately 10% of cells within the FAE that have 
previously been reported to be M cells (Mabbott et al., 2013). In variations on the Caco-2 cell 
line model, one study reported that 20-70% of cells within a monolayer co-cultured with Raji B 
cells were observed to adopt an M cell-like morphology, without clearly defined apical 
microvilli (Roberts et al., 2010); another study reported a conversion rate of between 15-30% 
based on morphological analysis (des Rieux et al., 2007).  
In addition to promoting M cell differentiation, the data presented here show that exogenous 
RANKL also reduced the proportion of Paneth cells, and likely also the number of goblet cells, 
present in the enteroid epithelium. In support of this, elevated goblet cell numbers have been 
observed in the FAE of mice with an epithelium-specific deletion of Traf6 (Kanaya et al., 2018). 
This effect could be a consequence of increased M cell differentiation, leaving fewer 
progenitor cells available to be directed into the other epithelial lineages, or due to redirection 
(specifically of Paneth and goblet cell progenitors) towards the M cell fate. Alternatively, 
RANKL may inhibit Paneth and goblet cell differentiation via an (as yet unknown) independent 
mechanism. Furthermore, goblet and M cell populations are expanded in mice following 
conditional deletion of Notch1 and reduced following deletion of Jag1 (encoding Jagged1) 
(Hsieh and Lo, 2012). These findings are in line with the data presented here and support the 
hypothesis that M cells and goblet cells share a common precursor, or at least similar lineage 
commitment requirements (Kanaya et al., 2018). Furthermore, they also support the relevance 
of RANKL-stimulated enteroids as a model of the FAE, where goblet and Paneth cells are 
reported to be less abundant in vivo (Neutra, Mantis and Kraehenbuhl, 2001).  
We provide evidence that both NF-κB2 and RelB are required for RANKL-induced upregulation 
of Spib and Gp2, suggesting that alternative pathway NF-κB signalling is essential for M cell 
differentiation (Figure 5.17). These data are in agreement with a very recent study 
demonstrating that the increased expression of M cell markers in response to RANKL is largely 
abolished in enteroids generated from an independent strain of Relb-/- mice (Kanaya et al., 
2018). Overexpression of Relb and Nfkb2 in the enteroids was also sufficient to upregulate Spib 
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but not Gp2. The same study showed that canonical NF-κB signalling is also important for M 
cell differentiation as inhibition of IκB kinase-β – a crucial component of the canonical pathway 
– impaired upregulation of M cell markers in response to RANKL (Kanaya et al., 2018). 
Overexpressing canonical pathway subunits, NF-κB1 and RelA, also induced M cell markers but 
to a lesser degree than RANKL or NF-κB2/RelB (Kanaya et al., 2018). Conversely, expression of 
Spib and functional maturation of M cells was shown to be unaffected in c-Rel-deficient mice 
(Sehgal et al., 2017).  
Findings from another very recent study indicate that a second transcription factor, Sox8, acts 
independently of SpiB to drive M cell differentiation in response to RANKL (Kimura et al. 2019). 
The authors reported that Sox8 is upregulated in a RelB-dependent manner following RANKL 
stimulation and is necessary for induction of Gp2 expression by RANKL. Direct binding of Sox8 
to the Gp2 promoter region was demonstrated; however, similarly to SpiB, Sox8 alone was 
insufficient to generate mature GP2+ M cells and the authors suggest that SpiB may contribute 
to Gp2 induction by upregulating factors that stabilise Sox8 binding to DNA.  
Aside from RANKL signalling, there is also evidence that B cells have a role in promoting M cell 
differentiation (Kernéis et al., 1997; des Rieux et al., 2005; Ebisawa et al., 2011). The data 
presented here support this conclusion as we show that enteroids co-cultured with B cells 
express elevated levels of Spib mRNA. Co-cultured enteroids did not, however, show any 
change in expression of Gp2. This indicates that B cell-derived signals are insufficient to 
generate mature M cells. A limitation of our study is that we did not investigate whether co-
cultured enteroids contained functional M cells capable of transcytosis. No change in Spib 
expression is observed when enteroids are treated with a mixture of normal culture medium 
and medium conditioned by the same B cells. This might suggest that B cell-induced 
upregulation of Spib requires cell-cell contact; however, B cells in co-cultures did not appear to 
migrate into the Matrigel to a great extent so contact was likely to have been limited. It is 
possible that crosstalk between epithelial cells and B cells is required to induce expression or 
secretion of the M cell-promoting factors. Alternatively, it is also possible that the relevant 
factors are quite unstable or were not present at sufficient concentrations in the conditioned 
medium to stimulate Spib upregulation.  
It should also be noted that the species difference between murine epithelium and human Raji 
B cells may have reduced the effect of B cells on the epithelial cells. Evidence to support this 
comes from the study of Pringault and colleagues, where they observed that B cells isolated 
from Peyer’s patches of mice were ~5 times more effective at transforming Caco-2 cells to 
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functional M-like cells than human Raji B cells, as determined by enhanced translocation of 
latex particles (Kernéis et al., 1997). As well as secreted soluble factors – likely candidates 
including TGF-β and RANTES (Gullberg, 2005) – their study also indicated that cell-cell contact 
between B cells and epithelial cells is required in this system to support transformation to M-
like cells (Kernéis et al., 1997). Cell surface expression of β1-integrins may play a key role here 
in enhancing M cell functionality (Gullberg et al., 2006). In the study presented here, significant 
Raji B cell contact with epithelial cells was restricted by the Matrigel barrier.    
Overall, the evidence presented here provide important characterisation of RANKL-stimulated 
enteroids as a novel in vitro model of the FAE and are in agreement with others’ recent 
findings on the role of NF-κB alternative pathway signalling in M cell differentiation. Enteroids 
are a uniquely useful for unpicking the role of epithelium-intrinsic factors in M cell 
differentiation, given the opportunity they allow to isolate the epithelium from immune and 
stromal components. Given the close resemblance of these enteroids to the FAE in vivo – 
further characterised in the present study – this model will be a powerful tool for investigating 
the mechanisms of antigen sampling in this specialised region. One report published during the 
course of our own studies has begun to address this field, using 2D adult intestinal stem cell-
derived cultures stimulated with RANKL to investigate uptake of S. Typhimurium (Rouch et al., 
2016).  
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Figure 5.17. Current understanding of the molecular pathways regulating M cell 
differentiation. (A) M cell differentiation is driven by RANKL acting via its receptor, RANK, 
which is expressed throughout the epithelium. The endogenous source of RANKL is 
mesenchymal M cell inducer (MCi) cells in the sub-epithelial dome of Peyer’s patches. Some 
evidence also suggests that B cells may promote M cell differentiation by a currently unknown 
mechanism. (B) Downstream of RANK, TRAF6 drives both classical (RelA) and alternative (NF-
κB2/RelB) NF-κB signalling. The classical pathway upregulates expression of the M cell-
associated gene Marcksl1, while RelB is required for induction of key transcription factors, SpiB 
and Sox8. SpiB drives M cell differentiation by upregulating M cell-associated genes, including 
Ccl9, Aif1 and Tnfaip2 but seems to be insufficient to drive M cell maturation via expression of 
Gp2 alone. Sox8 is necessary for Gp2 expression, likely though direct binding of the Gp2 
promoter, while SpiB may contribute by upregulating additional regulatory co-factors. Other M 
cell-related genes, eg. Anxa5, are also thought to be induced by RelB signalling, independently 
of SpiB. Figure adapted from (Kimura et al., 2019) and (Kanaya et al., 2018). 
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Chapter 6 
 
Development of a fluorescent 
long polar fimbriae adhesin 
fusion protein to investigate 
targeting and uptake in M cell-
rich enteroids  
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6.1. Introduction 
The FAE is an important interface as its antigen sampling activity allows immune cells to survey 
the contents of the gut lumen and respond accordingly. Several studies have demonstrated 
the ability of FAE cells to bind and take up a range of external particles, including beads and 
even whole bacteria (Kernéis et al., 1997; Gullberg et al., 2000; de Lau et al., 2012; Rouch et 
al., 2016). This immune surveillance is required for normal intestinal IgA responses (Rios et al., 
2016). This function of the FAE is also exploited by enteropathogens as route of invasion, 
making the FAE important as a site of infection initiation (Miller, 2007).  
Uptake of bacteria by M cells within the FAE is thought to occur via specific ligand-receptor 
interactions, although few examples have so far been described. Uptake of several bacteria, 
including S. Typhimurium and E. coli, is mediated by the interaction of M cell-expressed GP2 
with bacterial adhesion FimH, a component of bacterial type I pili (Hase, Kawano, et al., 2009). 
Closely related to the fim operon encoding type I pili is the lpf operon, which encodes long 
polar fimbriae, another type of bacterial adhesion molecule (Bäumler and Heffron, 1995).  The 
lpf operon contains 5 genes, of which lpfA encodes the major fimbrial subunit. Like the type I 
fimbrial adhesin FimH, long polar fimbriae adhesin (LpfA) has also been shown to mediate 
preferential binding of S. Typhimurium and Crohn’s disease-associated adherent, invasive E. 
coli (AIEC) to M cells of the FAE (Baumler et al., 1996; Chassaing et al., 2011).   
In Chapter 5 of this thesis, it was confirmed that M cell differentiation can be induced in 
enteroid cultures by addition of exogenous RANKL, thus generating a highly physiologically 
relevant in vitro model of the FAE. This system could be used to investigate interactions of 
bacteria and their components with epithelial cells of the FAE. Due to the 3D nature of 
enteroids, luminal and basolateral compartments are separated, making it possible to study 
translocation or transcytosis of bacteria and antigens across the epithelium; however, delivery 
of substances to the luminal compartment in the enteroid model is only possible via 
microinjection.  
In Chapter 3 of this thesis, an assay to evaluate epithelial permeability was described, where a 
fluorescent dye was successfully microinjected into the enteroid lumen. These results confirm 
that this technique is possible. Although injection of a suspension of whole bacterial into the 
enteroid lumen has been described (Forbester et al., 2015; Leslie et al., 2015), it is significantly 
more technically challenging. Injection of a suspension of fluorescently labelled microspheres 
with a diameter of 1 μm was also impractical due to clogging of the needle opening.  
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Efforts were made to increase the dimensions of micropipettes to allow for the larger particles 
to pass through the tip; however, this resulted in greater difficulty in piercing the enteroid 
epithelium and significant damage to the enteroid epithelium. With this also comes an 
increased probability the injected substance leaking out of the enteroid lumen at disrupted 
sites. These issues were also encountered when using pre-pulled microcapillaries with a larger 
opening. An additional disadvantage of using inert latex microspheres is that they do not 
feature any of the bacterial surface molecules that are potential specific M cell receptors.  
An alternative approach was therefore pursued. Given the availability of a plasmid harbouring 
the gene encoding the S. Typhimurium long polar fimbriae major subunit, LpfA (Humphries et 
al., 2003), it was decided to construct a fusion protein that might be used to track the bacterial 
adhesion molecule by time-lapse confocal microscopy following injection into M cell-rich 
(RANKL-treated) enteroids. With no issues of particle size, microinjection of this recombinant 
protein could be performed in the same manner as previously described for FITC-dextran. This 
chapter describes the generation of a construct to produce such a fusion protein of LpfA and a 
fluorescent protein. A second construct is also generated to produce mCherry alone, for use as 
a negative control in the intended experiments described above.  
 
6.2. Hypothesis 
Recombinant LpfA, the major adhesion subunit of bacterial Lpf, can be used as a surrogate to 
track targeting, adhesion and transcellular uptake of S. Typhimurium by M cells in an enteroid 
model of the FAE. 
 
6.3. Aim 
To generate a fusion protein consisting of the S. Typhimurium adhesion protein, LpfA, and 
fluorescent protein, mCherry, that may be injected into the enteroid lumen and tracked by 
fluorescence microscopy to model bacterial adhesion and uptake in the enteroid model of the 
FAE.  
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6.4. Methods 
Plasmids 
The plasmid pAH97 and empty vector pGEX-4T-2 were generously provided by Professor 
Andreas Bäumler (Department of Medical Microbiology and Immunology, University of 
California, Davis, USA). pGEX-4T-2 is a bacterial plasmid for expressing glutathione (N-
terminally tagged) S-transferase (GST) fusion proteins, containing the sequence encoding GST 
inserted immediately before the multiple cloning site (Figure 6.1). The GST tag facilitates 
purification of the expressed protein and a thrombin cleavage site at the end of the GST 
sequence allows removal of the GST tag if desired. pAH97 is a pGEX-4T-2 construct expressing 
S. Typhimurium LpfA for generation of a GST-LpfA fusion protein (Figure 6.2). Generation of 
the pAH97 plasmid had been performed by PCR amplification of the sequence encoding the 
major fimbrial subunit, LpfA, using overhanging primers to add a BamHI restriction site at the 
5’ end and an XbaI site at the 3’ end of the resulting amplicon (Humphries et al., 2003). This 
had then been blunt-end cloned into the pCR2.1 vector, before being cut out and cloned in-
frame with GST into the pGEX-4T-2 vector using BamHI and EcoRI (Figure 6.3) (Humphries et 
al., 2003).  
 
The TOPO-mCherry cloning vector that carries the mCherry cDNA  encoding a 26.7 kDa red 
fluorescent protein (587 nm/610 nm excitation/emission maxima) was a kind gift from Dr 
Massimiliano Stagi (Department of Cellular & Molecular Physiology, University of Liverpool, 
UK), originally from originally from Tyler Jacks (Addgene plasmid # 68490; Akama-Garren et al., 
2016) (Figure 6.4).  
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Figure 6.1. Map of pGEX-4T-2 plasmid. pGEX-4T-2 is a vector for expression of GST-tagged 
recombinant proteins. Figure made using SnapGene Viewer (GSL Biotech, Chicago, IL, USA) 
with sequence from Addgene (https://www.addgene.org/vector-database/2877/).  
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Figure 6.2. Map of pAH97 plasmid. pAH97 is a pGEX-4T-2 construct expressing S. Typhimurium 
LpfA, for generation of a GST-LpfA fusion protein. LpfA is the major subunit of the long polar 
fimbrial operon. The expression product of pAH97 is therefore LpfA with a GST tag at the N-
terminus.  The sequence encoding LpfA was originally amplified by PCR from S. Typhimurium 
strain SR11 (Humphries et al., 2003).  
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Figure 6.3. Schematic showing steps performed by Baumler and colleagues to construct 
pAH97 plasmid encoding GST-LpfA fusion protein. Both pGEX-4T-2 vector and PCR-amplified 
LpfA gene fragment were digested with BamHI and EcoRI to generate sticky ends, then insert 
was ligated into the vector.  
 
  
  
194 
 
 
 
 
Figure 6.4. Map of TOPO mCherry plasmid. Figure from Addgene, plasmid #68490; 
http://n2t.net/addgene:68490. TOPO mCherry construct contains a 714 bp insert encoding 
mCherry, a red fluorescent protein.  
 
 
Bacterial strains and growth conditions 
E. coli strain DH5α transformed with either pGEX-4T-2 or pAH97 were grown from frozen 
stocks stored on Protect bacterial storage beads (Thermo Fisher Scientific) at -80°C. Competent 
BL21 (DE3) E. coli (Stratagene, now Agilent, Santa Clara, CA, USA) were transformed with new 
constructs since this strain allows high-level protein expression. For routine culture, both 
strains were grown on Luria Bertani (LB) agar under aerobic conditions at 37°C or in LB broth at 
37°C with shaking overnight at 200 rpm.  
Isolation of plasmid DNA 
To isolate plasmid DNA, frozen stocks of transformed DH5α cells carrying either pGEX-4T-2 or 
pAH97 were streaked on Luria-Bertani (LB) agar plates containing 100 μg/mL ampicillin (Sigma-
Aldrich) and cultured overnight at 37°C. Three single colonies from each plate were inoculated 
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into 25 mL LB broth supplemented with 100 μg/mL ampicillin and grown overnight at 37°C 
with shaking. Cells were harvested from 3 mL of the overnight culture by 
centrifugation at 4500 x g for 16 minutes at 4°C. Plasmid DNA was isolated using a 
QIAprep spin miniprep kit (Qiagen) and eluted in nuclease-free water. The concentration of 
plasmid DNA was determined by spectrophotometry using a Nanodrop Lite.  
Amplification of mCherry sequence by PCR 
The approach used to generate mCherry fusion constructs is summarised in Figure 6.5. Primers 
were designed to amplify the mCherry sequence with overhangs containing restriction sites for 
either BamHI (G^GATCC) and EcoRI (G^AATTC) or XbaI (C^TCAGA) and EcoRI restriction 
enzymes (RE), for cloning into pGEX-4T-2 and pAH97, respectively. Primers were synthesised 
by Eurogentec (Southampton, UK). Primer sequences are shown in Table 6.1. Standard PCR 
was performed with Q5 high-fidelity DNA polymerase and Q5 High GC Enhancer (New England 
Biolabs, Hitchin, UK) using 50 or 100 ng TOPO mCherry as template. A negative control 
reaction was performed without template DNA. Details of the PCR components are shown in 
Table 6.2. PCR was performed in a Multigene Optimax thermal cycler (Labnet) with the 
conditions described in Table 6.3. PCR products were purified to remove impurities such as 
primers, nucleotides and salts using the QIAquick PCR purification kit (Qiagen) and eluted in 
nuclease-free water. PCR products were separated by gel electrophoresis at 100 V in agarose 
gels of the percentages indicated with tris-acetate-EDTA (TAE) buffer, containing 1X SYBR Safe 
DNA gel stain (Invitrogen) and were visualised using a Biorad Universal Hood II 
transilluminator. 
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Table 6.1. Sequences of primers used to amplify and add restriction sites to mCherry 
sequence. Underlined sequences show the location of restriction sites for the noted enzymes; 
^ indicates the cutting site.  
 
Primer 
 
Sequence (5’-3’) 
Forward (XbaI) TGCT^CTAGAATCGCAAGCAAGGGCGAGGAGGA 
Forward (BamHI) TGCG^GATCCATCGCAAGCAAGGGCGAGGAGGA 
Reverse (EcoRI) CCGG^AATTCAAGACTTGTACAGCTCGTCC 
 
 
Table 6.2. Components of standard PCR to amplify mCherry sequence. 
  
Component 
 
50 μL reaction Final concentration 
5X Q5 reaction buffer 10 1X 
10 mM dNTPs 1  200 μM 
10 μM forward primer 2.5 0.5 μM 
10 μM reverse primer 2.5 0.5 μM 
Template DNA 50 ng/100 ng  
 
 
Table 6.3. Thermal cycling conditions used for standard PCR to amplify mCherry sequence. 
 
Step 
 
Number of cycles Temperature (°C) Time (s) 
Initial denaturation 1 98 45 
Denaturation 30 98 15 
Annealing 60 30 
Extension 72 60 
Final extension 1 72 120 
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Restriction digests 
A restriction digest was performed using NcoI (Promega, Madison, WI, USA) to verify the 
amplified mCherry sequence. The resulting fragments were separated by gel electrophoresis as 
above and their sizes were compared to expected fragments. Restriction digestion was also 
used to generate complementary sticky ends in recipient plasmids and inserts to facilitate 
cloning. For cloning into pGEX-4T-2, vector and insert were digested with BamHI and EcoRI; for 
cloning into pAH97, digests of vector and respective insert were performed with XBaI and 
EcoRI. All digests were carried out at 37°C for 15 minutes, followed by 5 minutes at 80°C to 
inactivate the enzymes.  
DNA ligation 
Ligation of mCherry into pAH97 and pGEX-4T-2 was performed with T4 DNA ligase (Promega) 
and 10 ng linearised vector DNA. The ratio of vector to insert DNA was 1:3. The template for 
ligation reactions is shown in Table 6.4. The reaction was allowed to proceed at 15°C 
overnight. 
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Figure 6.5. Schematic showing steps performed to generate constructs to express GST-
mCherry and GST-LpfA-mCherry fusion proteins. The sequence encoding mCherry protein was 
amplified by PCR from the TOPO mCherry plasmid using primer sets with overhangs to 
introduce the indicated restriction sites. Both mCherry amplicon and vectors (either pGEX-4T-2 
or pAH97) were digested with restriction enzymes to produce sticky ends as shown. Finally, 
inserts were ligated into vectors to produce the desired constructs.  
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Table 6.4. Composition of DNA ligation reactions. 
Component 
 
Volume (μL) Final concentration 
Vector DNA  10 ng 
Insert DNA for: 
pAH97 
pGEX-4T-2 
  
4 ng 
4.4 ng 
Ligase 10X buffer 1 1X 
T4 DNA ligase 0.25  
Nuclease-free H2O to 10   
 
 
Transformation of ligated constructs into competent bacteria 
BL21 (DE3) competent E. coli (Stratagene) were used for transformation with the ligation 
product. BL21 (DE3) cells were thawed on ice in 14 mL round-bottom Falcon tubes and 25 mM 
β-mercaptoethanol was added. They were then incubated for 10 minutes on ice with 
occasional swirling to mix. One μL ligation reaction (or control pUC18 DNA) was added and the 
cells were incubated for 30 minutes on ice. Cells were heat shocked at 42°C for 45 seconds, 
followed by 2 minutes on ice. Cells were allowed to grow in antibiotic-free Super Optimal 
broth with Catabolite repression (SOC) medium at 37°C for 1 hour with shaking, then 150 μL of 
transformation mixture was plated on LB agar plates containing 100 μg/mL ampicillin and 
cultured overnight at 37°C.  
DNA sequencing 
Plasmid DNA was extracted from 5 mL overnight cultures of transformed BL21 (DE3) cells using 
the QIAprep Spin Miniprep Kit (Qiagen) and eluted in nuclease-free water. DNA sequencing 
was performed by DNA Sequencing & Services (MRC I PPU, School of Life Sciences, University 
of Dundee, Scotland, www.dnaseq.co.uk) using Applied Biosystems Big-Dye Ver 3.1 chemistry 
on an Applied Biosystems model 3730 automated capillary DNA sequencer. Standard pGEX 
forward (CCAGCAAGTATATAGCATGG) and reverse primers (CCGGGAGCTGCATGTGTCAGAGG) 
were used. Sequence analysis and creation of plasmid maps was performed using SnapGene 
software (GSL Biotech, Chicago, USA).  
Expression of proteins from transformed bacteria 
Single colonies were cultured overnight in 20 mL LB broth containing 100 μg/mL ampicillin. The 
following day, 200 μL of these starter cultures were inoculated into 5 mL of LB broth with 100 
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μg/mL ampicillin and cultured at 37°C with shaking until they reached an optical density at 600 
nm (OD600) of 0.6-0.8. OD600 was measured using a GeneQuant Pro Spectrophotometer. 1 mL 
sample of the culture was removed for use as uninduced controls. To induce protein 
expression, the remaining culture was incubated at 27°C for a further 4 hours with 0.5 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG, Sigma-Aldrich). Induced cells in 1 mL were 
collected by centrifugation at 13,000 x g.  
To verify protein expression, both induced and non-induced cells were lysed by boiling for 5 
minutes in Laemmli sample buffer (with 1% v/v β-mercaptoethanol) for SDS-polyacrylamide gel 
electrophoresis (PAGE). Samples were separated by SDS-PAGE using 4% w/v acrylamide 
stacking and 12% w/v resolving gels at 50 V for 30 minutes, followed by 1 hour at 140 V. To fix 
proteins, gels were incubated for 30 minutes in 7% v/v acetic acid in 40% v/v methanol. Gels 
were then incubated for 1.5 hours in staining solution (0.5 mg/mL Coomassie Brilliant Blue G 
dye in 25% methanol). To destain, gels were rinsed for 1 minute in 10% v/v acetic acid in 25% 
v/v methanol, then rinsed with 25% v/v methanol, and finally agitated in 25% v/v methanol 
overnight. Coomassie staining of proteins was visualised using a BioRad Chemi Doc XRS+ 
system.  
6.5. Results 
6.5.1. Amplification of mCherry sequence from TOPO mCherry  
PCR amplification of the mCherry sequence from the TOPO mCherry generated a product of 
between 700-800 bp, corresponding with the expected product of around 732 bp (Figure 6.6 
A & B). The expected band consists of the mCherry sequence with the additional sequences 
introduced at either end containing restriction sites for enzymes EcoRI and XbaI. 
Amplification of mCherry in a separate PCR with an alternative reverse primer to introduce a 
BamHI site at the 3’ end also resulted in a single product of 700-800 bp (not shown). The 
identity of the insert was confirmed by restriction digest with NcoI, which generated 
fragments of the expected sizes of 444 and 287 bp (Figure 6.7 A & B).  
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Figure 6.6. Amplification of mCherry sequence by PCR. (A) Gel electrophoresis in a 1.2% w/v 
agarose gel of products following PCR amplification of mCherry from TOPO mCherry plasmid 
with primers to introduce EcoRI and XBaI sites at either end. Expected product size was 732 
bp. (B) Plot of distance migrated against DNA fragment size for DNA ladder in (A). PCR product 
was determined to have migrated 32.6 mm. Using the equation of the fitted curve, the size of 
the PCR product was therefore determined to be approximately 731 bp.  
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Figure 6.7. Restriction digestion of mCherry PCR amplicon. (A) Schematic showing expected 
results of digestion of mCherry amplicon with NcoI. The undigested mCherry amplicon is 
expected to be 731 bp in size. Digestion with NcoI is expected to result in two fragments of 444 
and 287 bp. Gel electrophoresis in a 2% w/v agarose gel of products from digestion of mCherry 
PCR product with NcoI. Lane 1 contains the digestion products; lane 2 contains the products of 
a control reaction performed without restriction enzyme. Ladder is 1 kb DNA ladder (New 
England Biolabs).  
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6.5.3. Cloning of mCherry sequence into pGEX-4T-2 and pAH97 
To generate complementary sticky ends, plasmids and inserts were digested simultaneously 
with either BamHI and EcoRI (for pGEX-4T-2) or XBaI and EcoRI (for pAH97) and inserts were 
ligated into plasmids to generate the new constructs, pGEX-4T-2-mCherry and pAH97-
mCherry (Figure 6.8). Competent BL21 (DE3) E. coli were transformed with the ligation 
product and grown on selective agar plates. No colonies were observed on control plates 
where only vector was included in the ligation reaction, indicating a low level of vector self-
ligation. Many colonies were observed on the positive control plate where cells were 
transformed with pUC18. Colonies were also observed on the plates spread with cells 
transformed with ligation mixture that contained both vector and insert, suggesting 
successful transformation.  
  
  
204 
 
 
 
Figure 6.8. Plasmid maps showing the structure of new plasmids pGEX-4T-2-mCherry and 
pAH97-mCherry.  
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To confirm successful transformation, five colonies from each transformation were selected 
and DNA was extracted. PCR was performed using the same primers described in Table 6.1 to 
amplify the mCherry sequence where present.  A PCR product corresponding with the 
expected size of the mCherry sequence was amplified from four colonies transformed with 
pGEX-4T-2-mCherry ligations and two colonies transformed with pAH97-mCherry ligations 
(Figure 6.9). Construction of the correct fusion proteins was also confirmed by DNA 
sequencing (see Appendix for full sequences). 
 
 
 
 
 
Figure 6.9. Validation of bacterial transformation by PCR amplification of mCherry sequence. 
Gel electrophoresis of PCR for mCherry to confirm transformation of colonies. Each lane 
corresponds to a single colony of cells transformed with the ratio of vector: insert indicated 
above. Gel was 1.5% w/v agarose. Ladder is 100 bp Hyperladder IV (Bioline).  
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6.5.4. Expression and purification of GST-mCherry and GST-LpfA-mCherry 
Expression was induced by IPTG in colonies indicated to be transformed by PCR (Figure 6.8). 
Analysis by SDS-PAGE showed that a new protein of approximately 50 kDa was present 
following IPTG induction in all cells transformed with pGEX-4T-2-mCherry (Figure 6.9). This 
corresponds with the expected size for GST-mCherry of approximately 53 kDa. In cells 
transformed with pAH97-mCherry, a new band was detected between 50-70 kDa following 
induction of protein expression, which matches the expected size of 67 kDa for the GST-LpfA-
mCherry fusion protein.  
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Figure 6.10. Confirmation of protein expression by Coomassie blue staining of bacterial 
lysates separated by SDS-PAGE. (A) Lysates of bacteria transformed with pGEX-4T-2-mCherry 
construct, collected prior to IPTG induction. (B) Lysates of bacteria transformed with pAH97-
mCherry construct following 4 hours of IPTG induction. pGEX and pAH97 refer to 
untransformed bacteria carrying the original plasmids for GST and GST-LpfA, into which 
mCherry was inserted. Protein markers are Precision Plus Protein Kaleidoscope Prestained 
Protein standards (BioRad).  
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6.6. Summary of results 
1. The sequence encoding mCherry was cloned by PCR into pGEX-4T-2 and pAH97 plasmids 
to create constructs encoding a GST-tagged mCherry-LpfA fusion protein and a control 
GST-mCherry fusion protein. 
 
2. Successful cloning was demonstrated by PCR and by sequencing. 
  
3. Constructs were transformed into competent E. coli and protein expression was 
demonstrated. 
 
6.7. Discussion 
As demonstrated previously for GP2 and FimH, specific ligand-receptor interactions contribute 
to adhesion, uptake and translocation of bacteria by M cells, which in turn leads to antigen-
specific immune responses in the mucosa (Hase, Kawano, et al., 2009). Overall, however, the 
mechanisms of antigen binding, uptake and translocation that contribute to antigen sampling 
by FAE M cells remain poorly characterised, which is currently hindering progress in 
development of oral vaccine strategies and therapies against enteric pathogens. The results 
presented here demonstrate construction of a GST-tagged fusion protein consisting of the S. 
Typhimurium adhesin, LpfA, fused to mCherry. Since LpfA has been shown to mediate 
adhesion of adherent-adhesive E. coli to the FAE, this construct will act as a tool to enable 
further investigation of interactions between enteric bacteria and intestinal epithelial cells, 
including M cells. We also generate a second fusion protein of GST and mCherry alone, which 
will act as a negative control in parallel experiments. 
Further work is needed before the fusion proteins can be used in such experiments. Here, we 
demonstrate that proteins corresponding with the expected size of the designed constructs 
are expressed by transformed E. coli; however, expression conditions may require optimisation 
to improve the level of expression or to avoid protein insolubility. Protein expression may then 
be performed on a larger scale. Following cell lysis, soluble protein may be purified using 
glutathione columns, to which the GST-tagged proteins will selectively bind. The thrombin site 
located at the C-terminal end of the GST tag will allow for on-column cleavage of the GST tag 
and the remaining portions of the fusion proteins may be eluted. Finally, contaminating 
thrombin must be removed by incubating with p-aminobenzamidine. 
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Following purification, it will be possible to inject the fusion proteins into the lumens of 
enteroids that have been stimulated with RANKL to induce differentiation of M cells. Unlike 
injecting whole bacterial particles, this will not require a larger microcapillary and should not 
therefore cause excessive damage to the epithelium of the enteroids. Injected enteroids may 
be incubated for different durations, before being fixed and stained with a fluorescently 
labelled phalloidin to delineate the cell boundaries. M cells may also be identified by 
fluorescent immunostaining of specific markers, such as SpiB or GP2. Examination by confocal 
fluorescence microscopy will allow the injected fluorescent bacterial adhesion protein to be 
tracked, with the hypothesis that it will accumulate at the apical surface of M cells and may 
even be taken up by M cells, as has been observed for FimH-expressing bacteria (Hase, 
Kawano, et al., 2009). If protein is taken up, clusters might be apparent in intracellular vesicles. 
In addition to the microinjection approach, the proteins generated here could also be useful in 
assays where enteroids are cultured as 2D monolayers (Rouch et al., 2016).   
A potential limitation of this approach is that a single isolated bacterial adhesin may be 
insufficient to stimulate uptake by M cells. Uptake may require M cell receptors to bind to 
multiple ligands on the same particle. For example, it has been proposed that the role of GP2, 
a protein secreted by the pancreas, may be to effectively opsonise bacterial particles in the 
small intestine by binding to FimH on bacterial type 1 pili and polymerising with surface-
expressed GP2 on M cells of the FAE (Ohno and Hase, 2010). It is also possible that additional 
signals, for example via pattern recognition or cytokine receptors, may be required to activate 
endocytosis of particles by M cells, or to promote their functional maturity. For instance, TNF 
has been seen to enhance expression of M cell markers in the RANKL-stimulated enteroid 
model (Wood, Rios and Williams, 2016). In any case, it should still be possible to observe any 
clustering of the LpfA fusion protein at the apical surface of M cells.  
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Chapter 7 
Summary of key findings 
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1. The distribution of different epithelial lineages varies between proximal and distal small 
intestine, with both Paneth and goblet cells being more abundant in distal compared to 
proximal small intestine.  
 
2. Murine enteroids established from proximal and distal regions of the small intestine 
retain region-specific characteristics during in vitro culture, in particular, mimicking the 
cell type composition of their parent tissue.  
 
3. An assay is developed to evaluate epithelial permeability in a 3D enteroid model. 
 
4. Permeability of the epithelium to FD4 is very similar in enteroids derived from proximal 
and distal small intestine.  
 
5. A peptide fragment of α-gliadin spanning amino acids 56-68 (P56-68) rapidly induces 
activation of the CFTR chloride channel in a dose-dependent manner, causing enhanced 
apical fluid secretion by small intestinal enterocytes. 
 
6. The effect of P56-68 on fluid secretion by enterocytes is specific to the peptide sequence, 
since another peptide of identical length and similar amino acid composition (P31-43) has 
no effect. 
 
7. The cytokine, RANKL, is confirmed to induce M cell differentiation in mouse enteroid 
cultures derived from both proximal and distal small intestine.  
 
8. Alternative pathway NF-κB signalling is essential for RANKL-induced M cell differentiation, 
as enteroids deficient in NF-κB2 or RelB – key components of the alternative pathway – 
did not exhibit upregulation of M cell-associated genes in response to RANKL. 
 
9. B cells appear to promote M cell differentiation but are insufficient to induce fully mature 
M cells. 
 
10. Plasmid constructs were generated to allow production of a fluorescently labelled 
bacterial surface adhesion protein, which can be microinjected into the enteroid lumen to 
enable investigation of adhesion, uptake and translocation by M cells.  
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Chapter 8 
Final discussion 
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8.1. Concluding discussion 
The intestinal epithelium forms a dynamic barrier, allowing the essential passage of water, ions 
and nutrients while excluding microbes from the intestinal tissue. Specialised follicle-
associated epithelium samples luminal antigens, facilitating generation of protective mucosal 
immune responses, including secretion of IgA back across the epithelium into the lumen. 
Growing evidence supports an integral role for epithelial barrier function in maintaining 
normal intestinal homeostasis. Impaired epithelial barrier integrity has been implicated in a 
number of pathological states, both intestinal and systemic (Odenwald and Turner, 2016).  
Intestinal permeability is increased in patients with IBD and the beneficial effect of anti-TNF 
therapies is thought to be by inhibition of the pro-inflammatory immune response, which 
allows mucosal healing, but also by inhibiting direct detrimental effects of TNF on tight 
junction integrity (Odenwald and Turner, 2016). Patients with coeliac disease also display 
enhanced epithelial permeability and abnormal transport of gliadin-derived peptides has been 
reported (van Elburg et al., 1993; Heyman et al., 2012). Disruption of epithelial barrier function 
also occurs during various infections; for example, effectors produced by S. Typhimurium, 
Vibrio cholera and enteropathic E. coli alter expression and localisation of tight junction 
proteins (König et al., 2016).  
Defects in barrier function may also have effects far beyond the intestine. Altered intestinal 
permeability has been reported in patients with systemic autoimmune diseases, such as type 1 
diabetes and graft versus host disease (Odenwald and Turner, 2013). Abnormal exposure to 
foreign antigens has been proposed to play a role in development of these conditions (Fasano 
and Shea-Donohue, 2005). In all cases, however, it is difficult to prove whether alterations in 
intestinal barrier function are drivers of pathogenesis or whether they occur as a consequence 
of the pre-existing disorder.  
Given the complexity of assessing intestinal permeability in vivo (Camilleri et al., 2012), 
relevant in vitro models could be very valuable. Since they were first described, the use of 
enteroid models to study the intestinal epithelium has become widespread (Sato et al., 2009; 
Huch et al., 2017). The technique has since been expanded to different regions of the 
gastrointestinal tract and other organs, including stomach (Barker et al., 2010), colon (Sato, 
Stange, et al., 2011), liver (Huch et al., 2015) and brain (Lancaster et al., 2013). Adult stem cell-
derived enteroids offer several advantages over traditional 2D cell line models: enteroids 
contain primary, untransformed cells and multiple differentiated cell types; it is possible to 
derive cultures from humans, mice or other animals; cultures may be maintained long-term 
and expanded in vitro; and finally, enteroids are amenable to genetic manipulation and 
standard laboratory techniques.  
Data presented in this thesis support the unique physiological relevance of enteroids, showing 
that they maintain a cell type composition specific to the region of the small intestine from 
which they were established. This evidence supports the finding that regional identity is 
intrinsically programmed in intestinal stem cells (Middendorp et al., 2014; Kraiczy et al., 2017), 
suggesting in addition that a region-specific differentiation programme is also intrinsically 
coded.  
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Enteroids have been used in the present studies as a model to probe different aspects of 
epithelial barrier function. As a key indicator of epithelial barrier function, an assay based on 
luminal microinjection of a florescent dye was developed to evaluate permeability of the 
enteroid epithelium to macromolecules. This assay was used to demonstrate that enteroids 
derived from proximal or distal segments of the small intestine exhibit similar permeability and 
to assess changes in permeability in response to common dietary peptides generated during 
digestion of gluten. Although neither peptide had a significant effect on epithelial 
permeability, we observed unexpectedly that one peptide caused significant enteroid swelling. 
This effect was shown to be mediated by the CFTR, indicating that increased apical chloride ion 
secretion is activated, leading to osmotic movement of fluid into the enteroid lumen.  
The physiological relevance, if any, of this phenomenon remains to be investigated. Further 
work will be required to determine whether gliadin P56-68 exerts the same effects in humans 
and whether this contributes to symptoms. These preliminary findings do, however, suggest a 
new hypothesis that indigestible gliadin fragments activate CFTR expressed by small intestinal 
enterocytes, resulting in increased movement of fluid into the gut lumen, which contributes to 
bloating, abdominal pain and diarrhoea reported by patients with coeliac disease, NCWS and 
gluten-sensitive IBS. While this effect of P56-68 should occur in all individuals, genetic factors 
may alter susceptibility and a recent magnetic resonance imaging study suggested that 
patients with IBS are hypersensitive to intestinal distension produced by ingestion of 
fermentable carbohydrates (Major et al., 2017).  
Finally, we used enteroids to examine development of M cells, a rare cell type that play an 
important role in epithelial barrier function by sampling luminal antigens and therefore 
facilitating mucosal sIgA responses. The evidence we present provides further support for 
recent findings showing the importance of alternative pathway NF-κB signalling for M cell 
differentiation (Kanaya et al., 2018). Analysis of co-cultures of enteroids with Raji B cells also 
supported a role for B cells in promoting M cell development, as suggested previously (Kernéis 
et al., 1997; Gullberg et al., 2000; Ebisawa et al., 2011). Raji B cells did not, however, induce 
upregulation of mature M cell marker, Gp2, suggesting that RANKL is also required.  
Overall, enteroids present an exciting new intestinal model, particularly for investigation of 
epithelial barrier function (Nakamura, 2018). This has already begun to be exploited in recent 
studies reporting the use of enteroids to characterise epithelial factors that regulate barrier 
function. For example, demonstrating that altered mucus secretion in enteroids established 
from patients with cystic fibrosis (Liu et al., 2015) and that autophagy regulates intestinal 
barrier function and protects from experimental colitis(Pott, Kabat and Maloy, 2018).  
Furthermore, enteroids have proved useful for examining immune cell regulation of epithelial 
barrier function. For instance, it has been shown that interferon-γ regulates secretion of 
antimicrobial peptides by Paneth cells and mucus secretion (Farin et al., 2014). Enteroid-
macrophage and enteroid-intraepithelial lymphocyte co-culture models have also been 
described (Nozaki et al., 2016; Noel et al., 2017). Given that they contain only epithelial cells 
and contain distinct luminal and basolateral compartments, enteroids allow a reductionist 
approach to unpicking epithelium-intrinsic factors that regulate barrier function. As 
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demonstrated here, additional complexity may be added if desired through co-culture with 
immune or stromal cells.  
Finally, the utility of enteroids to study host-microbe interactions has also been demonstrated 
and much discussed (Bartfeld, 2016; Hill and Spence, 2016; Leslie and Young, 2016). Intestinal 
organoids derived from human pluripotent stem cells were colonised by C. difficile following 
microinjection into the lumen, resulting in impaired epithelial barrier function (Leslie et al., 
2015). In a similar model, luminal microinjection of S. Typhimurium altered cytokine 
expression by the epithelium (Forbester et al., 2015). In murine enteroids derived from adult 
stem cells, S. Typhimurium disrupted tight junctions following colonisation from the 
basolateral surface of the epithelium (Zhang et al., 2014), while growth of luminally injected S. 
Typhimurium was found to be inhibited by α-defensins, a form of antimicrobial peptides 
secreted by Paneth cells (Wilson et al., 2015).  
A limitation of the enteroid model in relation to studying epithelial barrier function is that the 
luminal surface of the epithelium, most relevant for most infections, is not easily accessible. 
Microinjection, particularly of large bacterial particles, is technically difficult and not amenable 
to large-scale experiments. Additionally, standard protocols for enteroid culture involve 
suspension of the enteroids in Matrigel, a solid gel matrix. Since it contains mouse proteins, 
DNA and RNA, it is important that Matrigel is completely removed prior to further analysis. The 
presence of Matrigel also hinders rapid isolation and fixation necessary during certain time 
course experiments. Alternative configurations of enteroid culture are a possible solution; for 
example, protocols have been developed to grow enteroids as polarised 2D monolayers, which 
still feature multiple differentiated cell types (Moon et al., 2015; VanDussen et al., 2015; Scott 
et al., 2016). With the luminal surface easily accessible, monolayer cultures have been used to 
investigate uptake of S. Typhimurium by RANKL-induced M cells (Rouch et al., 2016) and 
transcytosis of IgA (Moon et al., 2014), although in our own experience we struggled to 
generate confluent monolayers and retain the capacity for expansion. There is also great 
interest in developing alternative matrices, which could have a precisely defined composition 
and allow customisation to include different aspects of the extracellular matrix (Gjorevski et 
al., 2016; Cruz-Acuña et al., 2017).  
With our increasing understanding of the role and regulation of intestinal epithelial barrier 
function, it seems likely that the epithelial barrier will become a target for therapeutic 
interventions (Odenwald and Turner, 2016). Many currently used drugs have adverse off-
target effects on the intestinal epithelium, including commonly prescribed proton pump 
inhibitors, which increase epithelial permeability through an unknown mechanism that may 
involve effects on tight junction regulation by the actin-myosin cytoskeleton (König et al., 
2016). Currently, the only drug designed to enhance epithelial barrier integrity is larazotide, a 
synthetic peptide that blocks zonulin receptors, whose activation otherwise increases 
epithelial permeability by regulating tight junctions (Fasano, 2011). Larazotide is currently 
entering phase III clinical trials for treatment of coeliac disease. Engraftment of stem cells is 
also under investigation as a potential therapy to repair epithelial barrier function (Yui et al., 
2012, 2018; Fukuda et al., 2014). This approach has revealed interesting insights about 
regional identity and epithelial repair, but its clinical application is still a long way off.  
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8.2. Implications for future studies                      
While the data presented here provide further evidence that intestinal stem cells retain 
region-specific characteristics in in vitro enteroid cultures, further investigation is required to 
determine the extent to which region-specific cell type composition is retained over multiple 
passages. Quantification of each cell lineage in enteroids following different numbers of 
passages would be interesting, as would a more in-depth examination of enteroendocrine cell 
sub-populations. Since chromogranin A expression level shows greater variation in peptide 
hormone-storing enteroendocrine cells, specific immunostaining of their peptide hormone 
products, such as gastric inhibitory peptide and cholecystokinin may allow a higher resolution 
survey of epithelial cell populations.  
These results also demonstrate that the origin of crypts used to establish enteroid cultures is 
relevant to their function and should therefore be a consideration during design of future 
studies. As the use of enteroid models is becoming more widespread, variations on the original 
culture protocols described by the Clevers group are also arising (Sato et al., 2009). 
Development of alternative protein matrices is likely to compound the issue of inter-study 
variability in terms of culture conditions. Thorough characterisation of cultures, including of 
their cell type composition, will therefore aid comparison between different studies. 
We also present evidence that a fragment of α-gliadin, generated during digestion of dietary 
gluten (Shan, 2002), causes apical fluid secretion by the epithelium as a result of CFTR 
activation but the upstream mechanism and physiological relevance of this finding remain 
unclear. Fluorescently labelled peptides would be useful tools to answer the question of how 
gliadin P56-68 induces CFTR activation, allowing peptides to be tracked to determine whether 
they are taken up into epithelial cells. Previous studies demonstrate that this approach is 
feasible, reporting entry of labelled peptides into Caco-2 cells via endocytosis (Schumann et al., 
2008; Barone et al., 2010), a conclusion supported by studies using gliadin-specific antibodies 
to track peptide uptake (Friis et al., 1992; Zimmer et al., 2010). The studies also suggest that 
gliadin peptides P31-43 and P56-68 may be differently trafficked in the endocytic system, 
which could contribute to the difference in their effects on the CFTR. 
The major pathway of CFTR activation is cAMP-dependent phosphorylation of its regulatory 
domain by protein kinase A (Moran, 2017). This is usually the result of stimulation by 
mediators such as glucagon, vasoactive intestine peptide, or adenosine, which activate 
adenylate cyclase, although some molecules act indirectly on CFTR by modulating other 
kinases and phosphodiesterases. A number of small molecules have also been reported to 
activate CFTR through direct binding (Becq et al., 2011). To determine the mechanism of 
gliadin P56-68-induced CFTR activation, it would be interesting to perform a screen to identity 
activation of upstream kinases and to determine whether P56-68 induces concurrent 
intracellular cAMP elevation, for which immunoassays are available (Ma, Vetrivel, et al., 2002). 
Gliadin peptide fragments clearly reach the lamina propria in coeliac patients in order to 
interact with HLA DQ2/8-positive T cells antigen-presenting cells. To model the earliest stages 
of gliadin interaction with the intestinal epithelium, however, it would be desirable to deliver 
gliadin peptides to the luminal surface of the epithelium rather than the basolateral surface, as 
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in these studies. We conducted preliminary experiments where gliadin peptides or forskolin 
were microinjected into the enteroid lumen; however, it seems that this approach did not 
produce sufficiently high concentrations of the injected material within the enteroid lumen, as 
neither P56-68 nor forskolin induced any swelling. Given that luminal volume varies between 
enteroids, it would be difficult to achieve a reproducible concentration in the lumen using this 
technique.   
It will also be necessary to address the question of whether the observed action of gliadin P56-
68 is physiologically and clinically relevant in humans. To this end, fluid secretion could be 
investigated in human-derived enteroids using the swelling assay; this has previously been 
demonstrated with enteroids derived from cystic fibrosis patients (Dekkers et al., 2013). If 
tissue, or blood samples to generate iPSC-derived organoids, could be obtained from patients, 
this assay might help to determine whether the epithelium of patients with coeliac disease, 
NCWS or gluten-sensitive IBS shows greater sensitivity to the P56-68-induced fluid secretion. 
Another informative experiment would be to deliver the synthetic gliadin peptides to mice via 
oral gavage and monitor for evidence of diarrhoea. It might also be possible to measure fluid 
secretion in response to injection of gliadin peptides in a ligated ileal loop model (Caserta et 
al., 2011).  
The data presented here indicate that enteroids are a suitable model in which to assess effects 
of food components on epithelial permeability and secretion. It would be interesting to use 
this model to examine the effects of dietary fibre, fat and emulsifiers, which have already been 
shown by our group and others to alter epithelial barrier function (Cani et al., 2008; Roberts et 
al., 2010, 2013; Chassaing et al., 2015). 
Our characterisation of factors regulating M cell differentiation indicates a key role for NF-κB 
alternative pathway signalling. Although recent studies have also demonstrated the essential 
role of NF-κB signalling (Kanaya et al., 2018), the precise factors required for full differentiation 
into mature, functional M cells remain unknown. A previous study identified SpiB-independent 
regulation of certain M cell-specific genes, including Marcksl1 and Anxa5 (Kanaya et al., 2012), 
while a recent study suggested that Spib expression alone is not sufficient to produce fully 
differentiated, Gp2-expressing  M cells (Kanaya et al., 2018). The authors propose that 
additional pathways, such as the MAPK pathway, may also be involved, making these 
interesting targets for future studies.  
We also present data suggesting that B cell-derived factors drive Spib upregulation, which 
could in turn promote M cell development. B cells have previously been implicated in M cell 
differentiation (Kernéis et al., 1997; Gullberg et al., 2000; Ebisawa et al., 2011), but the 
identities of the factors involved are so far unknown. In the context of the enteroid model, it 
would be interesting to examine whether co-culture with B cells enhances M cell 
differentiation stimulated by RANKL. The model could also be improved by using primary 
isolated murine B cells, although the culture conditions would likely require optimisation. 
Intraepithelial lymphocytes co-cultured with enteroids within the Matrigel were observed to 
interact with and migrate between enterocytes (Nozaki et al., 2016). Since B cells are found in 
close proximity to M cells in Peyer’s patches, it is possible that such cell-cell contact would 
enhance the effect of B cells on M cell differentiation.  
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The regulation of M cell fate determination is also currently poorly understood. Examination of 
the distribution of M cells in RANKL-stimulated enteroids might help to elucidate the 
underlying mechanisms. Given the scattered distribution of M cells observed in previous 
studies, it is likely that M cell differentiation is regulated by lateral inhibition, possibly involving 
the influence of Jagged1 and Notch (Hsieh and Lo, 2012).  
The development of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 
technologies has opened up numerous possibilities for gene editing and application of the 
technique to enteroids has already been demonstrated (Schwank et al., 2013; Driehuis and 
Clevers, 2017).  
Although we demonstrate upregulation of Spib expression following RANKL treatment at both 
mRNA and protein levels, it will be necessary to demonstrate that these M cells are capable of 
antigen uptake and translocation. During preliminary experiments, we struggled to inject 
larger particles, such as beads, into the enteroid lumen without causing extensive damage to 
the enteroid epithelium. To address this challenge, we generated a plasmid construct to allow 
production of a fluorescently labelled version of LpfA, a bacterial adhesin subunit. This protein 
will be easily injectable and allow investigation of whether LpfA  binds specifically to M cells, as 
it has previously been shown to mediate selective binding of S. Typhimurium to the FAE 
(Baumler, Tsolis and Heffron, 1996). The LpfA fusion protein with allow modelling of bacterial 
adhesion, uptake and translocation in M cells.  
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APPENDIX 1 – Buffers and solutions 
Lysogeny broth 
10 g Tryptone 
5 g Yeast extract 
5 g NaCl 
1 L ddH2O 
 
Lysogeny broth agar 
10 g Tryptone 
5 g   Yeast extract  
5 g  NaCl 
15 g  Agar 
1 L  ddH2O 
 
Phosphate buffered saline 
8 g NaCl 
0.2 g KCl 
1.44 g  Na2HPO4 
0.24 g KH2PO4 
1 L ddH2O 
Adjusted to pH 7.4 
 
 
0.1 M phosphate buffer, pH 7.4 
40.5 mL 0.2 M Na2HPO4 
9.5 mL 0.2 M NaH2PO4 
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Lead aspartate 
0.066 g Lead nitrate 
10 mL 0.03 M aspartic acid 
Adjusted to pH 5.5 
 
1X TAE buffer 
4.84 g  Tris-base 
1.14 mL Glacial acetic acid 
2 mL  0.5 M EDTA 
1 L ddH2O 
 
5X SDS-PAGE sample buffer 
1 mL  0.5 M Tris-HCl 
0.8 mL  Glycerol 
1.6 mL  10% SDS 
0.4 mL  Beta-mercaptoethanol 
0.2 mL  0.05% (w/v) bromophenol blue 
4 mL ddH2O 
 
1X SDS-PAGE running buffer 
14.4 g Glycine 
3.03 g Tris-base 
1 g Sodium dodecyl sulphate 
1 L  ddH2O 
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APPENDIX 2 – Plasmid sequences (as determined by Sanger sequencing) 
Key: 
GST sequence 
LpfA sequence 
mCherry sequence 
Restriction sites 
 
 
GST-LpfA-mCherry – pGEX Fwd: 
TACANTGNCNNGGCTGCACCCGTTTGGTGGTGGCGACCATCCTCCAAATCGGATCTGGTTCCGCGTGG
ATCCGCTGAATCTGGTGACGGCACCATTAAATTCACCGGTGAAATCGTTGACGCGCCATGCGTCGTTTC
TACTGACTCCCAGAACCAGGAAGTTGTGCTGGGTCAGGTTAAGAAAAATATCTTCAAAGCCATTGGCG
ACAAGTCTTCTTCTAAGCCTTTCCAGATCAAACTGGAAGACTGTGACATCACCTCTAATACCAAAGTTAA
CGTAAGCTTCAATGGCGTTGGTGATACAGACGATGCGACACTGGTTTCTGTTAACACTGAAGCAGGTG
CGGCAACTGGCGTGGGCATCGGTATCTACGACAACGCTAACAAGCTTGTTGAAATGAACACCGGTAAA
TCCACCACTACGTTGGCTGCTGGTCAGACCGTGCTGTACTACACCGCTAACTACGTTGCAACAAAAGAT
ACTGTAACCACTGGTTACGGTAACGCAGAAGTGGACTTCAACCTGTCCTACGAATAATCGAATTTTCGT
TAATACAGACAATCATAATGGCAACGGAAATCCCGTTGCCATTTTTTCCAGCGGAGGCTCAGGAAGAG
AATCTCTAGAATGGCAAGCAAGGGCGAGGAGGATAACATGGCCATCATCAAGGAGTTCATGCGCTTCA
AGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCC
CCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGTGGCCCCCTGCCCTTCGCCTGGGAC
ATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACT
TGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCAAGGACGGCGGCGTGGT
GACCGTGACCCAGGACTCCTCCCTGCAGGACGGCCAGTTCATCTACAAGGTGAAGCTGCGCGGCACCA
ACTTCCCCTCCAACGGCCCCGTAATGCAAAAAAAAAACATGGGCTGGGAGGCCTCTTCCGAGGGAAGT
ACCCCAAGGACGGGCCCCTGAAGGGCAGATCAACCAAAGGCTGAAGCTGAAGANCGNNGCCCCTNCA
ACCTTGNGGTCAAGACCCCCTCAAGGGCAAAAAAGCCGGGGAGTGCCCGGGNCCAAAACNTCAACTN
NGGTGGGANNCCCNNCCCANNGGGGANANCCCATCGGGGAAAGNTAAANGGCCGNNGGGGCCCCC
CTCC 
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GST-LpfA-mCherry – pGEX Rev (reverse complement): 
GGGGCCCCNNNNTTTAAAAAAAAAAAAATTTTTTTTTTTNAAAAAANNCCCCCTTTGGGGGGCNAAAA
AATTTTTTTTTTTTTTTAAAACCCCCTTTTCCCCAAATTNNAAANNCTGGGGAAAGGGGNTGGGGNCNC
CCCCCCCCTTTTAAATCCCCAAAAGTTTAAANNNTAANNTTTTCCAAAAGGGGGGNTTNGNNTAAACN
NANGGGNGTTGGGNNCCCNTTGNTTTTTTTTTTTAAANNCTTNAAAACCAGGGGGGGGGCAAAATTT
TGGGGGGGGGCANTCGGGTTTTTTTTGGAAAAACNNTTAACCAAAGCTTTGTTGAAAATGGAACCCCC
GGTAAATTCCCCCCCCTTACCGTTGGGTTTCTTGGTTCAANACCCGGGGNNNTTTTTCCACCCGCTAAAT
TACGGTTGCAACAAAAAGATACTGTAACCCCCTGGTTTACGGTAACGCCAGAAAGTGGACTTTCAACCC
TTTCCTTACGAATAATTGAATTTTCGTTTAATACAGACAATCATAATGGCAACGGAAATCCCCGTTGCCA
TTTTTTCCAGCGGAGGGTTCAGGAAGAGAATCTCTAGAATGGCAAGCAAGGGCGAGGAGGATAACAT
GGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCG
AGATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCA
AGGGTGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACG
TGAAGCACCCCGCCGACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGC
GTGATGAACTTCGAGGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGT
TCATCTACAAGGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACC
ATGGGCTGGGAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGC
AGAGGCTGAAGCTGAAGGACGGCGGCCACTACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAA
GCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACATCAAGTTGGACATCACCTCCCACAACGAGGACTA
CACCATCGTGGAACAGTACGAACGCGCCGAGGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTAC
AAGTCTTGAATTCCCGGGTCGACTCGAGCGGCCGCATCGTGACTGACTGACGATCTGCCTCGCGNTTCG
GAGTAAGAGGAAATTTCAGNTTATNTNNAAAGA 
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GST-mCherry – pGEX Fwd: 
CCNATCGGCGTNCTANNGATTTANCGGGCNGCACCCGTTTTNGGGTGGCGACCATCCTCCAAATCGGA
TCTGGTTCCGCGTGGATCCATGGCAAGCAAGGGCGAGGAGGATAACATGGCCATCATCAAGGAGTTCA
TGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGA
GGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGTGGCCCCCTGCCCTTCG
CCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCC
CCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGC
GGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCTGCG
CGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCG
AGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACG
GCGGCCACTACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGC
CTACAACGTCAACATCAAGTTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGA
ACGCGCCGAGGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTCTTGAATTCCCGGGTCGA
CTCGAGCGGCCGCATCGTGACTGACTGACGATCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCT
CTGACACATGCAGCTCCCGGAAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAACAAAACAAGC
CCGTCAGGGCGCGTCACCGGGGGTTGGCGGGTGGTCGGGGGCGCACCCATGACCCAGTCACGTAGCG
ATAGCGGAAGNGTATAATTCTTGAAAAANAAAAGGGCCCCCGGGATACCCCCTATTTTTTAAAGGGTA
AAGGGCCAGGAAAAAAAAGGGGTTTCTTAAAANNCCCGGGGGGGCCCTTTTTCGGGGAAAATGGGG
GCGGGAAACCCCCAATTNGGTTTAATTTTTTCAAAAAAANNTNCCAAAAATTGTTTCCCCCCCCCAGGA
AAAAAAAACCCCTGNAAAAAGGGCTTNNAATAATTTTTGNAAAAGGGGAAAAAATTNGNAAATTTCN
AAAATTTCCCGGGGGGCCCCCCTTTTTCCCCTTTTTTTGGGGGGAAATTTGGGCCNTTCCNNNTTTTTTN
NCCCCCCCCCAAAAAAACCCGGGGGGGAAAAAAAAAAAAAAAGGGGGGAAAAAAANNTTTGGGGGG
GGGCCCAAAGGGGGGGGTTTAACCCCCAAAAGGGGGTTTTTCCCCNCCCCGGGGGAAAAAAACCCTTT
GGAAAATTTTTTTCCCCCCCCCNAAAAAGGTTTTTTT 
 
GST-mCherry – pGEX Rev (reverse complement): 
TACCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGC
CGACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGA
GGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTG
AAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGG
CCTCCTCCGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCT
GAAGGACGGCGGCCACTACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTG
CCCGGCGCCTACAACGTCAACATCAAGTTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAA
CAGTACGAACGCGCCGAGGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTCTTGAATTCC
CGGGTCGACTCGAGCGGCCGCATCGTGACTGACTGACGATCTGCNTCGCGCGTTCGGGGAAGGTTTCC
TNANGGTAGTCTANC 
 
